Development and validation of the force field parameters for drug-like molecules and their applications in structure-based drug design by Koziara, Katarzyna Barbara
  
 
 
Development and validation of the force field parameters for drug-like 
molecules and their applications in structure-based drug design 
 
 
Katarzyna Barbara Koziara 
 
MSci (Hons) Chemistry with an International Study Year 
 
 
 
 
 
 
 
 
 
 
 
A thesis submitted for the degree of Doctor of Philosophy at 
The University of Queensland in 2016 
 
School of Chemistry and Molecular Biosciences 
ii 
 
Abstract 
Computational approaches are widely used to help discover and develop new drugs, in particular, to 
understand how these molecules interact with their biomolecular targets. There are well-optimised 
and validated force field parameters available to describe interactions of common biomolecules, 
such as proteins, lipids and nucleotides. However, these force fields are not designed to represent 
heteromolecular ligands such as substrates, inhibitors, co-factors and potential drug molecules. 
Errors in parameters may result in incorrect predictions of ligand structure, orientation and 
conformation, which in turn can lead to the failure of computational drug design efforts. With over 
25% of all the structures in the Protein Data Bank (PDB) containing ligands and over a million 
ligand molecules of potential interest in drug design in other databases, ligand validation and 
parameterisation represents a significant scientific challenge. While several automated 
parameterisation protocols have been proposed to generate the parameters, none of the current 
procedures are properly validated. As a response to the high demand for interaction parameters for 
ligands compatible with the GROMOS force field, a web accessible Automated force field 
Topology Builder (ATB; http://atb.uq.edu.au/) and Repository was developed. The ATB and 
Repository is intended to facilitate the development of molecular force fields and generates 
parameters that can be used in X-ray refinement, structure-based drug design and study of 
biomolecule-ligand complexes. In this thesis, molecular dynamics (MD) simulations were used to 
calculate the thermodynamic properties for the validation and refinement of ATB force fields 
parameters. A fully automated validation protocol of the ATB force field parameters for small 
organic molecules based on thermodynamic and structural information was developed and 
incorporated into the ATB. A novel integration and convergence protocol which increases the 
efficiency of the TI method for free energy calculations was also proposed. The validation has 
shown good overall agreement between the experimental and computed values and indicated 
problematic functional groups with parameters to be refined. The generation of parameters for novel 
molecules that are compatible with a given biomolecular force field can be tedious, time-consuming 
and error-prone. Here, a novel method to refine parameters in classical force fields in an automated 
manner that can be extended to the parameterisation of all other atom types is also presented. 
Single-step perturbation protocols were developed for small halogenated molecules to establish 
alternative van der Waals parameters which describe the interactions of these molecules with high 
precision. Parameters were successfully refined against experimental hydration free energies, 
densities and heats of vaporisation. As a result, alternative van der Waals interactions parameters 
for chlorine and bromine were proposed. Properties calculated with these proposed parameters 
closely matched the experiment data. The quality of the ATB force field parameters in validating 
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the X-ray structures and investigating binding of ligands to the protein endothiapepsin was also 
investigated. Analysis of the MD trajectories showed that the protein structure remained relatively 
stable after 10 ns of simulations. The results for the validation of the ligands were mixed. While in 
some cases the simulations reproduced the binding mode and the interactions between the protein 
and the ligand with high accuracy suggesting the ATB parameters performed well, in other cases 
the complexes were unstable. This was despite the fact that the electron density for all ligands was 
well defined and the parameters for the ligand were generated using the same procedure. 
Endothiapepsin contains a catalytic dyad consisting of two aspartates that are generally assumed to 
share a proton. We demonstrated that the protonation of both the ligand and the residues with the 
binding site were critical to the ability to reproduce the crystal complex. To conclude, the work 
presented in this thesis provided insight into the development and validation of the force field 
parameters for drug-like molecules and their applications in structure-based drug design. 
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1.2 Thesis chapter summary 
 
This thesis focuses on validation and development of force field parameters for drug and drug-like 
molecules and their applications in structure-based drug design. It consists of six chapters.  
 
Chapter 1: Chapter one contains the general introduction to the research presented in the thesis. It 
includes background information on computational methods used in drug design as well as force 
field development and parameterisation, together with the challenges in these areas. The Automated 
Topology Builder (ATB) and Repository is also introduced. The aims of the thesis are listed and an 
overview of the methodology used to calculate hydration free energies is included. Methods such as 
thermodynamic integration and single step perturbation are presented.  
 
Chapter 2: Chapter two focuses on the testing and validation of force field parameters for a diverse 
set of ligand molecules generated by the Automated Topology Builder (ATB) version 2.0 and 
predictions of hydration free energies. This chapter describes the development of an automated 
validation protocol and presents the outcomes of a validation study based on structural and 
thermodynamic data for small organic ligands. The structural analysis for over 3000 compounds is 
described. The hydration free energies for a set of 214 drug-like molecules estimated using 
thermodynamic integration are presented and compared to experiment. The calculations were 
performed using a fully automated protocol that incorporated a dynamic analysis of the 
convergence and integration error in the selection of intermediate points. The quality of the ATB 
force field parameters is discussed and strategies to further refine the parameters provided by the 
ATB are outlined. 
 
Chapter 3: Chapter three describes challenges encountered during attempts taken to refine the 
force field parameters for halogens. Halogens were identified as the most problematic atoms in the 
validation study. A test set consisting of 34 organochlorides and 19 organobromides is presented. 
The importance of thermalisation in performing free energy calculations is demonstrated. The 
influence of other force field parameters, especially the assignment of carbon parameters while 
attempting to reparametrise halogen van der Waals interactions is examined. Corrections applied 
before the refinement attempts are listed. 
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Chapter 4: Chapter four describes the use of a single-step perturbation approach for the rapid 
development of atomistic force fields and its application to the refinement of halogen van der Waals 
parameters. The test set of 34 organochlorides and 19 organobromides identified in chapter three 
was used for parametrisation. The chapter presents the development of this efficient methodology to 
refine force fields against various experimental properties such as hydration free energies, densities 
and heats of vaporisation. In all cases the topology generation and the calculation of hydration free 
energies were fully automated with no manual intervention. Refined force field parameters for 
aliphatic and aromatic organochlorides and organobromides are proposed and possible further 
improvements associated with the refinement of the parameters for other atoms provided by the 
Automated Topology Builder are discussed. 
 
Chapter 5: Chapter five focuses on the validation of protein-ligand X-ray crystal structures via 
molecular dynamics simulations. An enzyme, endothiapepsin which is an aspartic proteinase 
involved in a number of biological processes relevant to amyloid diseases, malaria, common fungal 
infections, tumorigenesis and peptic ulcers, is investigated. This chapter describes attempts to verify 
the X-ray structures of endothiapepsin bound to 11 fragments as reported by Köster et al [1]. It 
presents approaches used to determine the quality of X-ray structures and the quality of force field 
parameters used to describe them. Similarities and differences between the X-ray and simulated 
structures are presented and challenges in representing and interpreting the experimental data in the 
molecular dynamics simulations are discussed. 
 
Chapter 6: Chapter six includes a general summary of the work performed in this thesis focusing 
on the validation and refinement of force field parameters for ligand molecules and the 
methodology proposed to perform the calculations. A summary of my work on the validation of 
protein-ligand X-ray crystal structures is also included. Final conclusions and an outlook on future 
research are presented. 
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1.3 General introduction 
 
1.3.1 Computer-aided drug design 
 
Structure based drug design is a process of finding new pharmaceutical agents based on the 
knowledge of biomolecular targets such as proteins or nucleic acids [2-4]. The drug is usually a 
small organic molecule that activates or inhibits the function of a biomolecule to result in a 
therapeutic benefit. The drug molecule must be designed to match a biological target so that they 
can interact and bind. Computer-aided drug design [5-7] (CADD) uses computational modelling to 
discover and refine molecules that interact with specific biomolecular targets. A scheme showing 
the role of CADD in drug design is shown in Figure 1-1. CADD aims to predict whether binding 
occurs between a given drug and a target and if so how strong is the interaction [2]. CADD provides 
a way to identify novel ligands and has reduced the time required for the discovery and optimisation 
of drugs with new therapeutic benefits. Computational approaches are also used in virtual 
screening, optimisation of selectivity and affinity and other pharmaceutical properties while 
maintaining affinity [5-7]. A variety of methods can be used to predict the conformational 
preferences of potential drug molecules and any conformational changes that may occur in the 
target biomolecule due to binding of a drug-like molecule. Ab initio quantum chemistry methods, 
density functional theory or semi-empirical methods can be used to provide optimised geometries 
for small isolated molecules. Due to their complexity, these methods are however too expensive for 
use in the optimisation of larger biomolecules such as proteins. Therefore, molecular mechanics and 
molecular dynamics simulations are the most popular approaches to predict the conformational 
changes and preferences for biomolecules-ligand complexes [2]. These methods however depend on 
empirically derived models to describe the interatomic interactions.  
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1.3.2 Challenges in computer-aided drug design 
 
The success of computer aided structure based drug design is highly dependent on the precise 
representation of the interatomic interactions used when solving the structures of protein-ligand 
complexes. Well-optimised and validated force field parameters exist for common biomolecules 
such as amino acids, nucleic acids, lipids and certain sugars, but not for heteromolecular ligands 
such as substrates, inhibitors, co-factors and potential drug molecules that bind to proteins. The 
Protein Data Bank [8] (PDB) currently contains more than 100000 structures, of which around 25% 
contain at least one ligand. The failure to describe such ligands appropriately can result in errors in 
predicting their structure, orientation and conformation, which in turn can lead to the failure of 
computational drug design efforts [2,6]. To improve the manner in which such ligands are 
modelled, accurate and well-validated parameters that can be used to describe the interaction 
between a given ligand molecule and the biomolecular receptor to which it binds are required. As 
there are over a million ligand molecules of potential interest in drug design, ligand 
parameterisation represents a significant scientific challenge. While several automated 
Target Identification 
 (genetics, bioinformatics, molecular biology) 
Structure determination 
 (X-ray crystallography, NMR spectroscopy) 
Biological Assays 
 (computer-based and high-throughput screening) 
Synthetic Chemistry 
 (peptidomimetics, combinatorial chemistry) 
Computer-Aided Design 
 (molecular modelling, computer graphics) 
Clinical Trials 
 
Figure 1- 1. The role of computer-aided drug design in drug discovery. 
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parameterisation protocols have been proposed, none of the current procedures are properly 
validated.  
 
1.3.3 Force fields 
 
A force field refers to a set of parameters and equations for use in molecular mechanics to describe 
the potential energy of a system of particles. Force field functions and parameter sets are derived by 
either fitting to experimental data or high-level quantum mechanical calculations. An all-atom force 
field includes explicit representation of all atoms, including nonpolar hydrogens. Alternatively 
some force fields include united atoms in which non-polar hydrogen atoms for example are treated 
together with the carbon atom to which they are attached. Well-defined and parameterised force 
fields for small organic molecules as well as biomolecules have been developed over the years. 
 
The MM family of force fields (MM2 [9], MM3 [10], MM4 [11,12]) and the Merck Molecular 
Force Field [13-15]  (MMFF) are parameterised against structural data obtained from vacuum 
simulations of small molecules. Both, the MM family of force fields and MMFF have complex 
potential energy functions expressed in terms of atomic properties. These are expensive to compute 
and are not compatible with the majority of force fields used to describe larger biomolecules such as 
proteins. 
 
Popular force fields for biomolecules include AMBER [16,17] (Assisted Model Building with 
Energy Refinement), CHARMM [18,19] (Chemistry at HARvard Molecular Mechanics), OPLS 
[20,21] (Optimized Potentials for Liquid Simulations) and GROMOS [22-27] (GROningen 
MOlecular Simulation).  AMBER was originally derived based on quantum-mechanical 
calculations for a number of organic molecules and it has been used for proteins and nucleic acids. 
The recently developed GAFF [16] (General AMBER force field) provides parameters for a wide 
range of small organic molecules and is intended for simulations of drugs and small molecule 
ligands in conjunction with existing AMBER force field for proteins and nucleic acids. The OPLS 
all-atom force field has been optimised to fit experimental properties of liquids, such as density and 
heat of vaporisation. Recently, bond stretching and angle bending parameters in OPLS have been 
adopted from the AMBER all-atom force field. The CHARMM family of force fields for proteins 
include: the united-atom CHARMM19 and the all-atom CHARMM22 force fields where the atomic 
partial charges were derived from quantum chemical calculations of the interactions between model 
compounds and water. In 2010, a general force field for drug-like molecules [28-30] (CGenFF) was 
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introduced covering a wide range of chemical groups present in biomolecules and drug-like 
molecules compatible with CHARMM. 
 
In contrast to the parameterisation of other biomolecular force fields, the parameterisation of 
GROMOS force field  is based primarily on reproducing the free energy of hydration and apolar 
solvation for a range of compounds such as proteins, nucleic acids, sugars and lipids. In principle 
this makes the GROMOS force field highly suited for the calculation of the thermodynamic 
properties of biomolecules such as ligand binding constants. A major limitation of the GROMOS 
force field is however the limited range of molecules for which parameters are available. 
 
1.3.4 GROMOS force field 
 
The main aim of the project is to develop and validate parameters for ligand molecules compatible 
with the GROMOS force field [24,25,27].  The GROMOS force field forms part of the GROMOS 
[31-33] (GROningen MOlecular Simulation) package a general-purpose molecular dynamics 
computer simulation program for the study of biomolecular systems.  
 
The physical interaction energies, Vphys (1), used in the GROMOS 53A6 [24,25] and 54A7 [27] 
force fields, can be divided into bonded, Vbon (2) and non-bonded interactions, Vnbon (3). The bonded 
interactions are the sum of bond, Vbond, bond angle, Vangle, harmonic (improper) dihedral angle, Vhar, 
and trigonometric (torsional) dihedral angle terms, Vtrig: 
 "#$%& = 	")*+ + "+)*+  (1) ")*+ = 	")*+- + ".+/01 + "$.2 + "324/ (2) "+)*+ = 	"56 + "789  (3) 
 
The non-bonded interactions are the sum of van der Waals (Lennard-Jones), VLJ and electrostatic 
(Coulomb with Reaction Field), VCRF interactions between all pairs of atoms which are much more 
difficult to obtain than data for bonded interactions. The parameterisation of non-bonded 
interactions is based on thermodynamic properties such as liquid density, heats of vaporisation and 
solvation free energies of small molecules. 
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1.3.5 Challenges in force field parameterisation 
 
The automatisation of empirical force field parameterisation is challenging as: (a) a complex 
potential energy surface must be described using a limited number of terms (b) there is a correlation 
between parameters describing different interactions (c) some terms such as partial atomic charges, 
do not directly represent physically observable properties (d) it is an under-determined problem 
with the number of parameters required to describe molecules being large compared to the limited 
availability of experimental data used for model validation [34]. 
 
1.3.6 Generation of new force field parameters for small molecules 
 
The generation of parameters for novel molecules that are compatible with a given force field can 
be tedious, time-consuming and error-prone. It normally involves searching for similar chemical 
groups and assigning parameters based on analogy. To overcome these difficulties, many of the 
popular force fields have developed special tools to facilitate the generation of new parameters for 
small molecules. 
 
There are multiple tools that can be used to create molecular descriptions useful in X-ray 
crystallography. Programs such as eLBOW [35] (electronic Ligand Builder and Optimisation 
Workbench) distributed with the PHENIX  package, automate the generation of geometric restraint 
information for refinement of novel ligands based on semi-empirical quantum mechanical AM1 
[36] calculations. LIBCHECK [37] (used by REFMAC [38] and Coot [39]) which is a part of the 
CCP4 [40] library also provides chemical and geometric descriptions of residues and ligands used 
in X-Ray refinement. The PRODRG2 [41,42] server provides descriptions of small molecules in 
various formats for use with GROMACS [43,44], CNS [45], REFMAC5 [38] and other programs. 
XPLO2D is a command-line tool that can be used to generate CNS/X-PLOR [45] topologies and 
parameters from coordinates for ligands. Pre-calculated topologies using XPLO2D are available via 
the HIC-UP [46] server. The program Hess2FF [47], constructs parameters and topology files to be 
used in crystallographic refinement of arbitrary molecules, based on a Hessian (force-constant) 
matrix. In each of these cases, the topologies generated are not suited for molecular simulations due 
to information on non-bonded interactions, bond order or particular atom type such as hydrogen 
atoms being missing. 
 
Programs and Web-servers have been developed specifically for providing parameters for 
molecular dynamics simulations. Antechamber [48] is a set of auxiliary programs for molecular 
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mechanic (MM) studies compatible with GAFF [16]. The YASARA AutoSMILES [49] server also 
generates GAFF compatible topologies using AM1 [36] calculations to optimise the geometry of 
ligands. SwissParam [50] provides topologies and parameters for small organic molecules 
compatible with the CHARMM all atoms force field [18,19], for use with CHARMM and 
GROMACS [43,44]. The data is derived from the Merck Molecular Force Field [13-15] (MMFF). 
The current implementation of ParamChem [28-30] uses the CHARMM General Force Field 
(CGenFF) program and assigns atom types, bonded parameters and atomic charges by analogy.  
 
Many of the tools discussed above have serious limitations due to the fact that the empirical force 
fields on which they are based attempt to describe the potential energy surface using a limited 
number of terms. To generate the force field description automatically, one must select an 
appropriate local environment and partial charges to assign a correct atom type. This is often 
challenging as the parameters associated with different interactions are usually correlated. While 
partial atomic charges are often obtained by fitting to the electrostatic potential of a molecule 
obtained from quantum mechanics (QM) calculations, the partial charge on the atom is not an 
observable. Thus different methods lead to different charge assignments. The assignment of bonded 
parameters is also challenging. For example, bond angles found in an optimised geometry may 
differ from the ideal value due to effect of local environment coming from other terms of the force 
field [51]. Many of the automated tools described above are also not able to predict the correct 
geometry, stereochemistry, protonation and tautomeric states of the given molecule. This is due to 
the fact that the input format they require does not include all the essential information. 
Connectivity information, charge information and all the atoms must be present for a correct 
assignment. Some of the servers only create all atom or united atoms topology files. Also these 
automated tools do not provide an indication of uncertainty or alternative parameters when the 
definite assignment is not possible [51]. 
 
1.3.7 Automated Topology Builder 
 
As a response to the high demand for interaction parameters for ligands compatible with the 
GROMOS force field [24,25], a web accessible Automated force field Topology Builder (ATB; 
http://atb.uq.edu.au/) and Repository [51] was developed. The ATB and Repository is intended to 
facilitate the development of molecular force fields for molecular dynamics or Monte Carlo 
simulations of biomolecular systems.  
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The ATB is a unique server which can provide topologies and parameters for a wide range of 
molecules for use in molecular simulations, computational drug design and X-ray refinement. 
Unlike in other servers, the user is required to supply sufficient information to determine the 
geometry, stereochemistry, protonation and tautomeric state uniquely. The user is required to 
provide: a) a coordinate file in Protein Data Bank [8] (PDB) format (including all hydrogen atoms), 
b) a connectivity record in PDB format listing all interatomic bonds and c) the net charge on the 
molecule. Molecules can also be drawn and modified with JSME [52] and JSmol [53]. 
 
 The ATB uses quantum mechanical calculations combined with a knowledge-based approach to 
generate compatible parameters with a specific version of the GROMOS force field in both all and 
united-atom force field descriptions in a variety of formats. The molecules are initially optimised at 
the HF/STO-3G (or AM1 [36] or PM3 [54,55]) level then re-optimised at the B3LYP/6-31G* [56-
58] level of theory in implicit solvent (water). The initial charges are estimated by fitting the 
electrostatic potential using Kollmann-Singh [59] scheme. The Hessian matrix is also calculated 
[60]. The output includes building block files (all atom and united atom), interaction parameter files 
for the corresponding force field and optimised geometries (all atom and united atom). The building 
block and interaction parameter files are provided in a range of formats that can be used to generate 
the appropriate topology files. The flow-chart outlining the topology generation using the ATB is 
shown in Figure 1-2 [51]. 
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Figure 1- 2. Flow-chart of primarily steps in the generation of a topology for a molecule using the Automated 
Topology Builder. 
 
 
The symmetry is analysed to ensure assignment of identical parameters to equivalent atoms. Charge 
groups are assigned automatically using a graph-based approach [61].  The ATB provides 
alternative parameters in cases where a definitive assignment is not possible. The ATB also acts as 
a repository for molecules that have been parameterised as part of the GROMOS family of force 
fields and as a repository for pre-equilibrated systems for use as starting configurations in molecular 
dynamics simulations (solvent mixtures, lipid systems). 
 
However, the ATB has several limitations. The GROMOS force field does not contain parameters 
for all atom types – some of the atoms types such as halogens are known to be non-optimal. 
Specific atom types and parameters in GROMOS force field have been designed for simulations of 
biomolecules not small ligand species. The size of the molecules is also limited due to the fact that 
high-level QM calculations, required to determine the Hessian, are only performed if the molecule 
contains <50 atoms. Currently, force constants for dihedral angles are not estimated using the 
Hessian, but based on analogy. Charge scaling is also not applied and atom types are assigned on 
the basis of the local environment as determined by connectivity, rather than independently. The 
output formats of the topologies are also limited to GROMOS, GROMACS, and CNS formats. 
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1.4 Aims 
 
The main aim of the project is to validate and develop force field parameters for drug and drug-like 
molecules and their applications in structure-based drug design. Specifically, it aims to develop a 
fully automated protocol to validate the force field parameters against experimental data, refine 
force field descriptions for problematic ligand molecules in an automated manner and investigate 
the quality of ATB force field parameters in validating protein-ligand X-ray crystal structures via 
molecular dynamics simulations. 
 
1.5 Methodology 
 
1.5.1 Free energy of solvation 
 
The solvation free energy is the work required to transfer a molecule from the gas phase into 
solution, allowing a direct comparison with experiment [62]. The free energy of hydration is the 
free energy of solvation in water. Biomolecular processes such as protein folding, membrane 
formation, protein-protein interactions and ligand binding are closely related to the solvation free 
energy. Using solvation free energies for the refinement and verification of empirical force fields is 
an important application of free energy calculations. 
 
1.5.2 Free energy calculations using molecular dynamics simulations 
 
Classical molecular dynamics simulation is a technique by which the time evolution of a molecular 
system can be calculated. In classical mechanics, a system containing N particles can be defined in 
terms of a 3N dimensional position vector r and the associated conjugate momenta, p (also a 3N 
dimensional vector) of these individual particles. The Hamiltonian of the system, H, represents the 
total energy of the system, which is the sum of kinetic, K(p) and potential energy, V(r).  
 : ;, = = > = + " ; 																										(4) 
 
Kinetic energy, K(p), can be calculated using: 
 > = = 	 =BC2E4 = 1244 E4GBC										(5) 
 
Where pi =mivi and mi is the mass and vi is the velocity of the particle i. 
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The potential energy, V(r) describes the interactions between the particles in the system as well as 
external influences on the system. The functional form and parameters describing V(r) are called a 
force field. 
 
The free energy of a system can be calculated using equations from statistical mechanics which link 
the Helmholtz free energy, F, of a system to the canonical partition function, Z(N, V, T). 
 I J, ", K = 	−MNK ln Q J, ", K 																(6) 
 
Where kB is the Boltzmann constant, N is the number of particles, V the volume, T is temperature. 
Similarly, the Gibbs free energy, G, can be calculated from the isothermal-isobaric partition 
function [63] , Q(J, S, K), 
 T J, S, K = I J, ", K + S" = −MNK ln Q J, S, K 									(7) 
 
which means that in terms of a simulation,  sampling must be performed until the system has visited 
all of configurational space, that is each atom has sampled all possible positions with all possible 
momenta. Keeping in mind that position and conjugate momenta are 3N-dimensional vectors, it is 
not possible to calculate the absolute free energy of a system with many particles [64]. However, to 
understand the behaviour of a system, calculating the absolute energy is not necessary. Change in 
the free energy in a given process can be determined instead.  
 
1.5.3 Thermodynamic cycle 
 
Free energy is a state function and does not depend on the reaction pathway connecting state A and 
B. Therefore, one can use thermodynamic cycle to connect different end-states in the same 
ensemble and calculate ΔGsolv [62] (Figure 1-3).  
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ΔG1 represents the work which has to be done to remove all the non-bonded interactions within the 
molecule in vacuum. In this process, all the atoms in the molecule (state A) are transformed into 
atoms for which the Lennard-Jones and electrostatic interactions with all other atoms are set to zero 
– dummy atoms (state B). Atomic masses and all the bonded interactions within a molecule are not 
changed. ΔG2 represents the work which has to be done to move the dummy solute from vacuum to 
the solvent. As the available volume is not changed and molecules do not interact with the rest of 
the system, ΔG2 = 0. ΔG3 represents the work which has to be done to eliminate the solute-solvent 
and the solute-intramolecular interactions by the stepwise transformation of all atoms in a molecule 
(state A) into dummy atoms (state B) [62]. 
 
1.5.4 Methods to calculate free energy difference 
 
There are two standard methods used in the calculation of the free energy difference between two 
states (A and B) using the coupling parameter (λ) approach: thermodynamic integration (TI) and 
free energy perturbation (FEP). 
 
1.5.4.1 Thermodynamic integration 
 
The free energy of solvation can be calculated using the thermodynamic integration [63] (TI) 
approach. Using this approach, the difference in free energy between two states of a system A and B 
can be expressed as:  
 
 
 
ΔGsol
Molecule in solvent Molecule in vacuum 
ΔG1 ΔG3 ΔG2 
Dummy molecules in vacuum Dummy molecule in solvent 
Figure 1- 3. Thermodynamic cycle for the determination of solvation free energies. 
15 
 
																	∆TWN = 	T(XN) − 		T(XW) = YTYX Z [X	Z\Z] 	= 	 Y" ;YX Z [X	
Z\
Z] 																																							 8  
 
where V(r) is the potential energy of the system as a function of the coordinate vector r and λ is a 
parameter that couples the two states A and B. In the case of solvation free energy calculations, to 
remove the solute from the system, all non-bonded interactions involving solute atoms are scaled 
down to zero in a stepwise manner as a function of the coupling parameter, λ. In this case, the 
coupling parameter λ was used to scale the inter- and intramolecular non-bonded interactions 
involving the solute from 0 to 1, where 0 represents the full interaction and 1 no interaction. The 
angle brackets correspond to an ensemble average. Eq.8 was evaluated by determining the ensemble 
average of the derivative <∂V(r)/∂λ>λ at a number of discrete λ-points and integrating numerically. 
The free energy of solvation was calculated as the difference between the free energy calculated 
from a vacuum simulation of the solute and the free energy change when the solute is in the 
solution, according to the equation below: 
 _T&*0`.34*+ = _Ta→c	 defggE –_Ta→c iejkl  = 	
					= ∂V r
∂λ
λ
vac
dλ 
λ1
λ0
–
∂V r
∂λ
λ
water
dλ 
λ1
λ0
  = ∂V r
∂λ
λ
vac
–
∂V r
∂λ
λ
water
dλ 
λ1
λ0
            (9) 
 
 
1.5.4.2 Using thermodynamic integration  
 
Thermodynamic integration (TI) is a highly accurate method of calculating free energy differences. 
The choice of intermediate states for the free energy simulation is nevertheless crucial for the 
efficient use of the TI method. Challenges are also encountered while trying to choose the right 
starting structure for each intermediate λ-point. Sampling too many λ-points for too long will lead 
to high computational costs. However, if not enough intermediate λ-points were sampled, the TI 
method will not yield correct results. It is also inefficient to use the same number of intermediate 
states to simulate various molecules as shapes of the free energy curves differ. Other challenges 
include determining when convergence has been reached and deciding whether specific points 
should be sampled for longer. The compromise between the computational costs and time and 
accuracy must be found.  
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1.5.4.3 Free energy perturbation    
 
In the free energy perturbation [63] (FEP) approach the difference in free energy is estimated as a 
relative probability of finding a system in a given state. 
 ∆TWN = TN(XN) − TW(XW) = 	−MNK	 ln 	 km m n ; Z\ m	 n ; Z]o\p Z] 					(10) 
 
Eq. 10 gives a probability of finding a configuration of state B in the ensemble of configurations of 
state A. This approach requires sampling of the complete phase space of the reference system which 
is problematic. In finite sampling, the ensemble average only converges to the correct answer if 
configurations sampled in state A also have a high probability in state B, which means that end state 
B must not be too different from the reference state A. For this reason, the free energy between two 
states A and B is normally obtained as the integral over a series of intermediate λ values as 
expressed in eq. 11. 
 
∆TWN = TN(XN) − TW(XW) = 	−MNK	 ln 	 km m n ; Z\ m	 n ; Z]o\p Z] [X 	Z\Z] 						(11) 
 
 
1.5.4.4 Biased single step perturbation  
 
An alternative method that avoids the simulation of uninteresting intermediate states is to use a 
well-chosen biased reference state which incorporates both the physical states A and B. This is 
called the single-step perturbation (SSP) approach [65-68]. Using this approach, a single simulation 
of an initial reference state, R, is performed. From that, the difference in free energy corresponding 
to multiple different alternate states can be calculated as: 
 ∆TW8 = −MNK		 ln km(n ; )(r])m(n ; )(rs)o\p Zs 							(12) 
 
By adding a biasing potential, we transform the problem from sampling low energy regions of a 
series of intermediate states to a reference state that encompasses all alternative states of interest. 
Sampling of the biased state may be slow, however, as the same reference state simulation can be 
used to calculate a wide range of the end states, considerable gain in efficiency is achieved. 
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1.5.4.5 Single step perturbation with no biasing potential 
A variation of the SSP method [65-68] described above uses an appropriate reference state without 
a biasing potential. This method is based on an assumption that the reference state contains 
configurations appropriate to alternative final states i.e. the perturbation is small. Given that the 
initial sets of parameters in the force field are already highly optimised, no biasing functions were 
required. This method is especially efficient when refinement of force field parameters is attempted 
as the single reference state simulation can be used to calculate a wide range of the end states. 
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2.1 Chapter 2 
 
Testing and validation of the Automated Topology Builder (ATB) version 2.0: Prediction of 
hydration free energies. 
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2.2 Abstract 
 
The Automated force field Topology Builder and Repository (ATB; http://atb.uq.edu.au) was tested 
and validated against structural and thermodynamic properties of heteromolecular ligands. The 
structural analysis for over 3000 compounds indicated that the geometry of the molecules optimised 
using ATB was well maintained. The hydration free energies for a set of 214 drug-like molecules, 
including 47 molecules that form part of the SAMPL4 challenge have been estimated using 
thermodynamic integration and compared to experiment. The calculations were performed using a 
fully automated protocol that incorporated a dynamic analysis of the convergence and integration 
error in the selection of intermediate points. The system has been designed and implemented such 
that hydration free energies can be obtained without manual intervention following the submission 
of a molecule to the ATB. The overall average unsigned-error (AUE) using ATB 2.0 topologies for 
the complete set of 214 molecules was 6.7 kJ/mol and for molecules within the SAMPL4 7.5 
kJ/mol. The root mean square error (RMSE) was 9.5 and 10.0 kJ/mol respectively. However, for 
molecules containing functional groups that form part of the main GROMOS force field the AUE 
was 3.4 kJ/mol and the RMSE was 4.0 kJ/mol. This suggests it will be possible to further refine the 
parameters provided by the ATB based on hydration free energies. 
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2.3 Introduction 
 
Molecular dynamics simulations represent valuable tool to investigate a variety of biochemical 
processes including membrane transport, protein folding and conformational changes as well as 
drug binding [1]. There are well-optimised and validated force field parameters available for 
common biomolecules [2-12], however these force fields are not design to describe heteromolecular 
ligands. The generation of parameters for novel molecules that are compatible with a given 
biomolecular force field can be tedious, time-consuming and error-prone. It normally involves 
searching for similar chemical groups and assigning parameters based on analogy. With over 
100000 structures in the Protein Data Bank [13] (PDB) of which 25% contain at least one ligand 
and over a million ligand molecules of potential interest in drug design in other databases, ligand 
validation and parameterisation represents a significant scientific challenge. While several 
automated parameterisation protocols have been proposed to generate ligand parameters [14-19], 
none of the current procedures are properly validated. As a response to the high demand for 
interaction parameters for ligands compatible with the GROMOS force field [10,11], a web 
accessible Automated force field Topology Builder (ATB; http://atb.uq.edu.au/) and Repository 
[20] was developed.  
 
The GROMOS family of force fields aims to reproduce the thermodynamic properties of 
biomolecular and related systems. The estimation of solvation free energies is thus central to the on-
going refinement and validation of this family of force fields and, in turn, the ATB. Structural 
validation is also crucial in testing the ATB methodology. Here we present results for the structural 
validation of over 3000 molecules and hydration free energies in SPC water for a total of 214 
organic molecules including the 47 molecules that formed part of the current SAMPL4 challenge 
[21]. Topologies were generated automatically using the ATB version 2.0. Hydration free energies 
were calculated using thermodynamic integration in conjunction with a fully automated protocol 
designed to return final values within a given uncertainty, based on a dynamic analysis of the 
statistical and integration error. The effectiveness of this protocol is discussed together with an 
analysis of the differences between the calculated and experimental values for the 214 test 
molecules. 
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2.4 Methodology 
 
This section introduces the methodology applied in testing and validating the Automated Topology 
Builder 2.0 against structural and thermodynamic data.  
 
2.4.1 Root mean square deviation (RMSD) calculations  
 
The root mean square deviation [22] (RMSD) is a commonly used quantity in determining the 
differences between two sets of values. The positional RMSD is a measure of the average distance 
between equivalent atom pairs and it remains one of the most frequently used indicators of the 
similarity between two structures: 
 
tuvw = 	 1J	 x4yz4{c 													(1) 
  
where δ is the distance between N pairs of equivalent atoms. 
 
2.4.2 Free energy calculations 
 
Calculations of the solvation free energy, ΔGsolv, were performed. This allowed a direct comparison 
with experiment [23] and the validation of the ATB force fields. The free energy of solvation was 
calculated using the thermodynamic integration (TI) approach [24]. With this approach the 
difference in free energy between two states of a system A and B can be expressed as:  
 
																	∆TWN = Y" ;YX Z [X	
Z\
Z] 																																							 2  
 
where V(r) is the potential energy of the system as a function of the coordinate vector r and λ is a 
parameter that couples the two states A and B. In this case the coupling parameter λ was used to 
scale the inter- and intramolecular non-bonded interactions involving the solute from 0 to 1 (where 
0 represents the full interaction and 1 no interaction). To avoid sampling singularities in the 
potential energy function and in the derivative with respect to λ (as well as minimise numerical 
instabilities during the simulations) the non-bonded interactions were scaled using the λ-dependent 
soft-core interaction function of Beutler et al. with αLJ = 0.5 and αelectrostatic = 0.5 nm2 [25,26]. While 
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using the λ-dependent soft-core interaction function of Beutler et al. as implemented in GROMOS, 
there is no requirement or advantage in performing the removal of the charge and LJ interactions in 
separate stages as is sometimes required by other codes.  
 
Eq. 2 was evaluated by calculating the ensemble average of the derivative <∂V(r)/∂λ>λ at a series of 
discrete λ-values. The values of <∂V(r)/∂λ>λ were then integrated using the Trapezoidal 
approximation. The Trapezoidal approximation was used simply for consistency with existing code. 
Due to the number of intermediate λ-values calculated, the final answer was insensitive to the 
integration method used with the difference between the values obtained using Simpsons rule or the 
Trapezoidal approximation being negligible (< 0.1 kJ/mol). The solvation free energy was 
calculated as: 
 _T&*0` = _Ta→c	 defggE –_Ta→c iejkl = 	
														= ∂V r
∂λ
λ
vac
dλ 
λ1
λ0
–
∂V r
∂λ
λ
water
dλ   =
∂V r
∂λ
λ
vac
–
∂V r
∂λ
λ
water
dλ                (3)  
λ1
λ0
 
λ1
λ0
 
 
 
For the combined integral in eq. 3 to hold as written the same λ-values must be sampled in water 
and in vacuum.  
 
2.4.3 Integration protocol 
 
The first estimate of the shape of the integration curve was determined by calculating <∂V(r)/∂λ>λ 
at 9 equally spaced λ-points between λ = 0 and λ =1. Potential turning points in the curve were then 
localised using first derivative of a series of cubic splines fitted to the initial 9 points. A new point 
was added at the estimated location of the turning point for which the absolute value of the 2nd 
derivative was the highest and the <∂V(r)/∂λ>λ was calculated at this point. Following that, the 
location of the turning points was reassessed and this procedure was repeated until all turning points 
had been located to within a specified value (0.05λ).   
 
After all the turning points were identified, additional λ-points were added or simulations at existing 
λ-points were extended in the regions of the curve with the largest uncertainty until the estimate of 
the total error fell below a chosen threshold. The threshold in this study was 1 kJ/mol. This was 
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achieved by dividing the curve into a series of overlapping intervals consisting of three consecutive 
λ-values. The uncertainty in each interval was estimated from the change in the total integral 
following the exclusion of the central point, and by taking the difference in the integral calculated 
using either the upper or the lower bound of the uncertainty in the central point. The uncertainty 
was calculated using block averaging [27]. The total integration error, Ertot, was calculated from the 
sum of the errors in each region, normalised for any overlap between regions as: 
 
|l3*3 = |l4} y 									(4) 
 
where Eri  is the maximum error for a particular region and n is the normalisation factor.   
 
If the exclusion of the central λ-point in a given interval gave rise to the largest error, a new point 
was added at the midpoint of the largest sub-interval within that region. If the three points that made 
up a given region were evenly spaced then two new points, one on either side of the midpoint, were 
added. If the maximum error was due to the uncertainty within a particular point, the sampling at 
that point was extended by 200 ps. The error in the affected regions was then updated and the total 
integration error recalculated. This procedure was repeated until the total error fell below the target 
threshold. 
 
As an additional test of convergence the systems in water were simulated twice at each λ-value 
using different initial configurations. The initial configurations for λ0 (full interaction with water) 
and λ1 (no interaction) were taken from the optimised geometry at the B3LYP/6-31G* level of 
theory [28-30]. Other initial configurations for the two water simulations at each λ-point were taken 
as the final frames of the two neighbouring λ-values.  Systems in vacuum were simulated using four 
sets of initial configurations taken from the middle and final frames of each of the two water runs. 
This was done to ensure a more complete sampling of the available configurational space.  
 
2.4.4 Convergence protocol 
 
Simulations were run for 200 ps at each λ-value or until the ensemble average of the derivative 
<∂V(r)/∂λ>λ had been deemed to have converged. To determine whether the ensemble average of 
the derivative <∂V(r)/∂λ>λ had converged the distribution of the variance for successive time 
periods during the simulation was analysed. The two-sample Kolmogorov-Smirnov (KS) statistic 
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was used to quantify the degree of similarity between the distributions. <∂V(r)/∂λ>λ was considered 
to have converged if the KS statistic for adjoining regions was less than 0.05. 
 
2.4.5 Topology generation 
 
The parameters and topology files for all molecules were generated automatically by the ATB 
version 2.0 and used without modification unless otherwise noted. The parameters were generated 
based on a single initial conformation. In the case of molecules that formed part of the various 
SAMPL challenges [21,31-33] this conformation was taken directly from the structural coordinates 
provided.  The structures of other molecules were generated using a range of molecule building 
programmes. 
  
2.4.6 Simulation parameters for hydration free energy 
 
Force field descriptions for molecules were generated using the Automated Topology Builder 
(ATB) 2.0 based on the GROMOS 53A6 [10,11] parameter set. The molecular dynamics 
simulations and free energy calculations were performed using the GROMOS11 [34] package. The 
starting structures for the simulations in water were taken from the QM optimised geometries 
generated by the ATB.  To generate water systems each solute molecule was solvated in a cubic 
periodic box filled with an equilibrated configuration of SPC water [35]. The size of the box was 
chosen such that the minimum distance between the solute and the box wall was 1.4 nm. The 
system was energy minimised using a steepest descent algorithm. Initial velocities were assigned 
from a Maxwell-Boltzmann distribution corresponding to a temperature of 298.15 K. Bond lengths 
were constrained using the SHAKE algorithm [36] with a geometric tolerance of 10-4. The 
equations of motion were integrated using the time step of 2 fs. All simulations were performed at 
constant temperature (298.15 K) and pressure (1 atm) using a Berendsen thermostat and barostat 
[37]. The coupling times were 0.1 and 0.5 ps, respectively. The isothermal compressibility was 
4.575 × 10-4 kJ-1 mol-1 nm-3. Non-bonded interactions were calculated using a triple-range scheme. 
Interactions within a shorter-range cutoff of 0.8 nm were calculated every time step. Interactions 
between 0.8 and 1.4 nm were updated every 5 steps together with the update to the pairlist. A 
reaction field was applied to correct for the truncation of electrostatic interactions beyond the long-
range cut-off using a relative dielectric permittivity of 61 [38]. The vacuum systems were generated 
from a given configuration in water by simply deleting all water molecules within the simulation 
box. In this case pressure coupling was not applied and the temperature was maintained by using 
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stochastic dynamics with a reference temperature of 298.15 K and an atomic friction coefficient of 
91 ps-1. 
2.5 Results and Discussion  
 
The results of testing and validation of topologies and parameters generated by the ATB version 2.0 
against structural and thermodynamic data are presented in this section.  Molecular geometries were 
investigated by using root-mean-square deviation (RMSD) between QM optimised and vacuum 
minimised structures for over 3000 compounds submitted to the ATB. Further validation included 
comparing predicted and experimental hydration free energies for a test set of 214 molecules 
including chemically diverse small organic molecules, drug and drug-like molecules.   
 
2.5.1 Validation of the ATB against structural data  
 
The results of the validation study of the ATB parameters against structural data is presented here. 
 
2.5.1.1 Root-mean-square deviation in vacuum 
 
An initial validation of the topologies and parameters generated by the Automated Topology 
Builder (ATB) was performed by structural analysis. A total of all 3310 molecules in the database 
on the 1-3-2013 was tested. The number of atoms in the molecules varied from 4 to 659. The 
molecular weights ranged from 17 to 4453 atomic units. The molecules considered contained 
carbon, hydrogen, oxygen, silicon, sulphur, phosphorus, nitrogen and halogens (chlorine, bromide, 
fluorine) and included amino acids, heteromolecules, lipids, nucleic acids, solvents and sugars.  
 
ATB generated structural files for each of the molecules by performing Quantum Mechanical (QM) 
optimisation in implicit solvent (water) at the B3LYP/6-31G* level [28-30] (≤ 50 atoms) using 
GAMESS-US [39] or at the HF/STO-3G level of theory (>50 atoms).  These ATB QM structures 
were later energy minimised in vacuum and these minimised structures were compared to the initial 
ATB QM optimised structures.  
 
An analysis of the RMSD after performing a least squares fit on all atoms for a total of 3310 
molecules resulted in the RMDS values ranging from 0.0 to 0.09 nm as presented in Figure 2-1. 
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Figure 2- 1. Distribution of RMSD values between QM and energy minimised structures in vacuum. 
 
 
From the distribution of values in Figure 2-1, it can be seen that 50% of molecules have an RMSD 
value below 0.01 nm and almost 95% have an RMSD value below 0.03 nm. Overall, the agreement 
between the QM optimised structures and the energy minimised structures using the ATB 
parameters is very good which suggests that the geometry of the molecules is well maintained. 
 
2.5.1.2 Root-mean-square deviation after molecular dynamics simulation in water 
 
To further validate the topologies, a test set consisting of 178 heteromolecules was selected out of 
the 3310 molecules. This subset only included molecules with a number of atoms from 6 to 40 as 
molecular dynamics simulations were computationally more expensive than generation of the QM 
structures. The molecular weights ranged from 28 to 410 atomic units. The molecules considered 
contained carbon, hydrogen, oxygen, sulphur, phosphorus, nitrogen and halogens (chlorine, 
bromide, fluorine). 
 
The topologies for 178 molecules were generated on the 1-3-2013 using the ATB version 2.0. Each 
molecule in the test set was simulated for 200 ps in SPC water [35] at 300 K at 1 atm using the 
GROMOS11 molecular dynamics (MD) simulation package [34]. The RMSD of the final structure 
32 
 
from the simulation with respect to the structure optimised quantum mechanically was calculated 
for each molecule after performing a least squares fit on all atoms.  
 
Figure 2- 2. Percentage distribution of RMSD values between QM and MD structures for 178 molecules. 
 
 
 
From the distribution of values shown in Figure 2-2 it can be seen that 50% of molecules have an 
RMSD value ≤ 0.1 nm with ~95% having an RMSD value ≤ 0.2 nm. Note, these values correspond 
to a single configuration taken at the end of the simulation. The RMSD values therefore reflect 
fluctuations due to thermal motion at 300 K including the effects of dihedral transitions. The test set 
included a number of highly flexible and/or hydrophobic molecules such as long aliphatic chains. 
Moreover, these results might also reflect the fact that some of the molecules have multiple low 
energy conformations. This explains why a small proportion of molecules show large deviations 
from the QM optimised structures when simulated in water.  
 
2.5.2 Validation of the ATB against thermodynamic data  
 
The aim of this study was to test and validate topologies and parameters generated by the ATB 
version 2.0 against experimental hydration free energies. This was achieved using a test set of 214 
molecules, of these, 167 had been used to test previous versions of the ATB. The selections of the 
molecules for the validation was limited by the availability of the experimental data to validate 
against. The set of 167 reference compounds used previously contained a combination of alcohols, 
alkanes, cycloalkanes, alkenes, alkynes, alkyl benzenes, amines, amides, aldehydes, carboxylic 
acids, esters, ketones, thiols and sulphides and included molecules from the earlier SAMPL0/CUP8, 
25.3%
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SAMPL1 and SAMPL2 challenges [31-33]. A full list of the molecules considered is provided in 
Appendix 2 - Table 2A-1. The other 47 molecules formed part of the SAMPL4 challenge [21] and 
are listed in Table 2-1. United-atom and all-atom topologies were simulated for comparison. 
Topologies for all the molecules used in this study are publicly available via the ATB repository. 
Free energies were computed using molecular dynamic simulations with thermodynamic integration 
approach in conjunction with the integration and convergence protocols reported in the 
methodology section. In all cases the topology generation and the calculation of the hydration free 
energies were fully automated with no manual intervention. No attempt was made to either optimise 
the ATB parameters based on knowledge of the chemical properties of a particular molecule or to 
force the system to sample a specific conformational or tautomeric state. This said, during the 
testing of the SAMPL4 molecules a problem with the algorithm that assigned exclusions was 
detected. Three molecules 033, 034 and 037 from SAMPL4 that contained an aromatic ring with a 
hydroxyl group ortho- to a methoxy group were not stable during energy minimisation. This was 
due to the fact that the hydroxyl hydrogen and the oxygen of the methoxy group have high opposing 
partial charges and are constrained to lie in close proximity. To avoid problems due to the high 
forces associated with this interaction these atoms were excluded. 
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Table 2- 1. A comparison between the experimental and calculated free energies of hydration for drug and drug-
like molecules from SAMPL4 using parameters assigned by the Automated Topology Builder (ATB). All values 
are in kJ/mol, calculated as per section 2.4. 
SAMPL 
IDa 
FE UAb FE Exp.c Diffd Name Structure 
001 -86.0 ± 1.4 -98.9 ± 1.3 12.9 ± 1.9 mannitol 
 
002 -9.5 ± 0.6 -10 ± 4 0.5 ± 4.0 linalyl acetate 
 
003 -20.8 ± 0.6 -20.0 ± 1.0 0.8 ± 1.2 nerol 
 
004 -16.6 ± 0.5 -18.6 ± 1.0 2.0 ± 1.1 geraniol 
 
005 -12.0 ± 0.6 -22.3 ± 0.4 10.3 ± 0.7 
1,2-
dimethoxybenzene 
 
006 -43.4 ± 0.7 -22.0 ± 0.8 21.4 ± 1.1 4-propylguaiacol 
 
009 -43.9 ± 0.5 -34 ± 3 9.9 ± 3.0 
2,6-
dichlorosyringaldehyde 
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OH OH
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O
CH3
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CH3
CH3
O
Cl
O
ClHO
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O
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010 -30.8 ± 0.5 -26.1 ± 1.6 4.7 ± 1.7 3,5-dichlorosyringol 
 
011 -40.3 ± 0.6 -33 ± 3 7.3 ± 3.1 
2-
chlorosyringaldehyde 
 
012 -17.0 ± 0.6 -15.7 ± 0.9 1.3 ± 1.1 dihydrocarvone 
 
013 -13.5 ± 0.5 -18.6 ± 1.8 5.1 ± 1.9 carveol 
 
014 -19.6 ± 0.6 -17.1 ± 0.7 2.5 ± 0.9 l-perillaldehyde 
 
015 -18.8 ± 0.5 -18.9 ± 0.4 0.1 ± 0.6 piperitone 
 
016 -16.7 ± 0.7 -13.4 ± 1.1 3.3 ± 1.3 menthol 
 
H3C
O
Cl
Cl
CH3
O
HO
CH3
O
Cl
OH
H3C
O
O
CH3
CH2
O
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CH3
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H2C
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CH3H2C
O
CH3
CH3
OH3C
CH3H3C
HO
CH3
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017 -12.1 ± 0.6 -10.6 ± 1.0 1.5 ± 1.2 menthone 
 
019 -3.8 ± 0.5 -15.8 ± 0.4 12.0 ± 0.6 
9,10-
dihydroanthracene 
 
020 -3.8 ± 0.4 -11.6 ± 0.4 7.8 ± 0.6 1,1-diphenylethene 
 
021 -27.6 ± 0.5 -31.9 ± 0.5 4.3 ± 0.7 1-benzylimidazole 
 
022 -36.9 ± 0.7 -28.4 ± 0.4 8.5 ± 0.8 mefenamic acid 
 
023 -12.0 ± 0.8 -39.1 ± 2.6 27.1 ± 2.7 diphenhydramine 
 
024 -2.9 ± 0.6 -31.1 ± 2.5 28.2 ± 2.6 amitriptyline 
 
025 -18.3 ± 0.5 -24.0 ± 0.6 5.7 ± 0.8 1-butoxy-2-propanol 
 
026 -23.1 ± 0.6 -22.2 ± 0.4 0.9 ± 0.7 
2-ethoxyethyl 
acetate 
 
027 -15.9 ± 0.5 -20.1 ± 1.6 4.2 ± 1.7 
1,3-bis-
(nitrooxy)propane 
 
CH3
CH3O
H3C
CH2
N
N
OHO
N
H
CH3
CH3
CH3
N
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028 -13.7 ± 0.5 -18.0 ± 1.6 4.3 ± 1.7 
1,3-bis-
(nitrooxy)butane 
 
029 -5.0 ± 0.6 -7.0 ± 0.4 2.0 ± 0.7 hexyl nitrate 
 
030 -19.5 ± 0.5 -9.6 ± 0.5 9.9 ± 0.7 hexyl acetate 
 
032 -32.6 ± 0.4 -30.5 ± 0.4 2.1 ± 0.6 3,4-dichlorophenol 
 
033 -30.3 ± 0.6 -29.1 ± 0.4 1.2 ± 0.7 
2,6-
dimethoxyphenol 
 
034 -36.6 ± 0.6 -24.3 ± 0.4 12.3 ± 0.7 
4-methyl-2-
methoxyphenol 
 
035 -23.9 ± 0.7 -19.6 ± 0.4 4.3 ± 0.8 
2-
hydroxybenzaldehyde 
 
036 -24.1 ± 0.5 -23.7 ± 0.4 0.4 ± 0.6 2-ethylphenol 
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037 -41.6 ± 0.7 -24.9 ± 0.4 16.7 ± 0.8 2-methoxyphenol 
 
038 -19.4 ± 0.5 -16.5 ± 0.4 2.9 ± 0.6 
2-
methylbenzaldehyde 
 
039 1.4 ± 0.5 -3.6 ± 0.4 5.0 ± 0.6 
1-ethyl-2-
methylbenzene 
 
041 -5.4 ± 0.5 -21.1 ± 0.4 15.7 ± 0.6 piperidine 
 
042 -4.1 ± 0.5 -13.1 ± 0.4 9.0 ± 0.6 tetrahydropyran 
 
043 7.6 ± 0.4 0.6 ± 0.4 7.0 ± 0.6 cyclohexene 
 
044 -7.6 ± 0.5 -21.3 ± 0.4 13.7 ± 0.6 1,4-dioxane 
 
045 -62.0 ± 0.6 -48.3 ± 1.2 13.7 ± 1.3 
2-amino-9,10-
anthraquinone 
 
O
H3C
OH
CH3
O
CH3CH3
NH
O
O
O
H2N
O
O
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046 -43.7 ± 0.6 -40 ± 3 3.7 ± 3.1 
1-amino-9,10-
anthraquinone 
 
047 -51.6 ± 1 -59 ± 5 7.4 ± 5.1 
1-(2-
hydroxyethylamino)-
9,10-anthraquinone 
 
048 -61.0 ± 0.6 -49.6 ± 1.5 11.4 ± 1.6 
1,4-diamino-9,10-
anthraquinone 
 
049 -11.4 ± 0.5 -13.2 ± 0.4 1.8 ± 0.6 dibenzo-p-dioxin 
 
050 -9.1 ± 0.4 -17.3 ± 0.4 8.2 ± 0.6 anthracene 
 
051 -52.9 ± 0.7 -39.9 ± 1.2 13.0 ± 1.4 
1-amino-4-hydroxy-
9,10-anthraquinone 
 
052 -8.0 ± 0.5 -12.0 ± 2.9 4.0 ± 2.9 diphenyl ether 
 
 
a Molecule identification number as assigned in the SAMPL4 challenge; b Hydration free energy calculated using united 
atom parameters from ATB 2.0; c Experimental hydration free energy [21]; d The unsigned difference between 
calculated and experimental free energies. 
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2.5.2.1 Structural validation for the hydration free energy test set 
 
As an initial validation of the topologies and parameters generated by the ATB, each molecule was 
energy minimised in vacuum and the resulting structure was compared to that obtained after 
geometry optimisation at the B3LYP/6-31G* level of theory [28-30] in implicit solvent (water) 
using GAMESS-US [39]. The RMSD after performing a least squares fit on all atoms was 
calculated for each of the 214 molecules. The maximum value of the RMSD was 0.073 nm. Over 
66% of molecules had an RMSD value below 0.01 nm. Approximately 94% had an RMSD value 
below 0.03 nm. This suggests that the geometry of the molecules is well maintained in all cases. 
2.5.2.2 Hydration free energies 
 
The hydration free energies calculated using united atom (UA) and all atom (AA) topologies for the 
167 test molecules used previously are provided in Appendix 2 - Table 2A-1. Values for the other 
47 molecules that formed part of the SAMPL4 challenge [21] are listed in Table 2-1 with additional 
information being provided in Appendix 2 - Table 2A-2. The results for all 214 molecules are also 
presented graphically in Figure 2-3, which shows a plot of the values calculated using UA 
parameters versus the experimental values. The 167 molecules (Table 2A-1) are shown as blue 
crosses while the SAMPL4 molecules (Table 2-1) are indicated by yellow triangles. The solid line 
has a slope of one and represents a one-to-one agreement between the calculated and experimental 
numbers. The two dotted lines represent a 5 kJ/mol deviation from the ideal line. As can be seen in 
Figure 2-3 the points are approximately equality distributed about the line corresponding to a one-
to-one agreement between the calculated and experimental values.   
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Figure 2- 3. A plot of the calculated versus experimental hydration free energies (FE) for 214 molecules.  Values 
were calculated using united atom ATB 2.0 topologies. SAMPL4 molecules (Table 2-1) are indicated by yellow 
triangles. The remaining 167 molecules indicated by blue crosses are described in Appendix 2 - Table 2A-1. The 
solid line has a slope of one and represents a one-to-one agreement between the calculated and experimental 
numbers. The two dotted lines represent a 5 kJ/mol deviation from the ideal line. Values are in kJ/mol. 
 
 
The overall statistics for the comparison to the available experimental data are given in Table 2-2. 
For the UA topologies the average error (AE) was 0.29 kJ/mol, the root mean square error (RMSE) 
was 9.5 kJ/mol, the average unsigned error (AUE) was 6.7 kJ/mol, the Kendall tau statistic (Tau) 
was 0.75, the Pearson correlation coefficient (R) was 0.91 and the slope of a line of best fit using 
linear regression was 1.12.  
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Table 2- 2. Statistics for the comparison of the experimental and calculated free energies of hydration for 
different sets of molecules calculated using parameters generated by the Automated Topology Builder (ATB). 
Values are in kJ/mol. 
  AEa RMSEb AUEc Taud Re Slopef 
Total UAg 0.29 9.49 6.71 0.75 0.91 1.12 
 AAh -3.43 10.31 7.21 0.77 0.92 1.17 
Small Organic  0.56 3.98 3.37 0.74 0.95 1.04 
SAMPL0  3.85 8.50 7.16 0.76 0.91 1.21 
SAMPL1  -0.03 13.34 9.63 0.64 0.82 1.33 
SAMPL2  -2.78 10.51 8.53 0.83 0.95 1.23 
SAMPL4 Sub.i UA 1.09 10.02 7.61 0.60 0.85 0.99 
 Rev.j UA 0.96 9.96 7.53 0.60 0.85 1.00 
 AA -3.60 9.82 7.75 0.62 0.89 1.11 
 
a Average error; b Root mean square error; c Average unsigned error; d Kendall’s tau statistic; e Pearson’s correlation 
coefficient; f Slope of linear regression; g United atom force field; h All atom force field; i Values submitted as part of 
the SAMPL4 challenge; j Revised values incorporating an analysis of convergence at each λ-value. 
 
Given the fact that the GROMOS 53A6 is a united atom force field, it is to be expected that the 
results for the UA topologies are slightly better than for the AA topologies. It should also be noted 
that the results obtained with ATB version 2.0 are essentially identical to those obtained using 
version 1.0. Values for 167 molecules calculated using version 1.0 are provided in Appendix 2 - 
Table 2A-1. The differences in the versions relevant to this study are primarily related to the 
treatment of symmetry in the molecules and the assignment of charge groups. Namely, it is ensured 
that chemically equivalent groups are assigned identical partial charges and where possible atoms 
are grouped into neutral charge-groups in-line with the design of the GROMOS force field. This 
involved small rearrangements in the assignment of partial charges. However, as these changes 
were small, no significant change in the hydration free energies was expected. The statistics for the 
SAMPL4 molecules were similar to those obtained for the whole data set and are discussed in more 
detail later.  
 
A set of 75 small organic molecules for which high quality solvation free energy data is available 
was used as an initial test of the ATB. This test set consisted of alcohols, alkanes, cycloalkanes, 
alkenes, alkynes, alkyl benzenes, amines, amides, aldehydes, carboxylic acids, esters, ketones, 
thiols and sulphides. The AUE for these molecules was 3.4 kJ/ mol, the RMSE was 4.0 kJ/mol and 
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77% of the molecules lay within 5 kJ/mol of the experimental value. The largest deviation from 
experiment was 8.5 kJ/mol. What is clear from this result is that while the ATB parameters perform 
well for the majority of molecules, certain functional groups lead to systematic deviations from 
experiment. This is illustrated graphically in Figure 2-4 which shows a plot of the calculated versus 
experimental hydration free energies for molecules containing a single identifiable functional group. 
While alcohols, thiols/sulphides, ketones and aldehydes are on average evenly distributed around 
the experimental values (average signed error < 2 kJ/mol), the hydration free energies of esters and 
carboxylic acids are systematically underestimated by 6 and 5 kJ/mol respectively. In contrast, alkyl 
benzene groups and alkenes as well as amides and primary amines are overestimated by between 3 
and 5 kJ/mol on average. 
 
Figure 2- 4. Comparison of calculated with experimental hydration free energy (FE) values for 75 small organic 
molecules classified by a characteristic functional group. The solid line has a slope of one and represents a one-
to-one agreement between the calculated and experimental numbers. The two dotted lines represent a 5 kJ/mol 
deviation from the ideal line. Values are in kJ/mol. 
 
 
Of the set of 167 molecules, 92 were taken from previous SAMPL challenges [21,31-33]. The AUE 
for molecules in the SAMPL0, SAMPL1 and SAMPL2 data sets was 7.2 kJ/mol, 9.6 kJ/mol and 8.5 
kJ/mol respectively. The RSME for molecules in the SAMPL0, SAMPL1 and SAMPL2 data sets 
was 8.5 kJ/mol, 13.3 kJ/mol and 10.5 kJ/mol respectively. These are significantly larger than for 
other molecules in the data set and dominate the statistics. Approximately 40% of the molecules in 
the SAMPL data sets still lay within 5 kJ/mol of the experimental value but, the largest deviation 
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from experiment was 42 kJ/mol. This is in part a reflection of the uncertainty in the experimental 
hydration free energies of molecules contained in SAMPL challenges (which were as large as 8 
kJ/mol) and in part a reflection of the fact that these molecules contained a range of functional 
groups not commonly found in biomolecular systems. For example, molecules containing multiple 
halogens showed the largest deviations from experiment. This suggests that it will be possible to 
greatly improve the overall performance of the ATB by optimising the parameters for a small 
number of atom types. Indeed, sulphur-containing compounds, carboxylic acids, esters, amides and 
amines are known to be not optimal within the GROMOS force field [10]. 
 
2.5.2.3 Analysis of the SAMPL4 data set 
 
Blind challenges where answers are initially concealed from the participants have gained much 
popularity over the recent years as these tests prevent participants biasing their results and better 
assess the true predictive ability of the methods used. SAMPL4 [21] represents the fifth annual 
SAMPL blind challenge consisting of hydration, host-guest, and binding free predictions. Most 
importantly, participation in the SAMPL4 challenge allowed the validation of the parameters from 
the ATB 2.0 by comparison not only to the experimental values, but also to predictions made by 
other experts in the field.  
 
The hydration free energies that were submitted as part of the SAMPL4 challenge (id 529) were 
based on UA topologies and calculated over 2 days using an initial iteration of the automated 
pipeline described in the methods. The values and overall statistics for ATB 2.0 UA topologies 
using an updated version of our automated pipeline with improved convergence checking are 
provided in Tables 2-1 and 2-2. The hydration free energies for 23 of the 47 molecules were 
predicted within 5 kJ/mol of the experimental value. The largest deviations from experiment, 27 and 
28 kJ/mol, were for two aliphatic tertiary amines diphenhydramine (023) and amitriptyline (024), 
respectively. Other molecules for which the calculated hydration free energy deviated significantly 
from experiment included piperidine (041), which contains a secondary amine, and 4-
propylguaiacol (006), 4-methyl-2-methoxyphenol (034) and 2-methoxyphenol (037) each of which 
contains a methoxy group.  
 
Parameters generated by the ATB 2.0 for SAMPL4 molecules were ranked in the middle for the 
majority of the challenge criteria. Among the 49 submissions, the best prediction had the AUE of 
3.8 kJ/mol. This confirms that the ligand optimisation represents a significant scientific challenge. 
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2.5.2.4 Automated TI protocol 
 
The automated protocol to obtain the hydration free energies based on thermodynamic integration 
(TI) proved highly effective. TI was the method of choice because the convergence of the overall 
integral can be effectively monitored and systematically improved. In TI, the convergence does not 
rely on the degree of overlap of two ensembles and is not dependent on an exponentially weighted 
function as in the case of perturbation approaches. To maximise the efficiency of the method the λ-
values were preferentially placed in regions of high curvature and the convergence at each point 
monitored independently. This ensured sampling was concentrated in those regions that had the 
greatest impact on the overall hydration free energy. Plots of <∂V(r)/∂λ>λ versus λ for 3 example 
molecules are shown in Figure 2-5. The individual lines in each panel represent the change in free 
energy in water, vacuum and the difference between vacuum and water. Note, an implicit 
assumption in the estimation of the total error is that existing points represent, to some degree, the 
highest order feature of the underlying curve. In some sense this aspect of the problem is 
irreducible, as the form of the underlying function is not known. However in practice, given the 
shape of the curves illustrated in Figure 2-5, 9 equally spaced points were sufficient to identify the 
turning point in all cases.  
 
Figure 2- 5. Example thermodynamic integration curves generated by the automated protocol for 
methylcyclohexane (a) 1,4-dioxane (b) 5-fluorouracil (c).  Values of <∂V(r)/∂λ>λ in water and vacuum are shown 
in squares and triangles respectively, the final free energy curve (Eq. 3) is shown in circles. 
 
 
Overall statistics for two sets of calculated values for molecules in the SAMPL4 challenge using 
UA topologies are listed in Table 2-2. For the values submitted as part of the challenge (sub. UA) 
the system was simulated two times for 200 ps at each λ-value. The revised values (rev. UA) were 
obtained after the values of <∂V(r)/∂λ>λ had been deemed to have converged at each λ-value based 
on the criteria described above. Overall, the difference between the two sets is negligible. However, 
by ensuring the convergence of <∂V(r)/∂λ>λ at each λ-value the overall number of points required 
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to achieve a specific integration error could be greatly reduced resulting in a 2 fold increase in 
computational efficiency with no loss of precision. Note, in all but one case the systems were 
simulated until the uncertainty in the integration was ≤1 kJ/mol. In one case the algorithm was 
terminated once a total time limit was reached (SAMPL4 ID 001). In many cases the integration 
error was significantly less than one. For these cases the computational efficiency of the algorithm 
could be improved further by lowering the default initial sampling values.  
 
2.5.2.5 Computational cost 
 
The computational costs associated with the analysis of the SAMPL4 [21] results comprised of two 
parts: the generation of the parameters and the calculation of the free energy values themselves. The 
time required to generate the parameters is dominated by the time required to optimise the 
molecules at the B3LYP/6-31G* level of theory which is highly dependent on the size of the 
molecule. The average time required for the optimisation of SAMPL4 molecules was 26 central 
processing unit (CPU) hours. The average simulation length and computational time used to obtain 
the values listed in Table 2-1 for the SAMPL4 compounds are shown in Table 2-3. As can be seen, 
to achieve a statistical uncertainty of 1.0 kJ/mol or less, the mean total simulation length per 
molecule was 14 ± 4 ns and the mean time per molecule was 175 ± 50 CPU hours. Table 2-3 also 
shows how the average simulation time and final result vary with the statistical uncertainty. The last 
row in Table 2-3 illustrates the average difference in the results compared to that obtained using a 
tolerance of 1.0 kJ/mol. Note the actual difference between the results is much less than the 
statistical uncertainty.  
 
Table 2- 3. Average simulation lengths and computational times required to achieve a given statistical error. The 
free energy (FE) difference is the average difference between the free energies obtained for a given statistical 
error calculated with respect to an error of 1 kJ/mol. 
 1 kJ/mol Error 2 kJ/mol Error 3 kJ/mol Error 4 kJ/mol Error 
Simulation Time (ns) 14 ± 4 12 ± 3 10 ± 3 9 ± 2 
CPU (hrs) 175 ± 50 150 ± 37 125 ± 37 112 ± 25 
FE Difference (kJ/mol) - 0.6 ± 0.6 1.1 ± 0.9 1.2 ± 0.9 
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2.6 Conclusions 
 
Automated validation of the force field parameters against structural (optimised geometries) and 
thermodynamic (hydration free energies) data has been incorporated into the Automated Topology 
Builder (ATB version 2.0) methodology. Structural validation has shown good overall agreement 
between the QM optimised structures and the energy minimised structures using the ATB 
parameters for over 3000 molecules. A set of 214 molecules including those of the SAMPL0, 1, 2 
and 4 challenges has been used to test and validate the all atom and united atom topologies 
generated using the ATB version 2.0 against structural and thermodynamic data. Very good 
agreement between the QM optimised structures and the energy minimised structures for these 214 
molecules was also obtained. There was good overall agreement between the predicted and 
experimental hydration free energies for the majority of molecules investigated. Predictions within 
5 kJ/mol from the experimental values were considered as being in a good agreement as 5 kJ/mol is 
approximately an error of 1 order of magnitude in binding free energy. Such a degree of precision 
would allow a reasonable confidence in determining the interactions, especially the binding, 
between ligand:biomolecular complexes for which the parameters would eventually be used. For 
117 of 214 molecules examined, the predicted hydration free energy was within 5 kJ/mol of the 
experimental value, with the AUE between the calculated and experimental values of 6.7 kJ/mol 
and the RMSE of 9.5 kJ/mol. The AUE for a set of small organic molecules with high quality 
hydration free energy data was only 3.4 kJ/mol and the RMSE was 4.0. The AUE for SAMPL0, 1, 2 
and 4 ranged between 7.2 and 9.6 kJ/mol with the RMSE between 8.5 and 13.3 kJ/mol reflecting 
both the intrinsic uncertainty in some of the experimental values included in the SAMPL data sets, 
as well as the fact that the GROMOS force field is primarily intended for biomolecular systems and 
has yet to be optimised for certain functional groups. These results also highlight another challenge 
related to the force field validation and parameterisation such as scarce experimental data of high 
quality. As shown above it is challenging to reach the satisfactory agreement between the calculated 
and experimental values if an acceptable error between the two is lower than the error in the 
experimental value. Systematic differences between the calculated and experimental values for 
specific functional groups were noted. This suggests that further significant improvements in the 
predictive ability of the ATB will be possible. Such improvement can focus on identifying 
problematic functional groups and reparameterisation. Non-bonded interactions in the force fields 
such as the van der Waals and electrostatic interactions are less reliable than the bonded terms 
validated against a plethora of high quality experimental data. The force field could be improved by 
reparameterisation of such non-bonded interactions against available experimental data for atom 
types which are not commonly found in biomolecules and were not extensively validated before. 
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Finally, it should be noted that the values presented are based on fully automated protocols that 
require no manual intervention. This novel integration and convergence protocol increases the 
efficiency of the TI method for free energy calculations. The protocol determines the starting 
structure for the simulation at each lambda point, length of the simulation required to achieve 
convergence at a given lambda point and a total number of lambda points required for a sufficient 
sampling of the curve. The actual values submitted as part of the SAMPL4 challenge itself were 
generated over a period of 48 hours using a distributed computing resource. The automated TI 
protocol is able to calculate hydration free energies and it will be extended in the future to perform 
solvation free energy calculations with other solvents to extend the scope of the validation protocol. 
As the GROMOS force field parameters were also refined against liquid densities and heats of 
vaporisation, a validation test involving these properties would also provide invaluable information. 
The implementation of robust parameterisation and validation protocols within the ATB combined 
with the increasing availability of distributed computing resources provides the potential to perform 
free energy calculations in a high throughput manner and undertake large-scale optimisation of 
molecular force fields. This large-scale optimisation of problematic force fields parameters is 
performed in the following chapters of this thesis. 
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3.1 Chapter 3 
 
Challenges in refinement of the force field parameters for halogens. 
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3.2 Abstract 
 
The development and validation and of force field parameters for heteromolecular ligands is crucial 
for the success of computer-aided drug design. Precise interaction parameters are highly sought 
after for organohalides that constitute 40% of the newly introduced drugs. However, 
organochlorides and organobromides, were amongst the molecules that showed the poorest 
agreement with experimental hydration free energies in the validation study from Chapter 2. In this 
chapter, a test set consisting of 34 organochlorides and 19 organobromides was selected for the 
purpose of investigating the challenges involved in force field parametrisation of halogen 
interactions. Calculations of hydration free energies, densities and heats of vaporisation were 
performed and compared with experimental values to assess the influence of potential problems 
associated with the thermalisation of the solute on calculations of hydration free energies and the 
effect of varying the parameters of atoms in the local environment of the halogen on calculations of 
the above properties. The overall average unsigned-error (AUE) for the test set of 34 
organochlorides was 6.33 kJ/mol using the protocol outlined in Chapter 2 and 5.50 kJ/mol for 
calculations of hydration free energies with correct thermalisation. This suggests that correct 
thermalisation in hydration free energy calculations improves the predictability of experimental 
data. Further examination of the hydration free energies indicated that the development of different 
halogen parameters for aromatic and aliphatic molecules can further improve the accuracy of 
calculated properties. Investigation of the effect of the local environment by altering the carbon 
parameters to which the halogen was attached for certain organochlorides indicated a need to 
consider not only the halogen, but also the parameters of the surrounding carbons. Simply by 
selecting alternate GROMOS parameters for fully saturated carbons it was possible to reproduce 
experimental liquid densities, heats of vaporisation and hydration free energies with a higher 
accuracy. All the changes and corrections made in this chapter resulted in a better reproducibility of 
experimental properties, however the discrepancies between the calculated and experimental values 
for organohalides were still significant. A large-scale optimisation of molecular force fields for 
halogens is therefore suggested. 
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3.3 Introduction  
 
The development and validation of force field parameters for heteromolecular ligands is crucial for 
the success of computer-aided drug design. A number of automated parameterisation protocols have 
been proposed to develop force field descriptions for ligands including: Antechamber [1], the 
YASARA AutoSMILES server [2], SwissParam [3], the web server ParamChem [4-6] and the web 
accessible Automated force field Topology Builder and Repository [7-9] (ATB, 
http://atb.uq.edu.au/). While widely used the quality of parameters developed via such protocols 
remains an open question and large scale validation and testing approaches are sought after. 
 
The development of a fully automated validation protocol that was implemented into the ATB 
methodology to assess the quality of generated force field parameters was described in Chapter 2. 
The ATB parameters for a chemically diverse set of small molecules compatible with the 
GROMOS force field were validated against a range of structural and thermodynamic properties. 
This validation study demonstrated that the parameters generated by the ATB could reproduce these 
properties with high precision for many compounds. Nevertheless, areas where improvements could 
be made were identified. Organohalides, especially organochlorides and organobromides, were 
amongst the molecules that showed the poorest agreement with experimental hydration free 
energies [9]. As atom types in the GROMOS force field have been parameterised primarily for 
simulations of common biomolecules, it is not surprising that parameters for atom types such as 
halogens are non-optimal [9].  
 
Numerous studies have been performed in recent years to better understand the role of halogens and 
their interactions in biological systems and drug discovery, especially substrate specificity, binding 
and molecular folding [10-14]. Indeed, 40% of newly introduced drugs contain halogens [15]. 
Modelling the behaviour of halogens for the purpose of computer simulations in molecular 
mechanics is challenging. Halogens are associated with halogen bonding, a non-covalent interaction 
that occurs between a halogen atom (Lewis acid) and a Lewis base. Iodine, bromine and chlorine 
are able to form such a halogen bond [16]. Indeed, the chemistry of halogenated compounds is 
largely guided by a region of positive electrostatic potential, a σ-hole, on the extension of one of the 
covalent bonds to the atom. The σ-hole is caused by the anisotropy of the charge distribution on the 
atom [17,18]. Non-bonded interactions in biomolecular force fields are generally represented by 
partial atomic charges and Lennard-Jones parameters and in some instances polarisability is also 
included. However, halogen bonding non-covalent interactions are described poorly. The 
electrostatic potential around molecules in most empirical force fields is represented by single point 
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charges centred on atomic positions which results in partial negative charge being assigned to a 
halogen atom. This results in repulsive as opposed to attractive electrostatic interactions with 
heteroatoms with lone pairs. While such force fields do not account for the anisotropic distribution 
of the charge density on the halogen atom (the σ-hole) there is also an ongoing debate as to the 
importance of this interaction to improve the description of halogens and their interactions in 
computational studies. For example it is possible to introduce a positively charged extra-point or 
pseudo-atom to mimic the σ-hole located on the halogen atom [19-21]. Other methods to construct 
the σ-hole have also been proposed [22]. Alternatively, attempts have been made to mimic halogen 
bonding by adjusting just the atom centred partial charges [23]. A polarisable ellipsoidal force field 
that describes the anisotropic charge distribution as a combination of a negatively charged sphere 
and a positively charged ellipsoid has also been proposed [24]. None of these studies have however 
demonstrated conclusively that these changes lead to a significant improvement in the description 
of the halogen. Given the uncertainty in regard to whether the addition of specific halogen bonding 
terms are required, here the focus has been on understanding the extent to which a simple change in 
the van der Waals interaction parameters of halogens can improve the modelling of the 
experimental properties from the GROMOS force field. Note, while we have chosen here to focus 
on the refinement of the Lennard-Jones parameters, the methods presented could be latter expanded 
to include explicit models of halogen boding. Indeed, the ultimate aim of the work on 
parametrisation is to be able to improve the interaction parameters for any atom type. 
 
After the completion of the work in Chapter 2 it was discovered that errors in the predictions of 
hydration free energies for organohalides and indeed all molecules in the validation study in 
Chapter 2 might also be due in part to the incorrect thermalisation of the system. In molecular 
dynamics, it is often desirable to sample configurations from canonical constant-temperature 
ensemble. Rescaling of velocities imposes a thermostat on the system to maintain the temperature 
constant on average. There have been several thermostats developed with various physical basis to 
apply to different circumstances. The primary method used in this work, the Berendsen weak 
coupling thermostat [25],  involves velocity rescaling. The velocities of the atoms in the system are 
multiplied by the ratio of the desired mean kinetic energy divided by the instantaneous kinetic 
energy. This scheme is highly effective for systems including large numbers of coupled degrees of 
freedom. However, problems can arise with degrees of freedom that are decoupled from the rest of 
the system. This is because the fluctuations in the kinetic energy responsible for contributions to the 
ratio can cause the average value of the scaling parameter to be greater than 1.0 even when the 
instantaneous kinetic energy has the proper mean and the ratio is generally less than 1.0. As a result, 
uncoupled degrees of freedom which in principle should remain constant, such as translational 
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motion of the system, can gain energy. This means for example, the overall center of mass motion 
must be periodically removed to prevent the slow accumulation of kinetic energy in translational 
motion, causing the so-called ‘flying ice cube effect’ [26-28]. 
 
Problems can also occur if a part of a system becomes uncoupled from the rest of the system. For 
example, during the hydration free energy calculations described in detail in section 1.5.4.1, all non-
bonded interactions involving solute atoms are scaled down to zero in a stepwise manner as a 
function of the coupling parameter, λ, where λ=0 represents the full interaction and λ=1 no 
interaction. Problems with the Berendsen weak coupling thermostat can arise when the interactions 
are being switched-off and the solute gradually becomes uncoupled from the solvent. A single 
system changes to two independent uncoupled systems and the thermostat cannot maintain the 
correct thermalisation between the two systems. There is the possibility that the solute and solvent 
can have different amounts of translational or rotational kinetic energy or that there is accumulation 
of the kinetic energy of the solute system in translational and rotational degrees of freedom at the 
expense of the internal ones, causing errors in the free energy derivatives.   
 
The effect described above results in a violation of the equipartition principle and is associated with 
global thermostats such as the Berendsen weak-coupling method [25] and the Nosé-Hoover 
thermostat [29,30]. One way to solve this problem is to use a local thermostat, such as Langevin 
[31] (stochastic) dynamics, that act on individual atoms rather than all the atoms with the same 
strength. In this case random noise and a friction term is used to maintain the canonical ensemble. A 
weak Langevin term in addition to the Berendsen thermostat was used in this study to ensure the 
correct thermalisation as the solute became uncoupled. 
 
The influence of the local environment, especially the use of inappropriate van der Waals 
interactions parameters for the atoms to which the halogen is attached, might be another reason for 
the poor predictions of hydration free energies for organohalides. Biomolecular force fields such as 
GROMOS [32-37], AMBER [38,39], OPLS [40,41]  and CHARMM [42,43] represent what is a 
complex potential energy surface using a limited number of terms. To describe chemical 
environment, different sets of the van der Waals interaction parameters are assigned to atoms based 
on the neighbouring species. Force field parameters are usually correlated with the van der Waals 
and partial charges being closely linked. To determine an appropriate atom type, local chemical 
environment must be first identified. Assignment of the parameters to describe the chemistry with 
high accuracy is challenging and slightest inaccuracies in assigning atom types can be significant 
[7].  
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Several carbon atom types are available in the GROMOS force field [32-37] to describe the van der 
Waals interactions between different types of carbon. Some atom types such as type 12 C (C12) 
representing the carbon that has no hydrogen atoms attached and type 14 CH1 (C14) representing 
aliphatic or sugar CH-groups with one hydrogen atom attached to a carbon are well parameterised. 
This is because a range of compounds containing these atoms types is available that the values can 
be parametrised against. Some atom types, such as 13 CH0 (C13) developed to describe carbon van 
der Waals interactions for carbon bound to 4 heavy atoms, were proposed based on a very limited 
set of compounds. Assignment of force field van der Waals parameters to describe the local 
environment is challenging as sometimes none of the available parameters is suitable for 
characterising a given molecule. As differences in the carbon parameters are significant (Figure 3-
1), the assignment of the incorrect atom type may result in significant errors in predictions of the 
interactions of the whole molecule. C13 is usually used to describe a carbon buried among -CH3 
groups, but it is also assigned to carbon surrounded by halogen atoms. It can be seen in Figure 3-1 
that the Lennard-Jones potential for C13 has effectively no attractive component, especially in 
comparison to the potentials of C12 and C14. Interestingly, beyond ~ 0.6 to 0.7 nm, C13 is almost 
the same as a dummy atom with no interactions, C0.  
 
Figure 3- 1. The Lennard-Jones potential for different carbon parameters from the GROMOS force field. 
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Empirical force field parameterisation for halogen atoms is challenging. In this chapter aspects that 
must be considered when choosing an appropriate test set for parametrisation are discussed. The 
methodology used to calculate hydration free energies is validated and the importance of 
thermalisation while performing the hydration free energy calculations is examined. The effect of 
local environment, especially the influence of carbon van der Waals interaction parameters on 
properties of organochlorides is considered.   
 
3.4 Methodology  
 
In this section the methodology used to choose a test set for parametrisation to investigate the effect 
of thermalisation, performing free energy calculations and for studying the influence of local 
environment in parametrisation attempts is introduced. 
 
3.4.1 Parametrisation test set  
 
Chlorines and bromines are usually a part of an aryl or saturated aliphatic region in drug or drug-
like molecules. Two sets of molecules were chosen to test the parameters of chlorine and bromine. 
These are presented in Figure 3-2 and 3-3.  These test sets consisted of 34 aliphatic chlorides and 19 
organobromides. There were 24 saturated aliphatic organochlorides and 10 aromatic ones. The 
bromine test set consisted of 15 aliphatic and 4 aromatic organobromides. The molecules chosen are 
simple compounds containing only carbon, hydrogen and chlorine or bromine to ensure the minimal 
influence of force field parameters other than those of the halogens on the results. The number and 
position of the halogen atoms varied across the molecules. The number and variety of molecules in 
the test sets was limited by the availability of experimental data. Hydration free energies, liquid 
densities and heats of vaporisation were calculated and compared with experimental values for the 
molecules to determine the quality of the existing halogen parameters before reparameterisation was 
attempted.  
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Figure 3- 2. The test set for the refinement of chlorine force field parameters (34) consisting of simple aliphatic 
(24) and aromatic (10) molecules. The description below each molecule corresponds to the molecule identification 
number as assigned by the ATB (ATB MolID) and the IUPAC name. 
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3811 
 
1-chloroheptane 
3813 
 
1,2,3-trichlorobenzene 
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Figure 3- 3. The test set for the refinement of bromine force field parameters (19) consisting of simple aliphatic 
(15) and aromatic (4) molecules. The description below each molecule corresponds to the molecule identification 
number as assigned by the ATB (ATB MolID) and the IUPAC name. 
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4056 
 
1-bromooctane 
4057 
 
2-bromo-2-
methylpropane 
4059 
 
1-bromo-2-
methylpropane 
24214 
 
1-bromo-2-
methylbenzene 
 
 
 
3.4.2 Local environment  
 
The effect of the parameters of atoms in the local environment of the halogen on liquid densities, 
heats of vaporisations and hydration free energies was tested by changing the value of GROMOS 
force field atom type 13 CH0 (C13). C13 was assigned to describe carbon interactions for 5 
organochlorides from the test set: 2802, 2804, 2806, 3800, and 3805. C13 is used in the GROMOS 
54A7 force field to describe a sp3 carbon, bound to 4 heavy atoms and was developed to describe a 
carbon attached to 3-4 -CH3 groups. Only one of the molecules, 3805, fits that description. To 
investigate the sensitivity of the models to changes in this carbon parameter, calculations of above 
properties were performed using the C13 van der Waals interaction parameters and for C13 
replaced by atom type 12 C (C12), atom type 14 CH1 (C14) and atom type 22 DUM (C0). C12 
represents carbon that has no hydrogens attached to it, C14 represents aliphatic or sugar CH-group 
with carbon attached to only one hydrogen and C0 is a dummy with interactions parameters set to 
zero. 
 
3.4.3 Topology generation  
 
The structures of organohalides were generated using the programmes JSME [44] and JSmol [45] 
embedded in the ATB. The parameters and topology files for all molecules were generated 
automatically by the ATB version 2.0 and used without modification. The parameters were 
generated based on a single initial conformation. 
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3.4.4 Free energy calculations 
 
The hydration free energy was calculated as described in sections 1.5.4.1 and 2.4. The integration 
and convergence protocols were based on those introduced in detail in sections 2.4.3 and 2.4.4. The 
methodology was modified slightly to improve sampling and increase efficiency. The first estimate 
of the shape of the integration curve was determined by calculating <∂V(r)/∂λ>λ at 11 rather than 9 
equally spaced λ-points between λ = 0 and λ =1. The initial configurations for 11 starting points 
were taken from the optimised geometry at the B3LYP/6-31G* [46-48] level of theory. The systems 
in water were simulated once rather than twice at each λ-value. Initial configurations for additional 
λ-points were taken as the final frames of one of the two neighbouring λ-values chosen randomly. 
Systems in vacuum were simulated using ten sets of initial configurations from ten equally spaced 
frames of the corresponding water run. This was done to ensure a more complete sampling of the 
available configurational space. 
 
3.4.5 Simulation parameters for hydration free energy 
 
Force field descriptions for individual molecules were generated using the Automated Topology 
Builder (ATB) 2.0 based on the GROMOS 54A7 [32-34] parameter set. The molecular dynamics 
simulations and free energy calculations were performed using the GROMOS11 [49] package as 
described in section 2.4. The methodology was slightly modified to ensure the correct 
thermalisation of the molecules dissolved in SPC water [50]. In this case in addition to pressure 
coupling, the temperature was maintained by applying stochastic dynamics with a reference 
temperature of 298.15 K and an atomic friction coefficient of 1 ps-1 for solute only in addition to the 
Berendsen thermostat.  
 
3.4.6 Density and heat of vaporisation calculations  
 
Parametrisation of the GROMOS family of force fields [32-37] is also based on thermodynamic 
properties such as liquid densities and heats of vaporisation. The estimation of these properties is 
thus central to the on-going refinement and validation of this family of force fields and, in turn, the 
ATB.   
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Density, ρ, was calculated according to the equation: ~ = 	n ,          (1) 
where m is the mass and V is the volume. ρ was calculated in kg/m3. 
 
The heat of vaporisation, Hvap, was calculated from the energy trajectories obtained from the 
condensed phase and gas phase simulations according to the equation: 
 :`.# = 	 (Ä/.& −	Ä04Å)/JÄuuÉÑ + tK     (2) 
 
where Ugas and Uliq are the total potential energies of a box of molecules in the gas and liquid phase,  
respectively. NUMMOL represents the number of molecules in the box. R denotes the gas constant 
of 0.008314 kJ/mol and T is the temperature. Hvap was calculated in kJ/mol. Note, quantum 
corrections for rigid bonds and intermolecular vibrational energies were omitted as these will be 
similar for the gas and liquid phases and therefore cancel. 
 
3.4.7 Simulation parameters for density and heat of vaporisation  
 
Force field topologies and parameters for molecules were generated as described in section 3.4.3. 
The molecular dynamics simulations and calculations of the density and heat of vaporisation were 
performed using the GROMOS11 [49] package. Starting configurations in the condensed phase and 
in the gas phase were generated by randomly placing 512 molecules in a cubic box in a random 
orientation. The structures for the individual molecules were taken from the QM optimised 
geometries generated by the ATB. Condensed phases boxes were generated such that the density of 
the box matched the experimental value. The systems were energy minimised and molecular 
dynamics simulations were performed with parameters reported in section 2.4.6.  MD simulations 
were performed at constant pressure (1 atm) using a Berendsen barostat with the coupling time 10 
ps. The isothermal compressibility was 4.575 × 10-4 kJ-1 mol-1 nm-3. Initial velocities corresponded 
to the temperature at which the experimental data were collected. A reaction field correction beyond 
the long range cut-off was applied using the relative dielectric permittivity corresponding to a given 
system. In the case of gas phase systems, stochastic dynamics with a reference temperature 
corresponding to the experimental temperature was used. Condensed phase systems were 
equilibrated for 5 ns. MD simulations were run for condensed and gas phase systems for 5 ns. The 
ene_ana gromos++ programme was used to obtain liquid densities and total potential energies for 
the systems to calculate heats of vaporisation. The liquid density and the heat of vaporisation were 
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calculated at 298.15 K and 1 atm for all molecules apart from properties of 1,1,1,2,2-
pentachloroethane (2806) calculated at 293.15 K. Calculated properties were then compared with 
the experimental values [51,52]. 
3.5 Results and Discussion  
 
Halogen containing molecules were found to perform poorly in the validation study described in 
Chapter 2. These molecules contained not just halogens but a range of functional groups. In this 
section, hydration free energies, densities and heats of vaporisation were calculated and compared 
with experimental values for a test set consisting of 34 organochlorides and 19 organobromides to 
understand the extent to which the halogen parameters for chlorine and bromine were problematic 
and to investigate the effect of thermalisation in performing free energy calculations and the 
influence of a local environment on the properties of organohalides. 
 
3.5.1 Effect of thermalisation on calculations of hydration free energies 
 
The hydration free energies calculated using united atom (UA) topologies for organochlorides 
provided in Table 3-1 show the values calculated with and without thermalisation applied to the 
molecule as it becomes uncoupled from the system as explained in sections 3.4.4 and 3.4.5.  
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Table 3- 1. A comparison between the experimental and calculated free energies of hydration with and without 
thermalisation of the molecule for 34 organochlorides from the test set. All values are in kJ/mol. 
ATB MolIDa FE Exp.b FE Therm.c FE Org.d 
1173 -3.5 5.3 5.3 
1177 -5.7 -4.2 -1.5 
1178 -4.2 -2.0 0.5 
1196 -2.6 0.7 -1.0 
1307 -4.5 8.0 8.0 
2801 -7.5 1.7 2.0 
2802 -0.8 7.7 9.4 
2803 -8.3 6.8 7.2 
2804 -5.4 6.9 8.2 
2805 -10.3 8.1 8.9 
2806 -5.8 6.3 7.6 
3169 -5.5 5.2 4.0 
3170 -1.4 0.2 0.3 
3171 -1.1 2.4 2.6 
3176 -4.7 -2.0 -0.4 
3791 -2.3 2.2 0.4 
3793 0.3 2.5 3.2 
3794 -5.6 -3.1 -0.7 
3795 -6.8 -0.1 2.1 
3797 -5.6 -0.1 1.2 
3798 -4.7 -2.1 -0.5 
3799 -3.3 1.5 2.4 
3800 0.3 8.3 9.4 
3801 -5.3 1.7 2.8 
3802 -4.1 -1.4 0.7 
3803 -7.9 -2.7 -2.2 
3804 -9.7 -4.1 -3.3 
3805 4.6 4.4 2.2 
3806 0.0 1.3 1.8 
3808 -0.7 1.4 1.0 
3809 -0.3 1.7 1.9 
3810 0.0 0.8 1.1 
3811 1.2 2.1 2.3 
3813 -5.2 -4.7 -2.6 
 
a Molecule identification number as assigned by the ATB 2.0; b Experimental hydration free energy[53]; c Hydration 
free energy calculated using united atom parameters from the ATB 2.0 with thermalisation applied. The error in the 
calculated values is ± 1.0 kJ/mol, calculated as per section 3.4; d Hydration free energy calculated using united atom 
parameters from the ATB 2.0 with no thermalisation correction. The error in the calculated values is ± 0.5 kJ/mol, 
calculated as per section 2.4. 
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The results showing the effect of ensuring correct thermalisation for organochlorine compounds are 
also presented graphically in Figure 3-4, which shows a plot of values calculated with and without 
correct thermalisation versus the experimental hydration free energies.  
 
Figure 3- 4. A plot of the calculated versus experimental hydration free energies for 34 organochlorides.  Values 
were calculated using united atom ATB 2.0 topologies. Values with correct thermalisation are indicated by blue 
circles and values without thermalisation are indicated by red circles (Table 3-1). The solid line has a slope of one 
and represents a one-to-one agreement between the calculated and experimental numbers. The two dotted lines 
represent a 5 kJ/mol deviation from the ideal line. 
 
 
The values calculated with no thermalisation are shown as red circles while the calculations taking 
thermalisation into account are indicated as blue circles. The solid line has a slope of one and 
represents a one-to-one agreement between the calculated and experimental numbers. The two 
dotted lines represent a 5 kJ/mol deviation from the ideal line. The overall statistics for the 
comparison to the available experimental data are given in Table 3-2. For the results without correct 
thermalisation the average unsigned error (AUE) between the calculated and experimental values 
was 6.33 kJ/mol, while for the values with correct thermalisation applied the AUE decreased and 
was 5.50 kJ/mol. It can be seen from the overall statistics in Table 3-2 and in Figure 3-4 that 
thermalisation has improved the hydration free energy prediction for most molecules, including 
over- and well as under-estimated compounds. A significant improvement was reported for all the 
aromatic molecules and values for the majority of the aliphatic molecules were also closer to the 
experiment data. These results highlight the importance of applying thermalisation as the molecules 
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become uncoupled during hydration free energy calculations and all the values from now on in this 
thesis will be calculated with thermalisation correction applied. Correct thermalisation improved the 
predictability of hydration free energies of organochlorides, however the discrepancies between the 
calculated and experimental values were still significant. Therefore, the effect of thermalisation 
cannot be the reason why hydration free energies for organochlorides are not predicted well. 
  
Statistics for the calculations of hydration free energies for organobromides are provided in Table 3-
2. Individual hydration free energies calculated for organobromides and listed in Appendix 3 - 
Table 3A-1 and presented graphically in Appendix 3– Figure 3A-1. 
 
Table 3- 2. Statistics for the comparison of the experimental and calculated free energies of hydration with and 
without correct thermalisation for organohalides. Values are in kJ/mol. 
 AEa RMSEb AUEc Taud Re Slopef 
Cl No Therm.g 6.19 7.77 6.33 0.13 0.05 0.05 
Cl Therm.h 5.49 7.14 5.50 0.19 0.17 0.20 
Br Therm.i -1.28 2.96 2.47 0.59 0.80 0.48 
 
a Average error; b Root mean square error; c Average unsigned error; d Kendall’s tau statistic; e Pearson’s correlation 
coefficient; f Slope of linear regression; g Hydration free energy calculated for 34 organochlorides without correct 
thermalisation; h Hydration free energy calculated for 34 organochlorides with correct thermalisation; i Hydration free 
energy calculated for 19 organobromides with correct thermalisation.  
 
3.5.2 Hydration free energies for organochlorides and organobromides  
 
With correct thermalisation in place, the calculated hydration free energies were compared with the 
experimental ones in more detail. From Table 3-1 and Table 3A-1 it can be noted that the hydration 
free energies were reproduced with various degrees of accuracy for the different molecules. The 
statistics for the comparison of the experimental and calculated free energies of hydration for 
different groups of organohalides are presented in Table 3-3.  
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Table 3- 3. Statistics for the comparison of the experimental and calculated hydration free energies for aliphatic 
and aromatic organohalides. Values are in kJ/mol. 
 AEa RMSEb AUEc Taud Re Slopef 
Cl_Alig 5.79 7.49 5.80 -0.05 -0.03 -0.02 
Cl_Aromh 3.17 3.65 3.17 0.30 0.28 0.53 
Br_Alii -1.67 3.24 2.82 0.43 0.73 0.38 
Br_Aromj 0.16 1.52 1.17 0.67 0.69 0.69 
 
a Average error; b Root mean square error; c Average unsigned error; d Kendall’s tau statistic; e Pearson’s correlation 
coefficient; f Slope of linear regression; g Aliphatic organochlorides; h Aromatic organochlorides; i Aliphatic 
organobromides; ; j Aromatic organobromides; 
 
From this data, it can be seen that there was a marked difference in the suitability of the current 
ATB parameters, σ = 0.35 nm and ε = 1.26 kJ/mol, for aromatic and aliphatic compounds. 
Therefore the molecules in these groups will be considered separately. Calculated hydration free 
energies for organochlorine compounds were significantly different from the experimental values 
for both aromatic and aliphatic compounds with a deviation of 3.17 kJ/mol and 5.80 kJ/mol 
respectively. Overall, the parameters for bromine performed better than the parameters for chlorine 
(Table 3-3). Current bromine van der Waals parameters, σ = 0.37 nm and ε = 2.92 kJ/mol, described 
aromatic organobromine molecules well with the AUE between the calculated and experimental 
values of 1.17 kJ/mol, close to the error tolerance used in the calculations. The deviation was 
slightly higher for aliphatic molecules with the AUE of 2.82 kJ/mol between calculated and 
experimental hydration free energy values. This is also illustrated graphically in Figure 3-5 which 
shows a plot of the calculated versus experimental hydration free energies for all organohalides 
from the test set. The findings reported here compliment results described in Chapter 2 which 
indicated that molecules containing halogens, which were not commonly found in biomolecular 
systems showed large deviations between the calculated properties and the experimental values. 
This also suggests that the overall performance of the ATB can be improved by optimising 
parameters for halogen atom types before consideration of terms such as off centre charges to 
mimic a σ-hole. 
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Figure 3- 5. A plot of the calculated versus experimental hydration free energies for organohalides. Values for 24 
aliphatic and 10 aromatic chlorides (Table 3-1) are indicated by green circles and light green triangles 
respectively. Data for 15 aliphatic and 4 aromatic bromides (Table 3A-1) is represented by red circles and 
maroon rhombuses respectively. The solid diagonal line has a slope of one and corresponds to a one-to-one 
agreement between the calculated and experimental numbers. Dotted lines indicate a 5 kJ/mol deviation from 
the ideal line. 
 
 
3.5.3 Effect of local environment  
 
The liquid densities, heats of vaporisations and hydration free energies were calculated using united 
atom (UA) topologies for 5 organochlorides containing GROMOS force field atom type 13 CH0 
(C13). The calculations of these properties were performed for the C13 van der Waals interaction 
parameters used originally and for C13 replaced by atom type 12 C (C12), atom type 14 CH1 (C14) 
and atom type 22 DUM  - a dummy atom (C0). The results are presented in Table 3-4. 
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Table 3- 4. A comparison between the experimental and calculated properties for different carbon van der Waals 
interaction parameters present in organochlorides. Values calculated using united atom parameters from the 
ATB 2.0. The standard deviation was taken as the uncertainty for liquid densities and heats of vaporisation. The 
error for hydration free energies was calculated as per the protocol in section 3.4. 
a) A comparison between the experimental and calculated liquid densities. All values are in kg/m3. The error in 
the calculated values is ± 4 kg/m3. 
ATB MolIDa/Carbon parameter type Exp.b C12 C14 C0 C13 
2802 1329.1 1359.9 1320.0 1185.8 1115.5 
2804 1532.8 1487.3 1463.3 1349.1 1306.6 
2806 1679.6 1569.9 1559.9 1459.2 1438.0 
3800 1584.6 1626.3 1568.7 1431.2 1336.0 
3805 836.9 924.7 901.5 798.4 752.1 
 
b) A comparison between the experimental and calculated heats of vaporisation. All values are in kJ/mol. The 
error in the calculated values is ± 0.3 kJ/mol. 
ATB MolIDa/Carbon parameter type Exp.b C12 C14 C0 C13 
2802 32.5 34.5 34.8 24.1 24.0 
2804 36.8 40.0 40.9 30.1 31.0 
2806 46.3 43.9 45.3 34.6 36.4 
3800 32.4 36.6 36.5 25.7 25.3 
3805 29.0 33.9 34.5 23.9 24.1 
 
c) A comparison between the experimental and calculated free energies of hydration. All values are in kJ/mol. 
The error in the calculated values is ± 1.0 kJ/mol. 
ATB MolIDa/Carbon parameter type Exp.b C12 C14 C0 C13 
2802 -0.8 3.6 2.6 8.7 7.7 
2804 -5.4 3.0 2.8 8.4 6.9 
2806 -5.8 3.0 2.5 8.1 6.3 
3800 0.3 3.3 2.7 7.9 8.3 
3805 4.6 -0.4 -1.3 4.9 4.4 
 
a Molecule identification number as assigned by the ATB 2.0; b Experimental value of a given property [51-53]. 
 
The results are also presented graphically in Figure 3-6 which shows plots of the values for the 
properties calculated with the alternative carbon parameters versus experimental data. The values 
calculated for C13 are shown in red, calculations for C12 are in blue, data for C13 is in black and 
values for dummy atoms are green circles. The solid line has a slope of one and represents a one-to-
one agreement between the calculated and experimental numbers. The two dotted lines represent a 5 
kJ/mol deviation from the ideal line for hydration free energies and heats of vaporisation and 100 
kg/m3 for liquid densities.   
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Figure 3- 6. A plot of the calculated versus experimental properties for different carbon van der Waals 
interaction parameters present in organochlorides. Values for C13 are indicated in red, data for C12 is in blue, 
calculations for C14 are in black and C0 in green (Table 3-4). The solid line has a slope of one and represents a 
one-to-one agreement between the calculated and experimental numbers. The two dotted lines represent a 5 
kJ/mol deviation from the ideal line for hydration free energies and heats of vaporisation and 100 kg/m3 for 
liquid densities.   
a) A comparison between the experimental and calculated liquid densities.  
 
 
b) A comparison between the experimental and calculated heats of vaporisation.  
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c) A comparison between the experimental and calculated hydration free energies. 
 
 
The overall statistics for the comparison to the available experimental data are given in Table 3-5. 
From the results, it can be noted that C12 and C14 predicted experimental values with similar 
accuracy. The predictions using C13 and C0 were also similar, but much different from the ones for 
C12 and C14. C12 and C14 predicted experimental liquid densities with high accuracy with the 
AUE of 63.10 and 55.77 kg/m3 respectively. The values calculated with C13 and C0 had the AUE 
between 2-3 orders of magnitude higher. Predictions of the heats of vaporisation followed a similar 
trend with the AUE for C12 and C14 of around 3 kJ/mol, while for C13 and C0 it was above 7 
kJ/mol. C12 and C14 also resulted in more accurate predictions of the hydration free energies with 
the AUE lower by over 2 kJ/mol comparing to C13. It can be seen that using C12 and C14 
improved the predictability of all the properties for all molecules, except 3805 which was identified 
as the only molecule that had a carbon buried among three –CH3 groups and for which C13 was 
expected to be the most suitable amongst the molecules in the chosen dataset. Interestingly, similar 
predictions were observed for C13 currently used to describe the molecules and C0 that represented 
a dummy atom with no interactions. Note, beyond 0.6 to 0.7 nm the Lennard-Jones potentials for 
both C0 and C13 are effectively zero. This means that although C13 is nominally larger than either 
C12 or C14, in reality if the groups surrounding the central atom are large, the use of C13 
effectively removes the interaction with the central atom. This suggest there is a compensation of 
error between the C13 atom type and atom type 16 representing CH3. Even though chlorine atoms 
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are large, some attractive interactions with the central atom seem to be important in describing 
interactions of the tested molecules. The C13 parameters performed poorly in all cases, apart from 
3805, therefore C12 parameters will be used to describe 2802, 2804, 2806 and 3800 from now on in 
this thesis. Changes in the description of the local environment for organochlorides resulted in a 
better reproducibility of experimental properties, however the discrepancies between the calculated 
and experimental values were still significant. Therefore, the effect of the local environment cannot 
be the sole reason why experimental properties of organochlorides are not predicted well. 
 
Table 3- 5. Statistics for the comparison of the experimental and calculated properties for different carbon van 
der Waals interaction parameters present in organochlorides. 
 AEa RMSEb AUEc Taud Re Slopef 
C13 Type       
Liquid density (kg/m3) -202.94 211.71 202.94 1.00 1.00 0.80 
Heat of vaporisation (kJ/mol) -7.26 7.48 7.26 0.60 0.97 0.79 
Hydration free energy (kJ/mol) 8.11 9.27 8.16 0.20 -0.36 -0.12 
C12 Type       
Liquid density (kg/m3) 1.02 70.00 63.10 0.80 0.98 0.82 
Heat of vaporisation (kJ/mol) 2.37 3.50 3.33 0.80 0.97 0.60 
Hydration free energy (kJ/mol) 3.93 6.33 5.90 0.00 -0.69 -0.26 
C14 Type       
Liquid density (kg/m3) -29.92 68.80 55.77 0.80 0.99 0.82 
Heat of vaporisation (kJ/mol) 2.98 3.71 3.36 0.80 0.97 0.67 
Hydration free energy (kJ/mol) 3.27 6.11 5.60 -0.40 -0.78 -0.32 
C0 Type       
Liquid density (kg/m3) -147.85 159.91 147.85 1.00 1.00 0.81 
Heat of vaporisation (kJ/mol) -7.72 8.04 7.72 0.80 0.97 0.67 
Hydration free energy (kJ/mol) 9.00 10.28 9.00 -0.40 -0.76 -0.27 
 
a Average error; b Root mean square error; c Average unsigned error; d Kendall’s tau statistic; e Pearson’s correlation 
coefficient; f Slope of linear regression. 
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3.6 Conclusions  
 
Halogen force field parameters were identified as non-optimal in the validation study described in 
Chapter 2. In this chapter, a test set consisting of 34 organochlorides and 19 organobromides was 
selected for the purpose of investigating the challenges involved in force field parametrisation of 
halogen interactions. Calculations of hydration free energies, densities and heats of vaporisation 
were performed and compared with experimental values to assess the influence of potential 
problems associated with the thermalisation of the solute on calculations of hydration free energies 
and the effect of varying the parameters of atoms in the local environment of the halogen on 
calculations of the above properties. The overall average unsigned-error (AUE) for the test set of 34 
organochlorides was 6.33 kJ/mol using the protocol outlined in Chapter 2 and 5.50 kJ/mol for 
calculations of hydration free energies with correct thermalisation. This suggests that correct 
thermalisation in hydration free energy calculations improves the predictability of experimental 
data. Further examination of the hydration free energies indicated that the development of different 
halogen parameters for aromatic and aliphatic molecules can further improve the accuracy of 
calculated properties. Investigation of the effect of the local environment by altering the carbon 
parameters to which the halogen was attached for certain organochlorides indicated a need to 
consider not only the halogen, but also the parameters of the surrounding carbons. Simply by 
selecting alternate GROMOS parameters for fully saturated carbons it was possible to reproduce 
experimental liquid densities, heats of vaporisation and hydration free energies with a higher 
accuracy. All the changes and corrections made in this chapter resulted in a better reproduction of 
the experimental properties, however the discrepancies between the calculated and experimental 
values for organohalides were still significant. These results indicate a need for a development of a 
large-scale refinement protocol to improve the force field parameters for halogen atoms. It was 
stated in the previous chapters that the development of parameters representing non-bonded 
interactions is more challenging than bonded interactions. Therefore, a large-scale optimisation of 
molecular force fields for halogens focusing on refinement of non-bonded van der Waals forces was 
undertaken and is presented and discussed in the next chapter of this thesis. 
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4.1 Chapter 4 
 
Single-step perturbation approaches for the rapid development of atomistic force fields: Refinement 
of halogen van der Waals parameters. 
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4.2 Abstract 
 
Organohalide compounds make up to 40% of newly proposed drug molecules. To be able to model 
these compounds computationally with a high degree of accuracy, well-defined and validated force 
field parameters are needed. In this chapter, single-step perturbation protocols were used to develop 
alternative van der Waals force field parameters for halogenated molecules compatible with the 
GROMOS force field as implemented in the Automated force field Topology Builder and 
Repository (ATB; http://atb.uq.edu.au/).  A test set consisting of 34 organochlorides and 19 
organobromides was used for parametrisation. Hydration free energies, liquid densities and heats of 
vaporisation were calculated and compared with experimental values. The overall average unsigned 
error (AUE) between the predicted and experimental values for aliphatic organochlorides was 5.8 
kJ/mol before the parametrisation and 2.7 kJ/mol for calculations using refined parameters. The 
decrease in the AUE from 3.2 to 1.2 kJ/mol was also noted for aromatic organochlorides and the 
AUE for aliphatic bromides decreased by 0.4 kJ/mol. The decrease in the AUE was also noted for 
common drug and drug-like molecules. The implementation of robust parameterisation protocols 
within the ATB combined with the increasing availability of distributed computing resources 
provides the potential to perform free energy calculations in a high throughput manner and 
undertake large-scale optimisation of molecular force fields. 
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4.3 Introduction 
 
A number of automated protocols for generating parameters for ligands compatible with 
biomolecular force fields have been proposed [1-6], including the web accessible Automated force 
field Topology Builder and Repository [7-9] (ATB, http://atb.uq.edu.au/). The development of a 
fully automated validation protocol that was implemented into the ATB methodology to assess the 
quality of generated force field parameters was described in Chapter 2. The validation study 
indicated that the ATB parameters reproduce the structural and thermodynamic properties of a wide 
range of compounds with high precision. However, the current parameters for halogen atoms 
proved to be non-optimal [9]. Parametrisation of halogen atom types is of particular importance as 
organohalide compounds make up to 40% of newly proposed drug molecules. The challenges 
associated with the refinement of force field parameters for halogens were discussed in Chapter 3. 
This study suggested that it might be possible to improve the accuracy with which a range of 
experimental properties of organohalides could be predicted by refining the halogen van der Waals 
interactions parameters. 
 
The non-bonded van der Waals interactions in the GROMOS family of force fields [10-15] are 
described using a Lennard-Jones (LJ) potential [16]: 
 "56 l = Öcylcy 	 − ÖÜlÜ 	= 4á	 àcylcy − àÜlÜ 	 												(1)	 
 
where r is the distance between the particles, Öcy = 4áàcy and ÖÜ = 4áàÜ. ε represents the depth of 
the potential well and σ is the finite distance at which the inter-particle potential is zero. They can 
be estimated as  à = 	 7âä7ãã  and á = 7ãäå7âä.  
 
In the GROMOS force field, the van der Waals interaction parameters between specific pairs of 
atoms are represented by unique C6 and C12 values equivalent to unique σ and ε values. Therefore 
by scaling σ and ε, one is able to improve these interactions in instances where current force field 
parameters do not represent the true interactions.  
 
The current ATB parameters for chlorine which are stored as the square root of C6 and C12 are ÖÜ 
= 0.09362 (kJ mol-1 nm6)1/2 and Öcy = 0.003911 (kJ mol-1 nm12)1/2 which are equivalent to σ = 
0.35 nm and ε = 1.26 kJ/mol and for bromine are ÖÜ = 0.1663 (kJ mol-1 nm6)1/2 and Öcy = 
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0.008092 (kJ mol-1 nm12)1/2 which are equivalent to σ = 0.37 nm and ε = 2.92 kJ/mol. To estimate 
the effect of changing the force field parameters of a given atom type on hydration free energies 
using the thermodynamic integration approach is computationally expensive, especially if large 
numbers of molecules must be considered. However, if the change in the parameters is small, the 
difference in free energy corresponding to multiple different alternate states can be calculated 
efficiently using perturbation approaches [17] as described in section 1.5.4. 
 
Single step perturbation (SSP) [18-21] is an approach where the difference in free energy 
corresponding to multiple different alternate states can be calculated from a single simulation of an 
initial reference state, R, using the expression: 
 ∆Tççé_ê*22 = 	∆TW8 = −MNK	 ln 	 km m n ; Z] m	 n ; Zso\p Zs 								(2)				 
 
 
Often the SSP method described above requires the use of a biasing potential to ensure 
convergence. However, in this case the initial sets of parameters in the force field are already highly 
optimised and the reference state contains configurations appropriate to alternative final states i.e. 
the perturbation is small. This method is especially efficient for the purpose of the refinement of 
force field parameters as the effect of many perturbations can be calculated in parallel based on a 
precalculated trajectory from a simulation of the initial reference state. 
 
The sensitivity of the free energy of hydration due to variations in parameters can then be calculated 
according to the equation below: 
 ∆T&*0` = ∆Tpë_21í + ∆Tççé_ê*22         (3)		 
 
where TI_ref represents the hydration free energy calculated with original force fields parameters 
for chlorine, σ = 0.35 nm and ε = 1.26 kJ/mol, and for bromine, σ = 0.37 nm and ε = 2.92 kJ/mol, 
using the thermodynamic integration approach for a given molecule as listed in section 3.5 and 
SSP_corr represents the correction to the TI_ref calculated via SSP for a given set of alternative 
parameters. 
 
This chapter describes the application of this single-step perturbation protocol to the selection of 
alternative van der Waals parameters for small halogenated molecules capable of predicting 
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hydration free energies with high precision. The test set consisting of 34 organochlorides and 19 
organobromides presented in Chapter 3 was used for parametrisation and hydration free energies, 
liquid densities and heats of vaporisation were calculated and compared with experimental values. 
The effectiveness of the protocol is discussed together with the analysis of the differences between 
the calculated and experimental values for the organohalides. The refined van der Waals 
interactions parameters are also validated against a set of drug-like molecules. Note, while the 
proposed methodology has been applied to halogens in the context of a classical force field, it can 
be easily extended to the parameterisation of other atom types and other force field terms. 
 
4.4 Methodology 
 
In this section the methodology used to refine the force field parameters for halogens via the single-
step perturbation and the methodology used to validate the refined values against experimental data 
is introduced. 
 
4.4.1 Topology generation 
 
The parameters and topology files for all molecules were generated automatically by the ATB 
version 2.0 [7-9] and used without modification. The parameters were generated based on a single 
initial conformation. The structures of organohalide molecules were generated using JSME [22] and 
JSmol [23] programs embedded in the ATB. In case of drug and drug-like molecules that formed 
part of the various SAMPL challenges [24-27] the conformations were taken directly from the 
structural coordinates provided. 
 
4.4.2 Single-step perturbation protocol  
 
The GROMOS11 software [28-30] was used to perform the single-step perturbation calculations 
used to determine the hydration free energies of the halogenated compounds. To perform the single 
step perturbation (SSP) calculation a 10 ns long simulation at λ=0 was run to obtain a trajectory of 
the reference state in vacuum and in water for all the molecules in the test sets. The coordinate 
trajectory was divided into packets and solvent molecules beyond a 1.4 nm cut-off were filtered off 
using a modified version of GROMOS++ filter program [31]. This was to reduce the size of the 
trajectories and processing time required. Dividing the trajectories into packets enabled the analysis 
to be run on multiple nodes in parallel. There were 1000 frames per packet. The setup of a SSP run 
involved choosing the range of perturbations to be applied. To investigate the effect of changing the 
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van der Waals parameters for halogenated compounds, sigma and epsilon values were selected 
forming a grid. The sigma and epsilon values chosen for each halogen sampled an area near the 
current van der Waals parameters. The range of sigma and epsilon was 0.2 to 0.65 nm and 1.0 to 5.0 
kJ/mol respectively for chlorine and 0.17 to 0.47 nm and 0.8 to 3.2 kJ/mol respectively for bromine. 
The range of values for both sigma and epsilon was then divided into 15 equally spaced points 
creating 225 grid points. Each grid point represented a new sigma/epsilon combination for which 
the hydration free energies were calculated. A modified version of the GROMOS++ program 
m_ener [31] was used to calculate (non-bonded) interaction energies for multiple sets of parameters 
for a specific atom type from the stored trajectory files. The perturbation formula was used to 
calculate the free energy difference between the two states was applied with the use of dg_ener 
GROMOS++ program. The whole process was applied to both the vacuum and water trajectories.  
 
The data was evaluated by adding a SSP correction for a given sigma/epsilon parameter 
combination to the previously determined TI value. The resulting sum was compared to the 
experimental value. The sigma/epsilon combination with the smallest absolute free energy error 
calculated according to the equation below was identified as being optimal: Free	energy	error	 = 	 TI	 +	SSPû–	SSPü − 	EXP       (4) 
where TI represents the hydration free energy calculated with the original force field parameters 
using the thermodynamic integration approach for a given molecule as listed in section 3.5, EXP is 
the experimental hydration free energy for a given compound, SSPw  and SSPv represent the 
corrections to the TI calculated via SSP in water and vacuum respectively, for a given set of 
alternative parameters. 
 
4.4.3 Single-step perturbation, liquid density, heat of vaporisation and hydration free energy 
calculations and simulation parameters 
 
Single step simulation parameters were as listed in section 3.4.5. The liquid density and the heat of 
vaporisation were calculated to validate the halogen parameters determined based on the 
optimisation of the hydration free energy as described in section 3.4.6. The liquid density and the 
heat of vaporisation were calculated at 298.15 K and 1 atm for all molecules apart from properties 
of chloroethane (1196) calculated at 273.15 K and values for 1,1,1,2,2-pentachloroethane (2806), 
1,4-dibromobenzene (1208) and 1-bromo-2-methylbenzene (24214) calculated at 293.15 K. The 
calculated liquid densities and the heats of vaporisation were then compared with the experimental 
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values [32,33]. Hydration free energies were calculated for a range of organohalides to test the 
refined halogen van der Waals parameters as described in section 3.4.4. Force field descriptions for 
molecules were generated as described in section 4.4.1. The molecular dynamics simulations and 
liquid density, heat of vaporisation and hydration free energy calculations were performed using the 
GROMOS11 [28-30] package as described in sections 3.4.5 and 3.4.7.  
 
4.5 Results and Discussion  
 
The aim of this study was to develop alternative halogen van der Waals parameters that can be used 
for studying biomolecule-ligand complexes and aid structure-based drug design. Multiple sets of 
alternative van der Waals force field parameters were tested in terms of their ability to reproduce 
experimental hydration free energies, liquid densities and heats of vaporisation. A test set consisting 
of 34 organochlorides and 19 organobromides was used for parametrisation. This set of compounds 
contained aromatic and as well as aliphatic molecules represented by alkyl and aryl halides. A full 
list of the molecules considered is provided in Figure 3-2 and Figure 3-3 in Chapter 3. The united 
atom (UA) topologies for all the molecules used in the study are publicly available via the 
Automated force field Topology Builder and Repository (ATB; http://atb.uq.edu.au/) [7-9]. All of 
the hydration free energies were calculated using the thermalisation procedure described in Chapter 
3. Baseline hydration free energies calculated via TI to which the SSP correction was applied were 
presented in section 3.5. 
 
4.5.1 Single-step perturbation approaches for refinement of halogen van der Waals parameters in 
the ATB against hydration free energies 
 
Single step perturbation was performed as described in sections 4.3 and 4.4.2. A sample grid map 
created using above methodology is shown in Figure 4-1. 
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Figure 4- 1. A sample grid map created for ATBMolID 1307 using the single step perturbation protocol. 
 
 
The plot shows the absolute error in the hydration free energy values calculated using the SSP 
protocol for different sigma/epsilon parameter combinations compared to the experimental values. 
Sigma values are presented on the x-axis and epsilon values are listed on the y-axis. The 225 
perturbations (15x15) are shown as black dots while the current ATB halogen van der Waals 
parameters are shown as a black cross. The colour bar indicates the magnitude of the average 
unsigned error (AUE) between the hydration free energy calculated with the respective parameter 
combination and the experimental values. Individual grid maps showing the AUE between the 
calculated and experimental hydration free energies for all molecules in the test sets are shown in 
Appendix 4 - Figures 4A-1 and 4A-2.  
 
The observation made in Chapter 3 regarding the need for different chlorine parameters to describe 
aliphatic and aromatic organohalides is also evident from the individual grid maps for each 
molecule from the test set (Appendix 4 - Figures 4A-1 and 4A-2). The region in dark blue, 
corresponding to optimal parameter combinations, lies in distinct areas of the grid for aromatic and 
aliphatic molecules. Differences in the shape of the region with low AUE for molecules also 
depended on the local environment, especially the proximity and number of halogen atoms in a 
given molecule. The more halogen atoms present in a given molecule, the narrower was the region 
with high accuracy parameter combinations. 
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In order to determine the van der Waals parameters that might be optimal for a range of molecules, 
combined grid maps were created by overlaying individual grid maps for all aliphatic 
organochlorides (Figure 4-2a), all aromatic organochlorides (Figure 4-2b), all aliphatic 
organobromides (Figure 4-2c) and all aromatic organobromides (Figure 4-2d) separately. The plots 
show the absolute error in the hydration free energy values calculated using the SSP protocol 
compared to the experimental values. Again, sigma values are presented on the x-axis and epsilon 
values are listed on the y-axis. The current ATB parameters are shown as black crosses. The colour 
bar indicates the magnitude of the AUE between the hydration free energy calculated with the 
respective parameter combinations and experimental values.  
 
Figure 4- 2. Combined grid maps showing the average unsigned error between the predicted and experimental 
hydration free energies calculated using the single step perturbation protocol for 24 aliphatic organochlorides 
(a), 10 aromatic organochlorides (b), 15 aliphatic organobromides (c) and 4 aromatic organobromides (d). 
 
 
                      a                                                                          b 
                      c                                                                         d 
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As can be seen in Figure 4-2, the shape of the favourable region was similar for alkyl and aryl 
molecules of different organohalides. The regions with the smallest AUE are clearly different for 
aryls and alkyls containing chlorine atom. It is also evident that the values of sigma and epsilon are 
correlated. The magnitude of the improvement in the hydration free energies that could be achieved 
after reparameterisation of the van der Waals parameters for chlorine was higher than for bromine. 
In case of the aliphatic organochloride compounds simply changing the van der Waals parameters 
could reduce the AUE between the calculated and experimental values from over 5 to 
approximately 2.5 kJ/mol (Figure 4-2a). For aromatic organochlorides the AUE could be reduced to 
2 kJ/mol (Figure 4-2b). In case of the alkyl organobromide compounds the AUE could be reduced 
to below 2.5 kJ/mol (Figure 4-2c). Current force field parameters for bromine worked well for aryl 
molecules. However, given the small number of compounds it can be seen that a wide range of 
parameters would give a difference in the hydration free energy predicted within less than 2.5 
kJ/mol from the experimental value (Figure 4-2d). In all cases, the current parameters described aryl 
molecules of a given halogen better than alkyl compounds. The difference in the magnitude of the 
possible improvement was also dependent on the quality of the initial van der Waals parameters for 
halogens as the SSP approach is the most reliable if the change is small. It should also be noted that 
for many gird points the corresponding AUE values were very similar and within calculation and 
experimental errors. This limits the certainty with which new van der Waals parameters could be 
determined. Finally, as the van der Waals parameters affect a range of properties, the development 
of alternative van der Waals values cannot only be based on the hydration free energies. Therefore 
additional testing is needed before a final set of van der Waals parameters for chlorine and bromine 
can be proposed. 
 
4.5.2 Validation of the parameters produced by the single-step perturbation protocols via liquid 
density and heat of vaporisation calculations for organochlorides and organobromides 
 
As shown in the previous section, sigma and epsilon values are correlated and a large region of 
parameter space was found that could improve the prediction of hydration free energies. In the 
search for optimal parameters, a narrower range of the parameters identified above was tested 
against liquid densities and heats of vaporisation. Liquid densities and heats of vaporisation for 
temperatures and pressures listed in section 4.4.3 were calculated for the grid points representing 
combinations of van der Waals parameters that were indicated to be close to optimal i.e. the average 
unsigned error (AUE) for the hydration free energy was < 3 kJ/mol for aliphatic organochlorides 
and organobromides and < 2 kJ/mol for aromatic organochlorides. Aromatic organobromides were 
not used in further parametrisation attempts due to the limited availability of experimental data and 
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the observation that current force field parameters are in the region of the grid with the AUE 
between the calculated and experimental values around 1 kJ/mol. It can also be noted that the region 
of favourable aromatic bromine parameters overlaps with the aliphatic parameters therefore refined 
aliphatic parameters could potentially be used to model aromatic compounds.  
 
Calculated liquid densities and heats of vaporisation for organohalides were compared with the 
experimental data and the AUE was determined. Individual grid maps for liquid densities and heats 
of vaporisation for the molecules from the test sets are presented in Appendix 4 –Figures 4A-3 to 
4A-8. The combined grid maps for liquid densities and heats of vaporisation are presented for 
aliphatic organochlorides (Figure 4-3), aromatic organochlorides (Figure 4-4) and aliphatic 
organobromides (Figure 4-5). The plots show values close to optimal, i.e. the average unsigned 
error (AUE) for the liquid densities and heats of vaporisation < 100 kg/m3 and < 5 kJ/mol 
respectively are sampled within previously selected range of AUEs for hydration free energies. 
 
Figure 4- 3. Combined grid maps showing the average unsigned error between the predicted and experimental 
liquid densities (a) and heats of vaporisation (b) for aliphatic organochlorides for the conditions listed in section 
4.4.3. 
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Figure 4- 4. Combined grid maps showing the average unsigned error between the predicted and experimental 
liquid densities (a) and heats of vaporisation (b) for aromatic organochlorides for the conditions listed in section 
4.4.3. 
 
 
Figure 4- 5. Combined grid maps showing the average unsigned error between the predicted and experimental 
liquid densities (a) and heats of vaporisation (b) for aliphatic organobromides for the conditions listed in section 
4.4.3. 
 
 
 
 
 
 
 
 
However, it can be seen that the region of parameter space that yielded the smallest AUE in terms 
of the hydration free energy predictions was not necessarily the same as that which shows the 
smallest AUE in the liquid density and heat of vaporisation. For aliphatic organochlorides, the 
sigma/epsilon parameter combinations that yielded the AUE in hydration free energy of below 2.5 
kJ/mol, σ = 0.4 nm and ε = 2.0 kJ/mol (Figure 4-2a), showed large deviations between the 
calculated and experimental liquid densities and heats of vaporisation (Figure 4-3). It can also be 
seen that parameter combinations that predicted liquid density well for aromatic organochlorides 
were not the parameters that predicted heats of vaporisation with the highest accuracy as presented 
Li
qu
id
 d
en
si
ty
 e
rr
or
 (k
g/
m
3 )
 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
                      a                                                                          b 
                      a                                                                          b 
Li
qu
id
 d
en
si
ty
 e
rr
or
 (k
g/
m
3 )
 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
93 
 
in Figure 4-4. Given this, van der Waals parameters had to be chosen for halogen atoms that 
provided a compromise in predicting all three properties. It was also observed that a number of 
sigma/epsilon configurations gave similar AUEs between the calculated and experimental 
properties. For example, any combination of sigma between 0.32 and 0.34 nm and epsilon between 
1.45 and 1.70 kJ/mol predicts the liquid density of aromatic organochlorides within 40 kg/m3 and 
any combination of sigma between 0.27 and 0.31 nm and epsilon between 1.45 and 1.57 kJ/mol 
predicts the heat of vaporisation of aromatic organochlorides within 1 kJ/mol (Figure 4-4).  
Therefore, it seems that within a given range, bearing in mind the uncertainty in the calculated and 
experimental values, a range of sigma/epsilon values will predict the experimental properties with 
acceptable accuracy. Final reparametrised van der Waals values for chlorine in alkyl 
organochlorides, for chlorine in aryl organochlorides and for bromine in alkyl organobromides were 
chosen by eye based on the above criteria and are presented in Table 4-1. 
 
Table 4- 1. Refined halogen parameters. 
 σ*(nm) ε*(kJ/mol) 
fÜ * 
(kJ mol-1 nm6)1/2 
fcy * 
(kJ mol-1 nm12)1/2 
Aliphatic chlorine 0.34±0.02 1.83±0.10 0.10634±0.00500 0.004180±0.000200 
Aromatic chlorine 0.32±0.02 1.49±0.10 0.08000±0.00400 0.002621±0.000100 
Aliphatic/Aromatic 
bromine 
0.39±0.02 2.43±0.10 0.18494±0.00900 0.01097±0.000500 
 
*Note, the values listed correspond to a specific grid point examined and are given with sufficient significant figures to 
make a 1-1 correspondence between σ and ε and  fÜ  and  fcy . The values are given ± the range over which similar 
results were obtained. 
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4.5.3 Validation of refined chlorine and bromine van der Waals interaction parameters  
 
Single step perturbation (SSP) approaches for refinement of halogen van der Waals parameters in 
the ATB against hydration free energies combined with validation of the parameters produced by 
this method against experimental liquid densities and heats of vaporisation calculated for 
organochlorides and organobromides yielded refined aliphatic and aromatic chlorine and aliphatic 
bromine van der Waals interaction parameters. Refined aliphatic and aromatic chlorine parameters 
were σ =0.34 nm, ε = 1.83 kJ/mol and σ =0.32 nm and ε = 1.49 kJ/mol respectively and aliphatic 
bromine van der Waals interaction parameters were σ =0.39 nm and ε = 2.43 kJ/mol. An 
investigation of the accuracy of refined parameters is presented in this section. 
 
4.5.3.1 Test set 
 
Refined van der Waals parameters developed for halogen atoms were validated by recalculation of 
the hydration free energies for all the 34 organochlorides and 15 organobromides from the test sets 
via the thermodynamic integration (TI) method as described in section 4.4. This test was performed 
not only to validate the refined parameters, but also to investigate the accuracy of the single-step 
perturbation (SSP) approach (Figure 4-6). Calculated hydration free energies for the set of 
molecules used are listed in Appendix 4 – Tables 4A-1 to 4A-3 and also presented graphically for 
aliphatic organochlorides (Figure 4-7), aromatic organochlorides (Figure 4-8) and aliphatic 
organobromides (Figure 4-9). 
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Figure 4- 6. A plot of unsigned errors in the hydration free energies with refined halogen parameters calculated 
between the single-step perturbation (SSP) and the experimental data against values calculated between the 
thermodynamic integration (TI) and the experimental data for 24 aliphatic and 19 aromatic organochlorides and 
15 aliphatic organobromides. The solid line has a slope of one and represents a one-to-one agreement between 
the values. The two dotted lines represent a 5 kJ/mol deviation from the ideal line. 
 
 
This accuracy of the SSP approach was tested by comparing the unsigned errors (UE) calculated 
between the values using this method and experimental data with the UEs calculated between the TI 
calculations and experimental values. The calculations were performed for 24 aliphatic and 19 
aromatic organochlorides and 15 aliphatic organobromides with the refined halogen parameters 
listed in Table 4-1. A plot comparing the UEs in hydration free energy values is shown in Figure 4-
6. The solid line has a slope of one and represents a one-to-one agreement between the values 
calculated using SSP and TI. The two dotted lines represent a 5 kJ/mol deviation from the ideal line. 
In Figure 4-6 an almost perfect agreement between the UEs in values calculated using the two 
methods was observed with the average unsigned error (AUE) of 0.29 kJ/mol, a slope of 1.01 and R 
of 0.99, indicating a similar accuracy of the SSP approach in predictions of the hydration free 
energies to the TI method.  
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Figure 4- 7. A plot of the calculated versus experimental hydration free energies (FE) for 24 aliphatic 
organochlorides.  Values were calculated using united atom ATB 2.0 topologies. Values with refined chlorine 
parameters are indicated by purple circles and values with original parameters are indicated by yellow circles 
(Table 4A-1). The solid line has a slope of one and represents a one-to-one agreement between the calculated and 
experimental numbers. The two dotted lines represent a 5 kJ/mol deviation from the ideal line. 
 
Figure 4- 8. A plot of the calculated versus experimental hydration free energies (FE) for 10 aromatic 
organochlorides.  Values were calculated using united atom ATB 2.0 topologies. Values with refined aromatic 
chlorine parameters are indicated by purple circles, values with refined aliphatic chlorine parameters are 
indicated by blue circles and values with original parameters are indicated by yellow circles (Table 4A-2). The 
solid line has a slope of one and represents a one-to-one agreement between the calculated and experimental 
numbers. The two dotted lines represent a 5 kJ/mol deviation from the ideal line. 
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Figure 4- 9. A plot of the calculated versus experimental hydration free energies (FE) for 15 aliphatic 
organobromides.  Values were calculated using united atom ATB 2.0 topologies. Values with refined bromine 
parameters are indicated by purple circles and values with original parameters are indicated by yellow circles 
(Table 4A-3). The solid line has a slope of one and represents a one-to-one agreement between the calculated and 
experimental numbers. The two dotted lines represent a 5 kJ/mol deviation from the ideal line. 
 
 
Figures 4-7 to 4-9 show plots of the values calculated using the refined parameters listed in Table 4-
1 and the original values before parameterisation versus experimental data.  The molecules with 
refined halogen parameters are shown as purple circles and values with the original parameters are 
indicated as yellow circles. Figure 4-8 also includes values calculated for aromatic organochlorides 
using parameters refined for aliphatic and aromatic compounds. The solid line in each plot has a 
slope of one and represents a one-to-one agreement between the calculated and experimental 
numbers. The two dotted lines represent a 5 kJ/mol deviation from the ideal line. The overall 
statistics are given in Table 4-2. From Figures 4-7 to 4-9 and Table 4-2 it can be seen that using the 
refined parameters, the hydration free energy predictions are closer to the experimental values for 
most molecules as was indicated by the single-step perturbation. The importance of splitting the 
parameters describing chlorine depending on chemical environment was emphasized by comparison 
of the average unsigned error (AUE) between calculated and experimental hydration free energies 
for aromatic organochlorides with values refined for aliphatic and aromatic species. The AUE with 
parameters designed for aromatic species reduced the AUE from 3.17 to 1.21 kJ/mol. When 
calculations for aromatic molecules were performed with parameters designed for aliphatic 
compounds, the improvement was only 0.16 kJ/mol (Table 4-2). Despite the significant 
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improvement of the AUE and the RMSE for the hydration free energies calculated with the refined 
parameters, such a marked improvement was not observed for the Tau, R and the Slope indicating 
that the perfect correlation between the values was not observed. 
Table 4- 2. Statistics for the comparison of the experimental and calculated free energies of hydration before and 
after refinement for aliphatic and aromatic organohalides. Values are in kJ/mol. 
 AEa RMSEb AUEc Taud Re Slopef 
Cl_Ali Orgg 5.79 7.49 5.80 -0.05 -0.03 -0.02 
Cl_Ali Refh 1.40 3.75 2.66 0.26 0.47 0.36 
Cl_Arom Orgi 3.17 3.65 3.17 0.30 0.28 0.53 
Cl_Arom Ref Alij -2.99 3.54 3.01 0.25 0.56 1.32 
Cl_Arom Ref Aromk 0.04 1.49 1.21 0.39 0.50 0.90 
Br_Ali Orgl -1.67 3.24 2.82 0.43 0.73 0.38 
Br_Ali Refm 0.05 3.01 2.44 0.31 0.67 0.30 
 
a Average error; b Root mean square error; c Average unsigned error; d Kendall’s tau statistic; e Pearson’s correlation 
coefficient; f Slope of linear regression; g Aliphatic organochlorides with original chlorine parameters; h Aliphatic 
organochlorides with refined chlorine parameters; i Aromatic organochlorides with original chlorine parameters; j 
Aromatic organochlorides with refined aliphatic chlorine parameters; k Aromatic organochlorides with refined aromatic 
chlorine parameters; l Aliphatic organobromides with original bromine parameters; l Aliphatic organobromides with 
refined bromine parameters. 
 
4.5.3.2 SAMPL challenges 
 
Refined parameters were also validated against the hydration free energies calculated for 
organohalide molecules with biological relevance from the SAMPL community challenges [24-27]. 
These molecules have a variety of other chemical groups in their structures apart from halogen 
atoms. 
 
The refinement results for 28 organochloride molecules from SAMPL challenges are presented in 
Appendix 4 - Table 4A-4 and graphically in Figure 4-10. 
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Figure 4- 10. A plot of the calculated versus experimental hydration free energies (FE) for 28 drug and drug-like 
organochlorides from SAMPL challenges.  Values were calculated using united atom ATB 2.0 topologies. Values 
with refined chlorine parameters are indicated by orange circles and values with original parameters are 
indicated by green squares (Table 4A-4). The solid line has a slope of one and represents a one-to-one agreement 
between the calculated and experimental numbers. The two dotted lines represent a 5 kJ/mol deviation from the 
ideal line. 
 
 
The effect of reparametrised chlorine and bromine van der Waals interaction parameters on the 
predictability of the whole SAMPL test sets [24-27] are presented in Appendix 4 - Table 4A-4 and 
graphically in Figure 4-11 for SAMPL0 (a), SAMPL1 (b), SAMPL2 (c) and SAMPL4 (d). 
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Figure 4- 11. A plot of the calculated versus experimental hydration free energies (FE) for molecules from 
SAMPL0 (a), SAMPL1 (b), SAMPL2 (c) and SAMPL4 (d) challenges.  Values were calculated using united atom 
ATB 2.0 topologies. Values with refined halogen parameters are indicated by orange circles and values with 
original parameters are indicated by green circles (Table 4A-4). The solid line has a slope of one and represents a 
one-to-one agreement between the calculated and experimental numbers. The two dotted lines represent a 5 
kJ/mol deviation from the ideal line. 
 
 
As in case of the molecules from the reparameterisation test sets, the SAMPL halogenated 
molecules also showed a decreased average unsigned error (AUE) between the calculated and 
experimental hydration free energies for the values calculated using the refined van der Waals 
parameters (Table 4-3 and Appendix 4 - Table 4A-4). The improvements in the hydration free 
energy predictions were around 1.0 kJ/mol compared to around 2.0 and 3.0 kJ/mol for aromatic and 
aliphatic organochlorides from the test set. The smaller improvement in these cases is most likely 
due to the other non-optimal atom types and groups present in the molecular structures of SAMPL 
molecules. With that in mind, the statistics in Table 4-3 still showed an overall improvement 
regarding the AUE and RMSE for all the SAMPL test sets apart from SAMPL4. The improved 
correlation between the values for all SAMPL test sets as indicated by the values for R and the 
                      a                                                                               b 
                       c                                                                             d 
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Slope closer to 1.0 for refined hydration free energies was also observed. These improvements were 
achieved by only parameterising chlorine and bromine van der Waals parameters for 28 
organochloride and 3 organobromide molecules that were included in these test sets. Further 
parameterisation of problematic atom types via single-step perturbation is suggested to improve the 
predictability of hydration free energies for molecules with multiple functional groups compared to 
the experiment.  
 
Table 4- 3. Statistics for the comparison of the experimental and calculated free energies of hydration before and 
after refinement of chlorine and bromine parameters for SAMPL molecules. Values are in kJ/mol. 
 AEa RMSEb AUEc Taud Re Slopef 
SAMPL0 Orgg 3.85 8.50 7.16 0.76 0.91 1.21 
SAMPL0 Refh 3.37 7.88 6.68 0.85 0.92 1.20 
SAMPL1 Orgi -0.03 13.34 9.63 0.64 0.82 1.33 
SAMPL1 Refj -2.22 12.89 9.58 0.63 0.82 1.28 
SAMPL2 Orgk -2.78 10.51 8.53 0.83 0.95 1.23 
SAMPL2 Refl -4.18 9.76 7.79 0.83 0.95 1.18 
SAMPL4 Orgm 0.96 9.96 7.53 0.60 0.85 1.00 
SAMPL4 Refn 0.84 10.09 7.60 0.60 0.85 1.00 
SAMPL Cl Orgo 3.31 11.91 8.85 0.70 0.87 1.13 
SAMPL Cl Refp -2.62 10.20 8.01 0.68 0.88 1.03 
 
a Average error; b Root mean square error; c Average unsigned error; d Kendall’s tau statistic; e Pearson’s correlation 
coefficient; f Slope of linear regression; g SAMPL0 molecules with original halide parameters; h SAMPL0 molecules 
with refined halide parameters; i SAMPL1 molecules with original halide parameters; j SAMPL1 molecules with 
refined halide parameters; k SAMPL2 molecules with original halide parameters; l SAMPL2 molecules with refined 
halide parameters; m SAMPL4 molecules with original halide parameters; n SAMPL4 molecules with refined halide 
parameters; o SAMPL organochloride molecules with original halide parameters; p SAMPL organochloride molecules 
with refined halide parameters. 
 
The results presented in this section underline the fact that force field parameterisation is a complex 
task. Many parameters are required to describe the behaviour of systems, with some of them being 
correlated. Therefore, refining against a range of experimental data was needed. Only the van der 
Waals parameters of the halogens were reparametrised in this study with other force field 
parameters remaining the same, but still contributing to the overall hydration free energy. Error 
cancellation is a common phenomenon where certain over- and under-estimated functional groups 
are present in a given molecule. That effect was observed for some of the SAMPL molecules where 
the refined chlorine parameters resulted in higher errors while predicting hydration free energies. 
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When the quality of the current force field parameters for other atoms and groups present in the 
molecular structures of organohalides was low, the improvements from the reparameterisation of 
halogen atoms had less influence on hydration free energies. The difference in the magnitude of the 
improvement achieved also depended on the quality of the initial van der Waals parameters for 
halogens. Uncertainties in the experimental data pose another difficulty as they were sometimes 
larger than the uncertainties in the calculations leading to possible over-fitting. Also, the parameters 
were obtained by fitting to the experimental data, therefore the resulting predictions are limited by 
the quality of the experimental model. 
 
4.5.4 Effect of local environment  
 
The importance of the local environment when calculating hydration free energies, liquid densities 
and heats of vaporisation using united atom (UA) topologies for 5 organochlorides containing 
GROMOS force field atom type 13 CH0 (C13) was discussed in sections 3.3 and 3.4.2. The study 
described in section 3.5.3 indicated that atom type 12 C (C12) and atom type 14 CH1 (C14) 
predicted experimental values with significantly higher accuracy than values predicted with C13 
and atom type 22 DUM, a dummy atom (C0) using the original chlorine van der Waals parameters. 
Therefore, C12 was used instead of C13 during refinement.  
 
After the parametrisation of the chlorine van der Waals interactions described in this chapter, the 
effect of the carbon parameters for atoms in the local environment was repeated using the refined 
chlorine van der Waals parameters, σ = 0.34 nm and ε = 1.83 kJ/mol. The results of changing C13 
van der Waals interaction parameters on the liquid density, heat of vaporisation and hydration free 
energies are presented in Table 4-4. 
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Table 4- 4. A comparison between the experimental and calculated properties for different carbon van der Waals 
interaction parameters for molecules with refined chlorine parameters. Values calculated using united atom 
parameters from ATB 2.0. The standard deviation was taken as the uncertainty for liquid densities and heats of 
vaporisation. The error for hydration free energies was calculated as per the protocol in section 3.4. 
a) A comparison between the experimental and calculated liquid densities. All values are in kg/m3. The error in 
the calculated values is ± 4 kg/m3. 
ATB MolIDa/Carbon parameter type Exp.b C12 C14 C0 C13 
2802 1329.1 1506.8 1456.2 1379.6 1286.6 
2804 1532.8 1651.2 1617.1 1549.6 1485.3 
2806 1679.6 1743.7 1723.9 1661.8 1622.0 
3800 1584.6 1838.9 1768.0 1706.5 1578.3 
3805 836.9 962.3 935.5 849.9 800.5 
 
b) A comparison between the experimental and calculated heats of vaporisation. All values are in kJ/mol. The 
error in the calculated values is ± 0.3 kJ/mol. 
ATB MolIDa/Carbon parameter type Exp.b C12 C14 C0 C13 
2802 32.5 48.3 48.0 36.1 35.0 
2804 36.8 58.1 58.6 46.1 46.2 
2806 46.3 65.5 66.8 54.3 55.5 
3800 32.4 56.4 55.3 42.9 40.8 
3805 29.0 38.1 38.4 27.5 27.5 
 
c) A comparison between the experimental and calculated free energies of hydration. All values are in kJ/mol. 
The error in the calculated values is ± 1.0 kJ/mol. 
ATB MolIDa/Carbon parameter type Exp.b C12 C14 C0 C13 
2802 -0.8 -3.0 -3.8* 2.5 1.5* 
2804 -5.4 -5.6 -5.5* 0.4 -1.3 
2806 -5.8 -6.9 -7.4* -1.6 -3.5 
3800 0.3 -5.1 -5.8* 0.0 0.0 
3805 4.6 -2.4* -3.3* 3.2 2.6 
 
a Molecule identification number as assigned by the ATB 2.0; b Experimental value of a given property [32-34]; 
*Values estimated from the SSP grids, rather than from the TI recalculations. 
 
The results are also presented graphically in Figure 4-12 which shows plots of the values for the 
properties calculated with the alternative carbon parameters and refined chlorine versus 
experimental data. The values calculated for C13 are shown in red, calculations for C12 are in blue, 
data for C14 is in black and values for dummy atoms are green circles. The solid line has a slope of 
one and represents a one-to-one agreement between the calculated and experimental numbers. The 
two dotted lines represent a 5 kJ/mol deviation from the ideal line for hydration free energies and 
heats of vaporisation and 100 kg/m3 for liquid densities.   
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Figure 4- 12. A plot of the calculated versus experimental properties for different carbon van der Waals 
interaction parameters for molecules with refined chlorine parameters. Values for C13 are indicated in red, data 
for C12 is in blue, calculations for C14 are in black and C0 in green (Table 4-4). The solid line has a slope of one 
and represents a one-to-one agreement between the calculated and experimental numbers. The two dotted lines 
represent a 5 kJ/mol deviation from the ideal line for hydration free energies and heats of vaporisation and 100 
kg/m3 for liquid densities.   
 
a) A comparison between the experimental and calculated liquid densities.  
 
 
b) A comparison between the experimental and calculated heats of vaporisation.  
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c) A comparison between the experimental and calculated hydration free energies. 
 
 
 
The overall statistics for the comparison to the available experimental data are given in Table 4-5. 
From the results, the opposite of what was observed in the study with original chlorine van der 
Waals interaction parameters was noted. For the calculations with the refined chlorine parameters, 
C12 and C14 predicted experimental values with similar accuracy. The predictions using C13 and 
C0 were also similar, but much different from the ones for C12 and C14. However, this time using 
C13 and C0, the predicted experimental liquid densities were closer to the experiment with the 
average unsigned error (AUE) of 38.07 and 44.03 kg/m3 respectively. The AUE values calculated 
using C12 and C14 were between 2-4 times higher. Predictions of the heats of vaporisation 
followed similar trend with AUE for C13 and C0 of around 6 kJ/mol, while the AUE for C12 and 
C14 was close to 18 kJ/mol. Refined chlorine parameters resulted in an increased accuracy of 
hydration free energy predictions for all carbon parameters with values ranging from 2.20 to 3.74 
kJ/mol and C13 and C0 again performing better than C12 and C14. However, the experimental 
hydration free energies for 2804 and 2806 (the most negative in the data set) were reproduced better 
with C12 and C14. 
 
Overall, it could also be seen that using C13 and C0 improved the predictability of all the properties 
for all molecules with refined chlorine van der Waals interactions, apart from the hydration free 
energies of 2804 and 2806. Conversely replacing C13 by C12 and C14 improved the predictability 
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of all the properties for all molecules, apart from 3805 when chlorine is set to the original value 
from the GROMOS force field (section 3.5.3). While C13 appeared to describe the interactions for 
3805, where carbon is buried among thee –CH3 groups, with high accuracy, similar accuracy was 
achieved by either changing the value of C13 to C12/C14 or alternatively changing the chlorine 
parameter to the refined value. Heats of vaporisation were reproduced slightly better when the 
carbons parameters were changed to C12 and C14 with no change to chlorine. Using the refined 
chlorine parameters with either C0 or C13 reproduced liquid densities and hydration free energies 
with the highest accuracy. Interestingly, the dummy atom C0 reproduced the experimental 
properties and follow similar trends to C13 indicating the differences were due to the long range 
attractive terms not the size of the atomic radius. 
 
Table 4- 5. Statistics for the comparison of the experimental and calculated properties for different carbon van 
der Waals interaction parameters for molecules with refined chlorine parameters. 
 AEa RMSEb AUEc Taud Re Slopef 
C13 Type       
Liquid density (kg/m3) -38.07 41.83 38.07 1.00 1.00 1.00 
Heat of vaporisation (kJ/mol) 5.59 7.08 6.19 0.80 0.95 1.51 
Hydration free energy (kJ/mol) 1.28 2.51 2.20 0.80 0.90 0.50 
C12 Type       
Liquid density (kg/m3) 147.97 161.30 147.97 0.80 0.98 1.01 
Heat of vaporisation (kJ/mol) 17.88 18.60 17.88 0.80 0.87 1.36 
Hydration free energy (kJ/mol) -3.18 4.10 3.18    0.80 0.85 0.37 
C14 Type       
Liquid density (kg/m3) 107.54 117.11 107.54 0.80 0.99 0.99 
Heat of vaporisation (kJ/mol) 18.04 18.72 18.04 0.80 0.90 1.45 
Hydration free energy (kJ/mol) -3.74 4.72 3.74 0.60 0.78 0.30 
C0 Type       
Liquid density (kg/m3) 36.91 60.32 44.03 0.80 0.99 1.02 
Heat of vaporisation (kJ/mol) 5.95 7.41 6.56 0.80 0.91 1.38 
Hydration free energy (kJ/mol) 2.32 3.58 3.00 0.60 0.78 0.35 
 
a Average error; b Root mean square error; c Average unsigned error; d Kendall’s tau statistic; e Pearson’s correlation 
coefficient; f Slope of linear regression. 
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4.6  Conclusions 
 
A test set consisting of 34 organochlorides and 19 organobromides was used for reparameterisation 
of van der Waals parameters for halogen atoms. Single-step perturbation protocols were 
successfully used to develop alternative force field parameters compatible with the GROMOS force 
field as implemented in the Automated force field Topology Builder and Repository (ATB; 
http://atb.uq.edu.au/). Respective hydration free energies, liquid densities and heats of vaporisation 
were calculated and compared with experimental values to determine the refined chlorine and 
bromine van der Waals parameters. The overall average unsigned error (AUE) between the 
predicted and experimental values for aliphatic organochlorides was 5.8 kJ/mol before the 
parametrisation and 2.7 kJ/mol for calculations using refined parameters. The decrease in the AUE 
from 3.2 to 1.2 kJ/mol was also noted for aromatic organochlorides and the AUE for aliphatic 
bromides decreased by 0.4 kJ/mol. The decrease in the AUE was also noted for common drug and 
drug-like molecules. This decrease however was not as significant as in the case of the simple 
halogen containing molecules, raising the question about future work potentially focusing on 
simultaneous parameterisation of multiple functional groups rather than parameterising each 
functional group separately. Further developments could also focus on improving a way in which 
the final parameters are chosen. Currently, the final van der Waals parameters to get the best 
compromise between the hydration, liquid density and heat of vaporisation data were chosen by 
eye. In the future, the parameters might be selected in a quantitative way weighting each criteria and 
performing a least square fit. Investigation of the local environment and altering the carbon 
parameters for certain organochlorides indicated a need for validation and reparameterisation of not 
only halogen, but also carbon parameters. The implementation of robust parameterisation protocols 
within the ATB combined with the increasing availability of distributed computing resources 
provides the potential to perform free energy calculations in a high throughput manner and 
undertake further large-scale optimisations of molecular force fields. 
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5.1 Chapter 5 
 
Validation of protein-ligand X-ray crystal structures via molecular dynamics simulations. 
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5.2 Abstract 
 
Inaccuracies in the interpretation of X-ray crystallography data for small ligand molecules forming 
complexes with proteins can result in incorrect predictions of the structure, position, orientation, 
stereochemistry, tautomeric state, orientation and conformation of such ligands. This can lead to 
errors in interpretation of reaction mechanisms and protein-ligand interactions. The accuracy with 
which the binding modes of inhibitors, substrates, cofactors and potential drug molecules in the 
active site of a protein is also paramount in drug design approaches where inaccuracies can result in 
the potential failure of such efforts. In this chapter, 11 X-ray crystallography structures of small 
ligands bound to endothiapepsin were studied via molecular dynamics (MD) simulations. The 
Automated Topology Builder (ATB) and Repository (http://atb.uq.edu.au) force field parameters 
were used to investigate the stability of these complexes in an attempt to validate the binding modes 
of the ligands. Analysis of the MD trajectories showed that the protein structure in all 11 systems 
remained relatively stable with the average RMSD between the X-ray and MD structures below 2.7 
Å. However, using the protonation states of the ligand and of the aspartic acids in the catalytic dyad 
assumed by Köster et al. (J. Med. Chem., 2011, 54, 7784-7796), the ligand conformation, binding 
mode, orientation and interaction with the neighbouring protein residues could only be validated in 
4 out of the 11 cases. This is despite the high accuracy of the electron density maps and low B-
factors for the ligands. However, simply by assigning different combinations of protonation state to 
the residues in the catalytic dyad and the ligand, 9 of the 11 complexes remained stable. This shows 
the importance of the consideration of the correct representation of both the protein and ligand and 
how MD simulations can be used to test assumptions and refine structures even in cases where high 
resolution structural data is available. 
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5.3 Introduction  
 
In this chapter, the stability of 11 X-ray structures of endothiapepsin-ligand complexes reported by 
Köster et al. [1]  have been examined using molecular dynamics (MD) simulations. The aims were 
to a) determine whether the parameters produced by the Automated Topology Builder (ATB; 
http://atb.uq.edu.au/) [2-4] for the ligands could reproduce the proposed crystal models in some or 
all of the cases and b) validate the proposed interactions between the protein and ligand in each 
case.  
 
X-ray diffraction (X-ray) from crystals plays a major role in determining tertiary protein structures 
at atomic resolution. However, it can only rarely be used to solve the protein structure directly [5]. 
Instead, information on the sequence and proposed geometry of the molecules is combined with the 
experimental diffraction data to generate an electron density map to which a structure is fitted. This 
new model is then used to generate a new electron density map and the process is repeated until the 
structures converge. It is models generated in this way which are used to study complexes with 
applications in rational drug design and structural biology [6-8]. The protein structures obtained are 
generally highly accurate. This is because the geometric parameters used to generate the initial 
models are well validated. However, the structures of small heteromolecular ligands that form 
complexes with these proteins are often much less precise [9]. This is mainly due to the fact that 
small non-covalently bound ligands possess a much higher degree of thermal motion and 
conformational disorder in comparison to the protein in the complex [10] [11]. This leads to the 
density of the ligand being not well-defined. Ambiguities in structures of ligands may also be due to 
the lack of optimised geometric constraints determining the local conformation [10]. X-ray 
refinement is also limited by the nature of the force fields used to generate the structures and the 
associated geometric constraints imposed, in particular the fact that electrostatic interactions are 
often ignored. This can mean that errors in the initial model propagate throughout the refinement 
stages. Even well-fitted electron density maps tend to display the features of the model used for 
their refinement therefore are subjected to model bias [12]. Further challenges come from the 
inability to determine the position of hydrogen atoms directly from crystallographic data and 
difficulties in assigning oxygen and nitrogen atoms in small molecules [10]. Less defined density 
results in less accurate predictions of the structure, position, orientation, stereochemistry, tautomeric 
state, orientation and conformation of ligands such as inhibitors, substrates, cofactors and potential 
drug molecules. This in turn can lead to errors in the interpretation of reaction mechanisms, protein-
ligand interactions and a potential failure of drug design approaches [13-15]. 
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Generally, it is assumed that if the modelled density fits well around the X-ray structure, a well-
defined force field designed to perform biomolecular-ligand simulations, which includes relevant 
information on non-bonded interactions, bond order and hydrogen atoms [16-27], should be able to 
reproduce the interactions assumed in the X-ray structure with high accuracy. Indeed, the ability to 
reproduce proposed crystal structures is widely used to validate biomolecular force fields. However, 
for this, reliable experimental data is needed. Köster et al. [1] recently crystallised 11 
endothiapepsin-ligand complexes at high resolution. 
 
Endothiapepsin complexes are extensively studied and a number of sequence determination and X-
ray crystallography experiments were conducted to determine the three-dimensional structure of 
endothiapepsin (Figure 5-1) and its inhibitors [28-33]. Endothiapepsin is an aspartic proteinase 
active at acidic pH. It is comprised of 330 amino acid residues and can be divided into two domains 
each containing approximately 179 amino acid residues. Each of the domains donates an aspartic 
acid to the catalytic dyad. Catalytic aspartate Asp35 is believed to be usually neutral and Asp219 
protonated [1]. However, the protonation state in complexes of endothiapepsin with ligands is less 
certain. The pKa of the ligands and protein residues can undergo a large shift as the ligand enters 
the binding pocket [34]. Therefore, it is possible that the deprotonation or protonation of both 
groups could allow for more thermodynamically favourable interactions with the ligand. Previous 
studies reported favourable interactions between ligands and di-protonated catalytic aspartates [35] 
and highlighted the importance of choosing the right aspartate to carry a proton in a 
monoprotonated site [35]. The two aspartate residues are involved in a catalytic mechanism 
involving nucleophilic attack of the active site water molecule on the scissile bond carbonyl 
(catalyses the cleavage of a peptide bond) [31-33,36,37]. The fold of the protein is mostly 
composed of β-sheet and areas of α-helix on the outside of the protein. Aspartic proteinase 
enzymes, including endothiapepsin, are found in plants, yeast, parasites, fungi, vertebrates, 
invertebrates, viruses and bacteria and involved in a number of biologically relevant processes 
playing major role in amyloid disease, malaria, common fungal infections such as candidiasis, 
tumorigenesis, peptic ulcer disease and maturation of the virus particle (HIV proteinase) [31-33,36]. 
Inhibitors to these enzymes are sought after as potential therapeutic agents in structure-based drug 
design [30,32,33,36]. 
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Figure 5- 1. The structure of endothiapepsin. 
 
 
 
Köster et al. [1] used a fragment library consisting of 364 entries to screen for endothiapepsin 
binding. Fifty-five hits which inhibited the enzyme by at least 40% were identified and soaked in to 
endothiapepsin crystals resulting in 11 crystal structures with compounds showing diverse binding 
modes. Of these, 7 ligands interacted directly with the catalytic aspartates, 2 ligands interacted with 
the catalytic aspartates via one or more water molecules and 2 ligands not did interact with the 
catalytic aspartates, but formed interactions with surrounding amino acids. Additional hydrogen 
bonds were also present for the majority of complexes. The complexity of the ligands combined 
with the precision of the electron density corresponding to the ligand makes this system an ideal 
case to test the ability of the ATB force field, as discussed extensively in Chapters 1-4, to reproduce 
a set of crystal complexes. 
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Figure 5- 2. Chemical formulas of the 11 compounds that formed complexes with endothiapepsin solved 
crystallographically by Köster et al. The description below each molecule corresponds to the PDB code of ligand-
endothiapepsin system (bold), the fragment ID by Köster et al. (italic), the molecule identification number as 
assigned by the ATB (ATB MolID; normal font) and crystal structure resolution (underlined). 
   
3PB5 (063, 26488, 1.90 Å) 3PBD (005, 28069, 1.70 Å) 3PBZ (109, 26217/ 28630, 
1.48Å) 
 
  
3PCW (216, 27812, 1.25 Å) 3PGI (041, 28064, 1.90 Å) 3PI0 (291, 26219/28656,    
1.64 Å) 
 
  
3PLD (290, 28066, 1.40 Å) 3PLL (306, 28068, 1.73 Å) 3PM4 (255, 26491/28710,  
1.68 Å) 
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3PMU (284, 26489, 1.43 Å) 3PMY (148, 26216/28657, 
1.38 Å) 
 
 
 
5.4 Methodology  
 
The methodology in this chapter consisted of electron density analysis, molecular dynamics 
simulations and an analysis of the root mean square deviation (RMSD) between different 
components of the simulated systems and the proposed crystallographic models. 
 
5.4.1 Electron density analysis  
 
Electron density maps were generated for the 11 ligands bound to endothiapepsin using the Electron 
Density Server (EDS) [38].  The maps were based on the crystallographical information provided 
by Köster et al. The 2 Fo - Fc density maps were generated at 1.0 σ. The positive Fo – Fc maps were 
created for + 2.0 σ and negative Fo – Fc maps were created at -2.0 σ. 
 
5.4.2 System set-up for simulation  
 
Two sets of simulations were performed. These differed in respect to the protonation states of the 
catalytic aspartates and the ligands in the systems investigated. The first series of simulations (set-
up 1) was based on the protonation states proposed by Köster et al. [1] where Asp35 was neutral 
and Asp219 was protonated. The protonation states of the ligands were assigned appropriate to the 
ligand being free in solution at the experimental pH of 4.6. In the second series of simulations (set-
up 2) both Asp35 and Asp219 were deprotonated and all of the ligands were protonated. 
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5.4.3 Topology generation  
 
The parameters and topology files for endothiapepsin were based on the GROMOS 54A7 force 
field [18-20] and generated using the GROMOS11 simulation package [39,40]. Protein 
conformations were taken directly from the X-ray structural coordinates as published in the PDB. 
Missing atoms were constructed using the Swiss PDB Viewer [41]. Hydrogen atoms were added 
using the GROMOS program gch. The parameters and topology files for all ligand molecules were 
generated automatically using the ATB version 2.1 [2-4] and used without modification. The ligand 
conformation was taken directly from the X-ray structural coordinates provided in the PDB after the 
addition of hydrogen atoms.  
 
5.4.4 Simulation parameters  
 
The molecular dynamics simulations and calculations were performed using the GROMOS11 
simulation package [39,40]. To generate the water systems each protein-ligand complex was 
solvated in a truncated octahedral periodic box filled with an equilibrated configuration of SPC 
water [42]. Sufficient Na+ ions were added to neutralise the system [42]. The size of the box was 
chosen such that the minimum distance between the solute and the box wall was 1.45 nm. The 
systems were energy minimised and molecular dynamics simulations were performed with 
parameters reported in Chapter 2. The complexes in water were initially equilibrated with all atoms 
within the protein and ligand positionally restrained for 0.5 ns. A further 0.5 ns of equilibration with 
only the protein restrained was then performed. Unrestrained molecular dynamics simulations were 
run for each complex. The length of these simulations was 10 ns. 
 
5.4.5 Root mean square deviation (RMDS) analysis  
 
The positional root mean square deviation (RMSD) [43] was introduced in Chapter 2 as a measure 
of average distance between equivalent atom pairs and is an indicator of the similarity between two 
structures. Here, the changes in the RMSD as a function of time were used to determine the stability 
of a given complex by comparing the X-ray and simulated structures. The protein RMSD provides 
information about conformational stability of the protein during the simulation. It was calculated by 
fitting all protein atoms from the simulated structure to the experimental protein structure. The 
stability of the ligand with respect to the binding pocket was determined by investigating the 
deviation of the ligand atoms after fitting the two complexes using atoms only within the protein. 
Time series of interatomic distances between specific ligand atoms and protein residues reported by 
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Köster et al. [1] were also generated to investigate the binding mode of the ligand in the binding 
pocket. This allowed changes in the orientation of the ligand within the binding pocket and changes 
in the nature of the interactions between the ligand and the protein to be identified. 
 
5.5 Results and Discussion  
 
5.5.1 Electron density analysis  
 
The electron density analysis focused on the interpretation of the electron density data for the 
ligands obtained by the experimentalists and how it matches the structure of the actual ligand. 
Electron density maps were generated as reported in section 5.4.1 and are shown in the Figure 5-3. 
The 2 Fo - Fc maps presented in grey show a good fit around the molecular structure for all 11 
ligands indicating the structures proposed can account for the electron density.  There are no regions 
of negative Fo - Fc. However, several structures have large regions of positive Fo - Fc shown in blue. 
This indicates that the proposed models may underestimate the electron density in these regions, 
potentially suggesting the presence of multiple overlapping conformations. Also, the 2 Fo - Fc maps 
for 3 ligands, 3PGI, 3PMY and 3PBZ, were discontinuous. This might indicate that these ligands 
are not stable in the binding pocket and/or the proposed models might not have been fitted onto the 
electron density correctly. Finally, in 4 cases, 3PCW, 3PBZ, 3PMY and 3PM4, it is possible that 
one or more alternative orientations of the ligand might fit equally well into the current 
interpretation of the electron density. 
 
Figure 5- 3. Electron density maps of the 11 compounds solved crystallographically by Köster et al. 2Fo – Fc maps 
generated at 1σ are shown in grey, the positive Fo – Fc  maps at +2σ  are in blue and the negative Fo – Fc maps at 
-2σ are in red. The description below each molecule corresponds to the PDB code of ligand-endothiapepsin 
system (bold), the fragment ID by Köster et al. (italic), the molecule identification number as assigned by the 
ATB (ATB MolID; normal font) and crystal structure resolution (underlined). 
 
  
 
3PB5 (063, 26488, 1.90 Å) 3PBD (005, 28069, 1.70 Å) 3PBZ (109, 26217/28630, 
1.48Å) 
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3PCW (216, 27812, 1.25 Å) 3PGI (041, 28064, 1.90 Å) 3PI0 (291, 26219/28656, 1.64 Å) 
 
 
  
 
3PLD (290, 28066, 1.40 Å) 3PLL (306, 28068, 1.73 Å) 3PM4 (255, 26491/28710,      
1.68 Å) 
 
 
 
 
 
3PMU (284, 26489, 1.43 Å) 3PMY (148, 26216/28657, 
1.38 Å) 
 
 
5.5.2 Protein stability  
 
The stability of the protein was quantified in terms of the RMSD as described in section 5.4.5. The 
protein RMSD was calculated by superimposing all the frames from the simulations on the X-ray 
structure and considering all the protein atoms with an atom fit to the entire protein structure. The 
protein RMSD between the MD and X-ray structures is presented in Figure 5-4:a for MD set-up 1 
in which Asp35 was deprotonated and Asp219 protonated as assumed by Köster et al. [1] when 
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generating their original models. The average RMSD is shown in column 2 of Table 5-1. Analysis 
of the MD trajectories showed that in all 11 systems the structure of the protein remained relatively 
stable over the 10 ns simulated with the average RMSD remaining below 2.5 Å. While there were 
variations between the complexes containing different ligands, e.g. 3PCW showed large 
fluctuations in the first few nanoseconds. Nevertheless, these were in general still within the 
uncertainty. As all the atoms within the protein were used in both the fit and the calculations of the 
RMSD, the inclusion of the loops between the elements of secondary structures could also account 
for these fluctuations in the RMSD. Note, the RMSD initially increased rapidly due to a 
combination of thermal motion and the system adjusting to the force field. 
 
Figure 5- 4. A plot of all atom protein RMSDs between the MD and X-ray structures calculated for the 11 
systems as a function of simulation time. The protein RMSD was calculated by superimposing all the frames 
from the simulations on the X-ray structure and considering all the protein atoms with an atom fit to the entire 
protein structure. The RMSD was measured in Å. 
a) MD set-up 1: deprotonated Asp35 and protonated 
Asp219; ligands protonated as appropriate for pH 4.6 
b) MD set-up 2: deprotonated Asp35 and Asp219; all 
ligands protonated 
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Table 5- 1. The average protein RMSD between the MD and X-ray structures calculated for the 11 systems over 
10 ns. In MD set-up 1 Asp35 was deprotonated, Asp219 was protonated and ligands protonated as appropriate 
for pH 4.6. In MD set-up 2 Asp35 and Asp219 were deprotonated and all ligands protonated. The standard 
deviation in the RMSD was taken as the uncertainty. The RMSD was measured in Å. 
 
PDB code of ligand-endothiapepsin system 
 
MD set-up 1 MD set-up 2 
3PB5 2.3 ± 0.3 2.3 ± 0.2 
3PBD 2.5 ± 0.2 2.4 ± 0.2 
3PBZ 2.0 ± 0.2 2.4 ± 0.4 
3PCW 2.4 ± 0.2 2.2 ± 0.2 
3PGI 2.0 ± 0.2* 2.2 ± 0.2 
3PI0 2.2 ± 0.2 2.0 ± 0.1 
3PLD 2.4 ± 0.3 2.1 ± 0.2 
3PLL 2.2 ± 0.2 2.6 ± 0.4 
3PM4 2.3 ± 0.3 2.4 ± 0.3 
3PMU 2.2 ± 0.3 2.7 ± 0.3 
3PMY 2.3 ± 0.2 2.2 ± 0.3 
Average 2.25 ± 0.3 2.32 ± 0.4 
* 3PGI includes data for only 4 ns of simulation 
 
5.5.3 Ligand stability in the binding pocket 
 
The stability of the binding pose of a ligand within the active site was also investigated by 
calculating the RMSD as described in section 5.4.5. The RMSD between the MD and X-ray 
structures was calculated for all ligand atoms after fitting the complex based solely on the atoms 
within the protein. The resulting RMSD as a function of simulation time for MD set-up 1 in which 
Asp35 was deprotonated and Asp219 was protonated as assumed by Köster et al. [1] is presented in 
Figure 5-5:a. The average RMSD is shown in column 2 of Table 5-2. Unlike the results for the 
protein, the RMSD of which varied little between the 11 complexes, the RMSD of the ligand with 
respect to its initial position in the protein varied significantly. In the case of 3PB5, 3PBZ, 3PGI 
and 3PI0 the average RMSD of the ligands was equal to or less than 3.0 Å and within 1.0 Å of the 
average RMSD of the protein. In these 4 cases it would appear that the binding pose suggested by 
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Köster et al. [1] is stable and that the force field as obtained from the ATB is capable of describing 
the interaction between the protein and the ligand with high accuracy. In the remaining 7 cases 
significant deviations from the proposed binding pose were observed. This is evident in Figure 5- 6, 
which shows the individual traces of the ligand RMSD (red) as a function of simulation time. In the 
case of 3PBD, 3PCW, 3PM4 and 3PLL there is a significant increase in the average RMSD of the 
ligand with respect to its initial position in the protein however the ligand clearly remains within the 
binding pocket. In the case of 3PM4 and 3PLL there are marked fluctuations in the RMSD over 
time suggesting the ligand is sampling alternative positions within the binding pocket. However, in 
3 cases 3PLD, 3PMU and 3PMY not only was there a marked increase in the average RMSD of 
the ligand but the RMSD progressively increased over the time simulated reaching above 8 Å 
indicating the ligand does not remain within the binding pocket. This suggests problems with either 
the initial starting conformation, the description of the protein or the description of the ligand. 
Given the fact that the density of the ligands in the complexes is so well defined the fact that only a 
third of the ligands were very stable while a third were clearly unstable is surprising. Of the 4 cases 
that performed well only one, 3PBZ, interacted directly with the catalytic dyad. Whereas of the 7 
ligands thought to interact directly with the catalytic aspartates 6 were unstable. This suggested that 
there might be a problem with the description of the interactions between the ligand and the 
catalytic dyad.  
 
5.5.4 Effect of the protonation state of the catalytic dyad 
 
In building their models Köster et al. [1] assumed that Asp35 was deprotonated and Asp219 
protonated in line with that expected for the holoprotein. However, the protonation state of a side 
chain cannot be observed directly using crystallographic techniques. It is also possible that the 
protonation state of the catalytic dyad is influenced by the presence of the ligands which themselves 
can potentially be charged. To test whether the protonation state of Asp35 and Asp219 could affect 
the stability of the complexes, a second series of simulations were performed in which both Asp35 
and Asp219 were deprotonated whereas the ligand was singly protonated with a charge of +1. 
These correspond to MD set-up 2. 
 
The stability of the protein in the MD set-up 2 was again examined in terms of the RMSD as 
described in section 5.5.2. The protein RMSD between the MD and X-ray structures is presented in 
Figure 5-4:b. The average RMSD is shown in column 3 of Table 5-1. Again, the protein structures 
remained relatively stable. The average RMSD calculated considering all the systems was slightly 
higher than for the MD set-up 1 (2.32 Å as opposed to 2.25 Å). There were also variations between 
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the complexes containing the same ligands for different MD set-ups, e.g. 3PMU showed large 
fluctuations over the 10 ns simulated in the MD set-up 2, but was stable for MD set-up 1. However, 
the opposite was true for 3PCW. The differences in the MD set-ups for the same molecules were 
within the uncertainty of a standard deviation indicating that the protonation state of the catalytic 
dyad did not significantly influence protein conformations. 
 
The stability of the binding pose of the ligand within the active site for MD set-up 2 was also 
investigated as described in section 5.5.3. The RMSD between the MD and X-ray structures is 
presented in Figure 5-5:b. and the average RMSD is shown in column 3 of Table 5-2. In 8 cases, 
3PB5, 3PBZ, 3PGI, 3PI0, 3PCW, 3PM4, 3PLD and 3PLL, the average RMSD of the ligand was 
equal to or less than 3.0 Å and within 1.0 Å of the average RMSD of the protein. However, in the 
case of 3PBZ, although the average RMSD is 2.9 Å, there is a large uncertainty of 1.7 Å. This was 
due to a rapid increase in the RMSD which reached 8.0 Å near the end of the simulation. It would 
appear that in the other 7 cases the binding poses suggested by Köster et al. [1] were stable and that 
the force field as obtained from the ATB is capable of describing the interaction between the protein 
and the ligand appropriately. This indicates that the pronation state of the catalytic dyad and the 
ligand play a central role in being able to reproduce the interactions suggested by Köster et al.  
 
In particular, the X-ray structures for 3PCW, 3PLD and 3PLL were well reproduced using the MD 
set-up 2. In all these systems, the ligand has an amidine functional group and these are the only 
systems where the ligand forms hydrogen bonds exclusively with the two catalytic aspartates. 
Modelling the amidine group as protonated and the aspartates as deprotonated reproduces the X-ray 
structure with much higher accuracy than the MD set-up 1 where Asp219 is protonated. The 
interactions of the ligand of 3PM4 with the catalytic dyad are also described well for the MD set-up 
2 where the protonated, as opposed to neutral ligand in MD set-up 1, interacts with catalytic 
aspartates and also the backbone nitrogen of Gly80 and oxygen of Gly221.  
 
The ligand RMSD values of 3PB5, 3PGI, 3PI0, where in the crystal the ligands appear to interact 
with the catalytic aspartates by either interstitial water molecules or show no direct interaction with 
the two catalytic aspartates, seem to be insensitive to the change of the pronation states of the 
aspartates and the ligand and performed well in both MD set-ups.  
 
In the case of 3PBZ and 3PBD much smaller fluctuations are observed for the direct interactions 
between the catalytic dyad and the neutral amine group of the ligand in the MD set-up 1 compared 
to the MD set-up 2 where the amine is protonated for 3PBZ.   
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3PMU and 3PMY performed very poorly in both cases with the RMSD progressively increasing 
over the entire time period simulated reaching above 8 Å, indicating the ligand was no longer 
within the binding pocket. Either the pronation states were not suitable for these systems in both 
cases or there are other problems related to either the initial starting conformation, the description of 
the protein or the description of the ligand. 
 
All in all, it can be concluded that despite the high precision of the ligand electron density maps 
discussed in section 5.5.1., the determination of the ligand conformation in the binding pocket was 
challenging. The selection of the protonation states for the purpose of the molecular simulation of 
different components of the X-ray protein-ligand systems played a vital role in determining the 
stability of the systems as presented in Figure 5-6. After testing two MD set-ups with different 
protonation states, 9 out of 11 ligands remained stable. Ligands of 3PBD and 3PBZ were more 
stable for the MD set-up 1. Ligands of 3PCW, 3PLD, 3PM4 and 3PLL were more stable for the 
MD set-up 2. 3PB5, 3PI0 and 3PGI remained in the binding pocket and the results of the 
simulations were insensitive to the protonation states. 3PMU and 3PMY were unstable under both 
conditions. To further validate these X-ray structures, binding modes, orientations and interactions 
of ligands with neighbouring protein residues were studied.  
 
Figure 5- 5. A plot of all ligand RMSDs between the MD and X-ray structures calculated for both MD set-ups for 
11 systems over the 10 ns long simulations. The ligand RMSD was calculated for all ligand atoms with an atom 
fit to all the protein atoms aligned with the X-ray structure. The RMSD was measured in Å. 
a) MD set-up 1: deprotonated Asp35 and protonated 
Asp219; ligands protonated for pH of 4.6 
b) MD set-up 2: deprotonated Asp35 and Asp219; 
all ligands protonated 
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Table 5- 2. The average ligand RMSD between the MD and X-ray structures calculated for both MD set-ups for 
11 systems over the 10 ns long simulations. The MD set-up 1 represents deprotonated Asp35, protonated Asp219 
and ligands protonated for pH of 4.6. The MD set-up 2 represents deprotonated Asp35 and Asp219 and all 
ligands protonated. The standard deviation in the RMSD was taken as the uncertainty. The RMSD was 
measured in Å. 
 
PDB code of ligand-endothiapepsin system 
 
MD set-up 1 MD set-up 2 
3PB5 2.8± 0.2 2.7± 0.3 
3PBD 3.8 ± 0.5 5.6 ± 1.7 
3PBZ 2.1 ± 0.2 2.9 ± 1.7 
3PCW 4.3 ± 0.6 1.8 ± 0.4 
3PGI 2.2 ± 0.5* 2.5 ± 0.5 
3PI0 3.0 ± 0.5 3.0 ± 0.5 
3PLD 5.9 ± 1.3 2.6 ± 0.5 
3PLL 3.4 ± 0.8 1.4 ± 0.2 
3PM4 4.5 ± 1.0 2.9 ± 0.6 
3PMU 6.3 ± 1.5 7.0 ± 2.1 
3PMY 5.4 ± 2.1 5.0 ± 2.4 
 
* 3PGI includes data for only 4 ns of simulation  
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Figure 5- 6. Individual plots of protein and ligand RMSDs between the MD and X-ray structures calculated for 
both MD set-ups for 11 systems over the 10 ns long simulations. The MD set-up 1 represents deprotonated 
Asp35, protonated Asp219 and ligands protonated for pH of 4.6. The MD set-up 2 represents deprotonated 
Asp35 and Asp219 and all ligands protonated. Protein and ligand RMSDs for MD set-up 1 are shown in black 
and red respectively and protein and ligand RMSDs for MD set-up 2 are shown in grey and coral respectively. 
The protein RMSD was calculated by superimposing all the frames from the simulations on the X-ray structure 
and considering all the protein atoms with an atom fit to the entire protein structure. The ligand RMSD was 
calculated for all ligand atoms with an atom fit to all the protein atoms aligned with the X-ray structure. The 
RMSD was measured in Å. The description below each molecule corresponds to the PDB code of ligand-
endothiapepsin system (bold), the fragment ID by Köster et al. (italic), the molecule identification number as 
assigned by the ATB (ATB MolID; normal font) and crystal structure resolution (underlined). 
  
3PB5 (063, 26488, 1.90 Å) 
 
3PBD (005, 28069, 1.70 Å) 
 
  
3PBZ (109, 26217/28630, 1.48Å) 
 
3PCW (216, 27812, 1.25 Å) 
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3PGI (041, 28064, 1.90 Å) 
 
3PI0 (291, 26219/28656, 1.64 Å) 
 
  
3PLD (290, 28066, 1.40 Å) 
3PLL (306, 28068, 1.73 Å) 
 
  
3PM4 (255, 26491/28710, 1.68 Å) 
 
3PMU (284, 26489, 1.43 Å) 
 
129 
 
 
 
 
3PMY (148, 26216/28657, 1.38 Å) 
 
 
5.5.5 Ligand stability and the binding mode 
 
To further validate the 11 X-ray structures, binding modes, orientations and interactions of ligands 
with neighbouring protein residues were studied. To compare the X-ray and MD ligand structures, 
the X-ray ligand structures and their orientations in the binding pocket were overlaid with the 
structures generated after 10 ns of simulation. Differences in the orientations are shown in Figures 
5-7 to 5-10. Distances between the ligand atoms interacting with endothiapepsin residues over time 
were also investigated to determine whether the specific interactions reported experimentally were 
maintained. These are displayed in Figures 5-7 to 5-10. 
 
5.5.5.1 Ligands most stable in the MD set-up 1 
 
3PBD and 3PBZ were more stable in the MD set-up 1. The distance over time plot for 3PBD 
showed that the ligand adopts two binding modes shown in cyan and pink as indicated by the step-
function presented in Figure 5-7. Despite a relatively stable ligand RMSD shown in Figure 5-6, 
mid-simulation the ligand reorientated such that with the exocyclic nitrogen atoms projected away 
from the catalytic dyad, before re-adopting the orientation similar to the one reported in the X-ray 
study. While the interactions of OD1(Asp35) with N10(lig) are retained after 10 ns, the interactions 
of OD1(Asp219) with N10(lig) are lost. A movement of the ligand away from Thr222 and Tyr79, 
reported by Köster et al. [1] as residues likely to form hydrogen bonding with the ligand, was also 
observed. For 3PBZ the X-ray orientation was maintained in the MD simulation and no major 
change in the ligand-aspartate distances over 10 ns were observed despite the slight tilt of the ligand 
(Figure 5-7). 
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Figure 5- 7. Validation of the X-ray structures for 2 systems with ligands stable in the MD set-up 1 a) X-ray 
predicted ligand structures (green) aligned with the ligand conformations after 10 ns long MD simulation (cyan) 
shown in space relative to the catalytic aspartates Asp35 and Asp219. Intermediate structures for ligands 
showing alternative conformations are shown in pink. b) Change in the distances between interacting ligand 
atoms and selected protein residues. The data was collected over 10 ns and measured in Å. The description below 
each molecule corresponds to the PDB code of ligand-endothiapepsin system (bold), the fragment ID by Köster 
et al. (italic), the molecule identification number as assigned by the ATB (ATB MolID; normal font) and crystal 
structure resolution (underlined). 
 
 
a) b) 
 
3PBD (005, 28069, 1.70 Å) 
 
 
a) 
 
b) 
 
3PBZ (109, 26217, 1.48Å) 
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5.5.5.2 Ligands stable in the MD set-up 1 and 2 
 
3PB5, 3PGI and 3PI0 remained in the binding pockets and the results were insensitive to the 
protonation states. However, the ligand of 3PI0 displayed two different binding modes.  
 
For 3PB5, the distances measured between the ligand atoms and the catalytic dyad shown in black, 
grey, red and orange in Figure 5-8 were generally maintained suggesting that the interactions 
reported by Köster et al. [1] were preserved in both MD set-ups with the MD set-up 2 showing less 
fluctuations and shorter distances. This also indicates that the interactions take place via a water 
molecule as the interactions are not very sensitive to the change in the pronation state. A good 
alignment between the six-membered ring from the X-ray and both MD set-ups was shown in 
Figure 5-8 as opposed to the misaligned mobile amine end of the ligands responsible for the loss of 
the interactions between the ligand and Asp81 and Ser115. Interestingly, the ligand RMSD was 
stable suggesting that the interactions with Asp81 and Ser115 do not influence the overall stability 
of the ligand in the binding pocket. 
 
3PGI could not be simulated past 4 ns for MD set-up 1 due to a repeated SHAKE error. This might 
have been caused by the incorrect protonation state of one or more components of the complex 
resulting in a highly strained structure. However, 3PGI was successfully simulated using the MD 
set-up 2. Similar orientations of ligands from the X-ray study and both MD simulations were 
shown, however the ligand in the MD set-up 1 moved away from the aspartate dyad (Figure 5-8). 
That was also indicated by the distance over time plot for MD set-up 1 reaching almost 10 Å for 
certain interactions. Köster et al. [1] proposed that the electron density of the ligand of 3PGI was 
less well-defined compared to the other nine ligands, indicating high mobility of the ligand due to  
no direct interactions with the catalytic dyad. This is also suggested by the fact that the distances 
between the ligand and the catalytic aspartates were large as opposed to the interactions of the 
ligand with Asp81, Gly80 and Thr222 that were retained for the MD set-up 2 (Figure 5-8). 
 
The ligand of 3PI0 remained in the binding pocket, but displayed two different binding modes 
shown in pink and cyan (Figure 5-8). The protonated pyridine-type nitrogen moved away from the 
catalytic dyad with deprotonated aspartates in the MD set-up 2 while the distance between the 
neutral pyridine-type nitrogen interacting with the deprotonated Asp35 and protonated Asp219 was 
largely retained in the MD set-up 1. The distance between the ligand and Asp81 was also affected 
by the changes in the orientation of the ligand for both MD set-ups and these interactions were not 
retained. 
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Figure 5- 8. Validation of the X-ray structures for 4 systems with ligands stable in both MD set-ups a) X-ray 
predicted ligand structures (green) aligned with the ligand conformations after 10 ns long MD simulation (cyan) 
shown in space relative to the catalytic aspartates Asp35 and Asp219. Intermediate structures for ligands 
showing alternative conformations are shown in pink. b) Change in the distances between interacting ligand 
atoms and selected protein residues. The data was collected over 10 ns and measured in Å. The description below 
each molecule corresponds to the PDB code of ligand-endothiapepsin system (bold), the fragment ID by Köster 
et al. (italic), the molecule identification number as assigned by the ATB (ATB MolID; normal font) and crystal 
structure resolution (underlined). 
 
 
a)  
MD set-up 1: 
b) 
3PB5 (063, 26488, 1.90 Å) 
 
 
a)  
MD set-up 2: 
b) 
3PB5 (063, 26488, 1.90 Å) 
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a)  
 
MD set-up 1: 
b) 
 
3PGI (041, 28064, 1.90 Å) 
 
 
a)  
 
MD set-up 2: 
b) 
 
3PGI (041, 28064, 1.90 Å) 
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a)  
 
MD set-up 1: 
b) 
 
3PI0 (291, 26219, 1.64 Å) 
 
 
a)  
 
MD set-up 2: 
b) 
 
3PI0 (291, 28656, 1.64 Å) 
 
 
5.5.5.3 Ligands most stable in the MD set-up 2 
 
Based on the ligand RMSDs, the ligands of 3PCW, 3PLD and 3PLL were identified as being most 
stable for the MD set-up 2. All three molecules form salt-type hydrogen bonds between the catalytic 
dyad and the amidine group of the ligand. The MD ligand structures of 3PCW and 3PLL showed 
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an almost ideal fit to the X-ray structures (Figure 5-9). The distance over time plots showed no 
major change in the ligand-aspartate distances over 10 ns.  
 
For 3PLD, two distinct ligand orientations were sampled during the simulations. Specifically there 
was a slight change in the orientation of the aromatic ring and the amidine group as shown in Figure 
5-9. The transition between these two states occurred roughly each ns as can be seen in the stepwise 
change in the RMSD in Figure 5-6 and in the distance plots in Figure 5-9, in particular for the 
OD1(Asp35) –N6(lig) distance shown in black. 
 
3PM4 was also identified as stable for the MD set-up 2. However, it also displayed two different 
binding modes shown in cyan and pink in Figure 5-9. This also involved a slight tilting of the 
molecule in the binding pocket. The distance over time plot showed no major change in the ligand-
aspartate distances over 10 ns. Significant fluctuations were observed for interactions of the ligand 
with the backbone nitrogen of Gly80 and oxygen of Gly221. 
 
Figure 5- 9. Validation of the X-ray structures for 3 systems with ligands stable in the MD set-up 2 a) X-ray 
predicted ligand structures (green) aligned with the ligand conformations after 10 ns long MD simulation (cyan) 
shown in space relative to the catalytic aspartates Asp35 and Asp219. Intermediate structures for ligands 
showing alternative conformations are shown in pink. b) Change in the distances between interacting ligand 
atoms and selected protein residues. The data was collected over 10 ns and measured in Å. The description below 
each molecule corresponds to the PDB code of ligand-endothiapepsin system (bold), the fragment ID by Köster 
et al. (italic), the molecule identification number as assigned by the ATB (ATB MolID; normal font) and crystal 
structure resolution (underlined). 
 
 
a) 
 
b) 
3PCW (216, 27812, 1.25 Å) 
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a) 
 
b) 
 
3PLD (290, 28066, 1.40 Å) 
 
 
 
a) 
 
b) 
 
3PLL (306, 28068, 1.73 Å) 
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a)  
 
 
b) 
 
3PM4 (255, 28710, 1.68 Å) 
 
 
5.5.5.4 Ligands not stable in either the MD set-up 1 or 2 
 
3PMU and 3PMY were unstable under both conditions. Distance analysis showed, similarly to the 
RMSD plots, a continuous increase in the distance between the ligands and protein residues 
reported in the X-ray study for the majority of the simulation time reaching above 10 Å (Figure 5-
10) indicating a high mobility of the ligands. A comparison of the ligand orientation in the X-ray 
and MD structures of 3PMU and 3PMY revealed almost complete misalignment of the ligand 
between the two states for both MD set-ups (Figure 5-10). The X-ray study does not report 
interactions between the 3PMU ligand with the catalytic dyad which offers a possible explanation 
for the overall instability of the system. From the distance plots of 3PMU and 3PMY, it can also be 
seen that the distances between the ligand and protein residues started to stabilise from 7 ns 
therefore extended simulations are suggested to further investigate these systems. The ligand in 
3PMY was also identified of one the cases where one or more alternative orientations of the ligand 
might fit equally well into the current interpretation of the electron density. Simulations starting 
from these alternative orientations should also be performed. A change in the protonation state of 
the ligands and interacting residues could also improve the convergence between the MD 
simulations and the crystals. 
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Figure 5- 10. Validation of the X-ray structures for 2 systems with ligands not stable in both MD set-ups a) X-ray 
predicted ligand structures (green) aligned with the ligand conformations after 10 ns long MD simulation (cyan) 
shown in space relative to the catalytic aspartates Asp35 and Asp219. b) Change in the distances between 
interacting ligand atoms and selected protein residues. The data was collected over 10 ns and measured in Å. The 
description below each molecule corresponds to the PDB code of ligand-endothiapepsin system (bold), the 
fragment ID by Köster et al. (italic), the molecule identification number as assigned by the ATB (ATB MolID; 
normal font) and crystal structure resolution (underlined). 
 
 
a)  
 
MD set-up 1: 
b) 
 
3PMU (284, 26489, 1.43 Å) 
 
  
a) 
 
MD set-up 2: 
b) 
 
3PMU (284, 26489, 1.43 Å) 
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a) 
 
MD set-up 1: 
b) 
 
3PMY (148, 26216, 1.38 Å) 
 
 
a) 
 
MD set-up 2: 
b) 
 
3PMY (148, 28657, 1.38 Å) 
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5.5.6 B-factor analysis 
 
The crystallographic B-factors can be interpreted as a measure of the precision with which the 
position of an atom is known and is often related to the mean square fluctuation of the atomic 
position. Here, the average B-factors from crystallographic data were calculated for each ligand to 
help interpret the results obtained via the MD simulations. The average B-factors are shown in 
Table 5-3. It might be expected that ligands which have a lower average B-factor would be more 
stable and have a lower RMSD in the simulations. No such general correlation was observed, 
however the B-factors of ligands that were not stable in the binding pocket were above 30 Å2. 3GPI 
was also characterised by a large B-factor which indicates that several atoms in this structure were 
highly mobile, potentially contributing to less well-resolved densities and affecting the refinement 
of the crystal structure models leading to the instabilities encountered during the simulation of MD 
set-up 1. 
 
Table 5- 3.  The average B-factors and B-factor range of the ligands in each of the 11 ligand-endothiapepsin 
systems. The values are calculated from the temperature factors provided in the X-ray crystal structure PDB 
files. 
 3PB5 3PBD 3PBZ 3PCW 3PGI 3PI0 3PLD 3PLL 3PM4 3PMU 3PMY 
B-factor 
(Å2) 
30.8 28.6 28.5 21.5 46.0 25.5 23.7 18.2 20.5 32.9 31.0 
Range 
(Å2) 
18.9 – 
41.0 
19.8 – 
36.4 
17.2 – 
37.7 
10.9 – 
43.9 
23.2 – 
61.1 
18.4 – 
37.6 
14.5 – 
34.9 
5.64 – 
29.5 
16.6 – 
24.2 
27.3 – 
36.7 
23.3 – 
42.0 
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5.6  Conclusions 
 
In this chapter, 11 X-ray crystallography structures of small ligand molecules bound to 
endothiapepsin were studied using molecular dynamics (MD) simulations and the Automated 
Topology Builder (ATB) and Repository (http://atb.uq.edu.au) force field parameters to investigate 
the stability of these complexes and to validate binding modes of the ligands. Analysis of the MD 
trajectories showed that the protein structure remained relatively stable after 10 ns of simulations. 
The results for the validation of the ligands were mixed. While in some cases the simulations 
reproduced the binding mode and the interactions between the protein and the ligand with high 
precision suggesting the ATB parameters performed well, in other cases the complexes were 
unstable. Using the protonation states of the ligand and aspartates in the catalytic dyad assumed in 
the crystal, the ligand conformation, binding mode, orientation and interaction with the 
neighbouring protein residues could only be validated in 4 out of the 11 cases. This was despite the 
fact that the electron density for all ligands was well defined and the parameters for the ligand were 
generated using the same procedure. Endothiapepsin contains a catalytic dyad consisting of two 
aspartates that are generally assumed to share a proton. However, simply by assigning different 
combinations of protonation state to the residues in the catalytic dyad and the ligand, 9 of the 11 
complexes were found to be stable. We demonstrated that the protonation of both the ligand and the 
residues with the binding site were critical to the ability to reproduce the crystal complex even in 
cases where high resolution structural data is available. This short study could be further improved 
by extending the length of simulations to investigate the interactions, especially the binding on 
larger time-scales and performing replicate studies to assure the reproducibility of the results. 
Alternative conformations of the ligands could also be investigated, especially in cases where there 
were uncertainties in the ligand position in the electron density. With the determination of the 
protonation states remaining challenging alternative combinations of protonation states of the 
protein and ligands could be tested.  
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6.2 General summary and conclusions 
 
Computational approaches are widely used to help discover and develop new drugs, in particular, to 
understand how these molecules interact with their biomolecular targets. There are well-optimised 
and validated force field parameters available to describe interactions of common biomolecules, 
however these force fields are not designed to represent heteromolecular ligands such as substrates, 
inhibitors, co-factors and potential drug molecules. Errors in the parameters for such molecules may 
result in incorrect predictions of ligand structure, orientation and conformation, which in turn can 
lead to the failure of computational drug design efforts. With over 25% of all the structures in the 
Protein Data Bank (PDB) containing ligands and over a million ligand molecules of potential 
interest in drug design in other databases, ligand parameterisation and validation represents a 
significant scientific challenge.  
 
While several automated parameterisation protocols have been proposed to generate parameters for 
arbitrary molecules, none of the current procedures are well validated. As a response to the high 
demand for interaction parameters for ligands compatible with the GROMOS force field, a web 
accessible Automated force field Topology Builder (ATB; http://atb.uq.edu.au/) and Repository was 
developed. The ATB and Repository is intended to facilitate the development of molecular force 
fields and generates parameters that can be used in X-ray refinement, structure-based drug design 
and the study of biomolecule-ligand complexes. 
 
The first part of this thesis focused on the use of structural and thermodynamic properties to 
validate parameters obtained using the ATB. A fully automated protocol to validate the ATB force 
field parameters for small organic molecules based on thermodynamic (hydration free energies) and 
structural (optimised geometries) information was developed and incorporated into the ATB 
methodology. It was shown that there is a very good overall agreement between the quantum 
mechanics (QM) optimised structures and the energy minimised structures obtained using the ATB 
parameters for over 3000 molecules. A set of 214 molecules including various drug and drug-like 
molecules was then used to test and validate the all atom and united atom topologies generated 
using the ATB against thermodynamic data. There was a good overall agreement between the 
predicted and experimental hydration free energies for the majority of molecules investigated. For 
117 of 214 molecules examined, the predicted hydration free energy was within 5 kJ/mol of the 
experimental value, with the average unsigned error (AUE) between the calculated and 
experimental values of 6.7 kJ/mol. The AUE for a set of small organic molecules with high quality 
hydration free energy data was only 3.4 kJ/mol. The AUE for different subsets of drug and drug-
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like molecules ranged between 7.2 and 9.6 kJ/mol reflecting both the intrinsic uncertainty in some 
of the experimental values, as well as the fact that the GROMOS force field is primarily intended 
for biomolecular systems and has yet to be optimised for certain functional groups. Systematic 
differences between the calculated and experimental values for specific functional groups were 
noted. This suggested that further significant improvements in the predictive ability of the ATB 
parameters were possible. The values presented were based on fully automated protocols that 
requires no manual intervention. This novel integration and convergence protocol increases the 
efficiency of the thermodynamic integration (TI) method for free energy calculations. The protocol 
determines the starting structure for the simulation at each lambda point, length of the simulation 
required to achieve convergence at a given lambda point and a total number of lambda points 
required for a sufficient sampling of the curve. The implementation of the robust parameterisation 
and validation protocols within the ATB combined with the increasing availability of distributed 
computing resources provides the potential to perform free energy calculations in a high throughput 
manner and undertake large-scale optimisation of molecular force fields. From this chapter, it can 
be concluded that the large scale validation of force field parameters is an important component of 
the parametrisation process. The assessment of the accuracy of the force field parameters is crucial 
to direct the parametrisation effects towards the most problematic issues and also provides 
important information to the users and gives them the confidence in using the force field. Validation 
study also indicated potential ways to improve the force fields. Non-bonded interactions in the force 
fields such as the van der Waals and electrostatic interactions are less reliable than the bonded terms 
validated against a plethora of high quality experimental data. The force field could be improved by 
reparameterisation of such non-bonded interactions against available experimental data for atom 
types which are not commonly found in biomolecules and were not extensively validated before. 
This chapter also highlights the limitations of the force field parametrisation, especially the limited 
availability of reliable experimental values. The high level of uncertainty in some of the 
experimental hydration free energies was particularly problematic. The importance of the 
development of automated methodology which made it possible to perform the large numbers of 
calculations required with no manual intervention is also indicated. The automated TI protocol is 
able to calculate hydration free energies and it will be extended in the future to perform solvation 
free energy calculations with other solvents to extend the scope of the validation protocol. As the 
GROMOS force field parameters were also refined against liquid densities and heats of 
vaporisation, a validation test involving these properties would also provide invaluable information. 
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Force field parameters for halogens were identified as non-optimal in the validation study described 
above. Therefore, a test set consisting of 34 organochlorides and 19 organobromides was selected 
for the purpose of investigating the challenges involved in force field parametrisation of halogen 
interactions. Calculations of hydration free energies, densities and heats of vaporisation were 
performed and compared with experimental values to assess the influence of potential problems 
associated with the thermalisation of the solute on calculations of hydration free energies and the 
effect of varying the parameters of atoms in the local environment of the halogen on calculations of 
all above properties. The overall AUE for the test set of 34 organochlorides was 6.33 kJ/mol using 
the protocol without a proper thermalisation of the solute and 5.50 kJ/mol for calculations of 
hydration free energies with correct thermalisation. This suggests that correct thermalisation in 
hydration free energy calculations improves the predictability of experimental data. Further 
examination of the hydration free energies indicated that the development of different halogen 
parameters for aromatic and aliphatic molecules would further improve the accuracy of calculated 
properties. The investigation of the effect of the local environment by altering the carbon 
parameters to which the halogen was attached for certain organochlorides indicated a need to 
consider not only the halogen, but also the parameters of the surrounding carbons. Simply by 
selecting alternate GROMOS parameters for fully saturated carbons it was possible to reproduce 
experimental liquid densities, heats of vaporisation and hydration free energies with a higher 
accuracy. All the changes and corrections made in this study resulted in a better reproducibility of 
experimental properties, however the discrepancies between the calculated and experimental values 
for organohalides were still significant. Therefore, a large-scale optimisation of molecular force 
fields for halogens was attempted in the following stage of the project. From this chapter, it can be 
concluded that the force field parametrisation is a multifaceted task, where aspects, such as the 
specific chemistry, the involvement of the local environment and the thermalisation of the system 
must be considered during the parametrisation of a specific atom type. The assessment of the 
contribution of these factors is important if potential errors and misinterpretations are to be avoided. 
 
The generation of parameters for novel molecules that are compatible with a given biomolecular 
force field can be tedious, time-consuming and error-prone. Here, a novel method to refine 
parameters in classical force fields in an automated manner was also presented. A previously 
determined test set consisting of 34 organochlorides and 19 organobromides was used for the 
reparameterisation of the van der Waals parameters for halogen atoms. Single-step perturbation 
protocols were successfully developed and used to propose alternative force field parameters 
compatible with the GROMOS force field as implemented in the ATB which could describe the 
interactions of organohalide molecules with water and itself with high precision. Hydration free 
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energies, liquid densities and heats of vaporisation for each molecule were calculated and compared 
with experimental values for a wider range of σ and ε combinations for both chlorine and bromine. 
This showed it was possible to obtain parameters for which the calculated properties closely 
matched the experiment data. The overall AUE between the predicted and experimental values for 
aliphatic organochlorides was 5.8 kJ/mol before the parametrisation and 2.7 kJ/mol for calculations 
using the refined parameters ultimately selected. The decrease in the AUE from 3.2 to 1.2 kJ/mol 
was noted for aromatic organochlorides and the AUE for aliphatic bromides decreased by 0.4 
kJ/mol. The decrease in the AUE was also noted for common drug and drug-like molecules. This 
decrease however was not as significant as in the case of the simple halogen containing molecules, 
raising the question about future work potentially focusing on simultaneous parameterisation of 
multiple functional groups rather than parameterising each functional group separately. An 
investigation of the effect of the local environment when using the refined chlorine van der Waals 
parameters by altering the carbon parameters to which the halogen was attached for certain 
organochlorides confirmed a need to consider not only the halogen, but also the parameters of the 
surrounding carbons. Again, the availability of distributed computing resources allowed this work 
to be performed in a high throughput manner and undertake large-scale optimisation. This method 
can be extended to parametrisation of other atoms types and against other experimental properties. 
In case of the halogen atoms, the method presented could be latter expanded to include explicit 
models of halogen bonding. Possible future improvements could also include parameterisation of 
water and incorporation of polarisation into the force field. Other problematic groups such as 
amines or esters could also be refined. While we have chosen here to focus on the refinement of the 
Lennard-Jones parameters, the approach can be used to refine any interaction parameters. From this 
chapter, it can be concluded that using a large scale approach, the parameters of the halogens, 
chlorine and bromine, could be successfully improved. It also highlights the importance of further 
parametrisation efforts as other problematic functions groups affect the predictability of the 
interactions of the whole molecule. Difficulties due to the limited availability of experimental data 
were again noted. Further developments could focus on improving a way in which the final 
parameters are chosen. Currently, the final van der Waals parameters to get the best compromise 
between the hydration, liquid density and heat of vaporisation data were chosen by eye. In the 
future, the parameters might be selected in a quantitative way weighting each criteria and 
performing a least square fit.  
 
In this thesis, 11 X-ray crystallography structures of small ligands bound to endothiapepsin were 
studied with molecular dynamics (MD) simulations and the force field parameters from the 
Automated Topology Builder (ATB) and Repository (http://atb.uq.edu.au). The stability of these 
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complexes was investigated and the binding modes of the ligands were validated. Analysis of the 
MD trajectories showed that the protein structure in all 11 systems remained relatively stable with 
the average RMSD between the X-ray and MD structures below 2.7 Å. However, using the 
protonation states of the ligand and aspartates in the catalytic dyad assumed in the crystal, the 
ligand conformation, binding mode, orientation and interaction with the neighbouring protein 
residues could only be validated in 4 out of the 11 cases. This is despite the high accuracy of the 
electron density maps and low B-factors for the ligands. However, simply by assigning different 
combinations of protonation state to the residues in the catalytic dyad and the ligand, 9 of the 11 
complexes were found to be stable. This shows the importance of the consideration of the correct 
representation of both the protein and ligand and how MD simulations can be used to test 
assumptions and refine structures even in cases where high resolution structural data is available. 
This short study could be further improved by extending the length of simulations to investigate the 
interactions, especially the binding on larger time-scales and performing replicate studies to assure 
the reproducibility of the results. Alternative conformations of the ligands could also be 
investigated, especially in cases where there were uncertainties in the ligand position in the electron 
density. With the determination of the protonation states remaining challenging alternative 
combinations of protonation states of the protein and ligands could be tested. 
 
To conclude, the work presented in this thesis provided insight into the development and validation 
of the force field parameters for drug-like molecules and their applications in structure-based drug 
design. 
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Table 2A- 1. A comparison between the experimental and calculated free energies of hydration for biologically relevant small molecules,  drug and drug-like molecules 
from SAMPL0, 1 and 2 challenges using parameters assigned by the Automated Topology Builder (ATB). Hydration free energy and error values in kJ/mol calculated as 
per section 2.4. RMSD in nm. 
ATB Molida FE UAb ATB 1.0 FE UAc ATB 2.0 FE AAd ATB 2.0 Exp. FEe RMSDf Name Type 
1061 -28.9±1.2 -29.1±0.5 -29.1±0.5 -27.7 0.003 Phenol alcohol 
861 -19.0±1.3 -19.2±0.4 -28.6±0.5 -22.9 0.009 Cycloheptanol alcohol 
860 -20.6±1.2 -20.1±0.5 -31.1±0.5 -22.9 0.003 Cyclohexanol alcohol 
859 -21.4±1.2 -21.4±0.6 -32.9±0.5 -23.0 0.005 Cyclopentanol alcohol 
856 -18.4±1.9 -19.3±0.6 -25.4±0.6 -16.8 0.007 4-heptanol alcohol 
853 -13.1±1.6 -13.1±0.5 -18.7±0.4 -16.3 0.009 2-methyl-3-pentanol alcohol 
851 -17.6±1.6 -16.7±0.5 -22.3±0.6 -17.0 0.011 3-hexanol alcohol 
850 -19.7±1.1 -8.8±0.4 -9.6±0.5 -16.4 0.049 2,3-dimethyl-2-butanol alcohol 
848 -23.9±1.1 -10.9±0.4 -12.7±0.5 -18.5 0.031 2-methyl-2-butanol alcohol 
847 -15.5±1.6 -16.4±0.5 -22.0±0.5 -18.2 0.012 3-pentanol alcohol 
846 -19.9±1.5 -17.9±0.5 -23.4±0.6 -18.7 0.006 2-pentanol alcohol 
845 -21.3±1.5 -22.4±0.5 -26.6±0.5 -18.5 0.005 3-methyl-1-butanol alcohol 
842 -19.1±1.1 -15.7±0.4 -21.4±0.5 -19.1 0.022 2-butanol alcohol 
836 -22.3±1.2 -22.3±0.4 -28.2±0.5 -18.9 0.009 2-methyl-1-propanol alcohol 
745 -19.3±1.8 -18.1±0.6 -22.4±0.4 -15.6 0.015 4-methyl-2-pentanol alcohol 
274 -24.4±1.5 -25±0.5 -24.9±0.5 -24.6 0.003 2-methylphenol alcohol 
113 -23.0±0.8 -16.1±0.5 -24.8±0.5 -19.9 0.004 Isopropanol alcohol 
17 -25.8±1.1 -28.6±0.4 -29.5±0.5 -26.6 0.003 4-methylphenol alcohol 
935 -13.4±0.8 -18.7±0.4 -18.7±0.4 -16.8 0.001 Benzaldehyde aldehyde 
V 
 
925 -10.2±1.3 -14.6±0.4 -15.2±0.5 -12.7 0.009 Pentanal aldehyde 
924 -9.7±1.0 -14.5±0.4 -14.8±0.4 -13.3 0.011 Butanal aldehyde 
923 -14.4±-10.4 -16.1±0.5 -15.1±0.3 -14.4 0.006 Propanal aldehyde 
786 10.7±1.0 8.2±0.3 9.9±0.4 10.0 0.005 Methyl butane alkane 
760 11.4±1.9 9.2±0.5 10.6±0.6 12.1 0.006 Octane alkane 
758 11.5±1.4 8.7±0.5 9.9±0.6 11.0 0.005 Heptane alkane 
467 10.1±0.9 8.6±0.4 10.0±0.5 10.4 0.004 Hexane alkane 
785 6.0±0.8 6.6±0.4 5.3±0.4 1.5 0.002 Cyclohexene alkene 
784 6.6±0.7 7.7±0.5 6.7±0.4 2.3 0.008 Cyclopentene alkene 
776 8.4±0.8 9.1±0.4 9.6±0.4 5.6 0.003 trans-2-pentene alkene 
773 8.3±0.8 7.4±0.3 7.7±0.3 5.8 0.002 1-Butene alkene 
772 8.4±0.6 7.1±0.3 7.8±0.3 5.3 0.001 Propene alkene 
771 -1.3±0.5 7.2±0.4 7.2±0.4 5.3 0.001 Ethene alkene 
752 10.4±1.3 8.3±0.4 8.4±0.4 7.0 0.004 1-hexene alkene 
814 0.2±1.7 1.7±0.5 0.3±0.5 -1.9 0.005 sec-Butyl benzene alkyl benzene 
813 0.3±1.6 1.0±0.4 1.1±0.6 -1.7 0.003 n-Butyl benzene alkyl benzene 
811 3.2±1.2 1.9±0.4 -0.4±0.5 -1.3 0.002 Isopropyl benzene alkyl benzene 
810 0.5±1.4 -0.8±0.4 -2.0±0.5 -2.2 0.002 Propyl benzene alkyl benzene 
806 -0.1±1.0 1.4±0.4 0.8±0.4 -3.3 0.002 Ethyl benzene alkyl benzene 
804 -3.8±0.8 -4.0±0.4 -4.0±0.4 -3.6 0.001 Benzene alkyl benzene 
21 2.8±0.8 2.2±0.4 1.5±0.5 -3.7 0.001 Methyl benzene (toluene) alkyl benzene 
1078 1.4±0.5 0.3±0.4 0.3±0.4 0.0 0.003 Ethine alkyne 
799 8.0±1.1 4.4±0.5 4.5±0.5 1.2 0.006 1-Hexine alkyne 
VI 
 
798 5.5±1.0 3.0±0.3 2.6±0.4 0.0 0.010 1-Pentine alkyne 
797 4.1±0.6 3.0±0.4 3.3±0.3 -0.7 0.005 1-Butine alkyne 
796 5.2±0.6 2.9±0.5 -0.1±0.4 -1.3 0.002 Propine alkyne 
1008 -34.4±1.1 -27.4±0.4 -33.9±0.5 -28.3 0.005 N,N-dimethyl acetamide amide 
1007 -28.3±0.9 -39.2±0.5 -42.0±0.4 -42.2 0.002 N-methyl acetamide amide 
19 -42.5±0.9 -34.6±0.6 -35.4±0.4 -39.4 - Propyl amide amide 
968 -10.5±0.9 -13.3±0.4 -14.1±0.4 -18.4 0.004 Propyl amine amine (primary) 
967 -9.8±0.7 -16.4±0.4 -17.6±0.4 -18.8 0.002 Ethyl amine amine (primary) 
966 -11.3±0.6 -12.9±0.4 -11.6±0.4 -19.1 0.002 Methyl amine amine (primary) 
15 -9.0±1.0 -13.7±0.4 -13.8±0.5 -18.3 0.003 Butyl amine amine (primary) 
936 -30.6±1.6 -32.2±0.6 -32.7±0.6 -26.6 0.009 Butanoic acid carboxylic acid 
22 -29.8±1.1 -31.8±0.5 -34.9±0.6 -28.0 0.009 Acetic acid carboxylic acid 
20 -31.6±1.0 -33.4±0.5 -33.1±0.5 -27.0 0.009 Propanoic acid carboxylic acid 
768 10.0±1.0 8.4±0.4 6.8±0.4 7.1 0.002 Methyl cyclohexane cycloalkane 
767 3.6±0.8 6.0±0.5 5.9±0.4 3.3 0.008 Cycloheptane cycloalkane 
766 10.5±0.8 9.2±0.4 7.6±0.5 6.7 0.003 Methyl cyclopentane cycloalkane 
764 5.4±0.7 8.0±0.5 6.7±0.4 5. 0.003 Cyclopentane cycloalkane 
763 9.5±0.6 9.9±0.4 7.5±0.4 3.1 - Cyclopropane cycloalkane 
965 -17.0±1.8 -19.2±0.6 -21.9±0.5 -17.9 0.002 Methyl benzoate ester 
943 -15.0±1.9 -17.3±0.6 -20.2±0.5 -12.3 0.006 Methyl propanoate ester 
942 -19.1±1.6 -21.3±0.6 -27.9±0.5 -12.9 0.002 Ethyl ethanoate ester 
940 -14.4±1.9 -18.9±0.6 -18.8±0.5 -10.4 0.011 Propyl methanoate ester 
939 -17.1±1.5 -20.6±0.6 -27.9±0.6 -13.9 0.004 Methyl ethanoate ester 
VII 
 
938 -21.8±1.8 -17.9±0.6 -18.8±0.6 -11.1 0.003 Ethyl methanoate ester 
937 -19.7±1.5 -19.3±0.4 -20.9±0.5 -11.6 0.003 Methyl methanoate ester 
885 -10.7±1.0 -14.3±0.5 -14.7±0.5 -14.3 0.007 Diethyl ketone ketone 
884 -12.8±1.2 -16.5±0.4 -21.0±0.5 -14.8 0.005 Methyl-1-propyl ketone ketone 
883 -12.5±0.8 -13.6±0.4 -16.2±0.4 -15.2 0.005 Methyl ethyl ketone ketone 
882 -15.9±0.7 -14.8±0.4 -19.1±0.6 -16.1 0.002 Dimethylketone ketone 
1088 -14.2±0.9 -13.9±0.4 -13.9±0.4 -10.7 0.005 Benzene thiol thiol/sulfide 
1057 -4.6±1.2 -3.6±0.4 -6.9±0.5 -11.4 0.007 Methyl thiobenzene thiol/sulfide 
1053 -6.8±0.7 -8.8±0.5 -11.0±0.4 -5.4 0.004 Ethyl thiol thiol/sulfide 
10 -8.4±0.5 -10.0±0.4 -11.3±0.4 -5.2 - Methyl thiol thiol/sulfide 
2905 -4.1±1.1 -5.4±0.5 -12.7±0.5 -9.9±0.8 0.002 Benzyl bromide SAMPL0 
1638 -29.7±2.5 -31.2±0.6 -42.2±0.8 -26.5±0.8 0.011 Ethylene glycol diacetate SAMPL0 
1637 -18.8±1.6 -22.1±0.6 -22.1±0.6 -16.0±0.8 0.003 Phenyl formate SAMPL0 
1634 -3.1±1.8 -4.3±0.6 -8.7±0.7 -17.7±0.8 0.017 Bis-2-chloroethyl ether SAMPL0 
1633 -27±4 -23.2±0.7 -35.9±0.7 -20.8±0.8 0.014 1,1-diacetoxyethane SAMPL0 
1631 -38.8±1.4 -34.2±0.6 -40.8±0.5 -40.8±0.8 0.021 N,N,4-trimethylbenzamide SAMPL0 
1630 -43.5±1.9 -40.9±0.6 -47.8±0.5 -46.0±0.8 0.017 
N,N-dimethyl-p-methoxy 
benzamide 
SAMPL0 
1629 26.7±1.1 23.9±0.5 23.9±0.5 4.5±0.8 0.004 m-bis-trifluoromethylbenzene SAMPL0 
1199 -29.9±2.7 -31.8±0.7 -41.3±0.7 -25.1±0.8 0.012 Diethyl propanedioate SAMPL0 
1023 -3.6±1.8 -6.1±0.6 -8.1±0.6 -14.8±0.8 0.017 1,2-diethoxyethane SAMPL0 
1022 -9.3±2.4 -10.0±0.6 -15.2±0.6 -13.7±0.8 0.012 1,1-diethoxyethane SAMPL0 
1020 -5.7±1.0 -7.6±0.5 -17.5±0.5 -12.2±0.8 0.016 Dimethoxymethane SAMPL0 
VIII 
 
2968 -47.7±2.9 -47.6±0.7 -62.2±0.9 -42±6 0.005 Azinphosmethyl SAMPL1 
2966 -53.8±2.3 -40.8±0.6 -40.8±0.6 -47.0±1.8 0.011 4-amino-4’-nitroazobenzene SAMPL1 
2928 -37.0±1.5 -44.8±0.5 -44.8±0.5 -33.3±5.7 0.009 1-amino-anthraquinone SAMPL1 
2925 -34.6±1.5 -36.8±0.6 -39.2±0.5 -33±8 0.006 Propanil SAMPL1 
2029 -32.1±2.5 -33.1±0.5 -41.0±0.6 -30.1±0.4 0.009 Methyparathion SAMPL1 
1994 -23.5±2.6 -24.8±0.6 -39.2±0.6 -53±8 0.033 Trichlorofon SAMPL1 
1984 -43.9±2.4 -47.7±0.5 -47.7±0.5 -31±8 0.012 1-amino-4-anilino-anthraquinone SAMPL1 
1983 -51±5 -58.8±0.8 -80.0±1 -34.1±0.9 0.010 Malathion SAMPL1 
1981 -41±4 -51.6±0.9 -62.6±1 -24±8 0.014 Dialifor SAMPL1 
1980 -33±3 -33.5±0.7 -41.8±0.8 -27±4 0.011 Carbophenothion SAMPL1 
1967 -41.9±2.7 -44.7±0.6 -48.1±0.6 -41.2±0.4 0.018 Aldicarb SAMPL1 
1964 -41.5±1.5 -42.4±0.7 -46.7±0.6 -38±8 0.007 Fenuron SAMPL1 
1962 -30±3 -34.6±0.7 -33.6±0.6 -26±8 0.014 Dinoseb SAMPL1 
1959 -31.1±2.8 -30.2±0.6 -37.7±0.7 -39±8 0.010 Pirimor (pirimacarb) SAMPL1 
1956 -74.6±1.9 -65.0±0.5 -65.0±0.5 -37±6 0.022 1,4,5,8-tetramino-anthraquinone SAMPL1 
1954 -12.0±2.6 -19.2±0.7 -22.3±0.7 -17±9 0.007 Vernolate SAMPL1 
1953 -2.4±2.9 -0.9±0.7 0.1±0.7 -13.6±0.4 0.038 Trifluralin SAMPL1 
1952 -100±4 -109.5±0.9 -115.1±0.9 -68±8 0.013 Thifensulfurone SAMPL1 
1951 -19.6±2.3 -17.7±0.5 -22.9±0.5 -27.9±1.8 0.013 Terbutryn SAMPL1 
1950 -53.3±1.9 -55.3±0.5 -58.2±0.4 -47±8 0.011 Terbacil SAMPL1 
1948 -40.5±1.8 -41.9±0.4 -44.5±0.5 -42.8±0.4 0.018 Simazine SAMPL1 
1947 -60.8±1.7 -67.5±0.5 -67.5±0.5 -69±8 0.010 Pyrazon SAMPL1 
1945 -21±3 -21.3±0.6 -30.5±0.7 -35.3±0.4 0.012 Prometryn SAMPL1 
IX 
 
1944 6±3 6.9±0.7 -0.1±0.8 -10±6 0.035 Profluralin SAMPL1 
1943 -24.7±2.7 -22.9±0.6 -32.2±0.7 -18.3±0.4 0.039 Phorate SAMPL1 
1942 -10.9±2.5 -15.1±0.7 -17.9±0.6 -15±8 0.008 Pebulate SAMPL1 
1941 -37.2±2.6 -31.7±0.7 -36.9±0.6 -28.2±0.4 0.009 Parathion SAMPL1 
1940 -61±3 -65.8±0.8 -70.1±0.7 -43±8 0.017 Oxamyl SAMPL1 
1939 -15.5±1.4 -16.3±0.4 -19.9±0.4 -25.1±0.4 0.047 Nitroxyacetone SAMPL1 
1936 -43.2±2.6 -41.8±0.6 -44.7±0.6 -45±8 0.011 Methomyl SAMPL1 
1934 -24.2±1.4 -22.3±0.5 -27.9±0.4 -22±6 0.012 Isophorone SAMPL1 
1933 1.6±1.4 -0.2±0.5 -3.8±0.5 -10.7±0.4 0.009 Heptachlor SAMPL1 
1932 -1.0±1.4 5.9±0.5 -15.0±0.6 -20.2±0.4 0.010 Endrin SAMPL1 
1931 -8.0±1.4 -17.6±0.6 -27.9±0.5 -17.7±1.1 0.012 Endosulfan alpha SAMPL1 
1930 -30±4 -27.6±0.8 -27.0±0.8 -24±8 0.016 Dinitramine SAMPL1 
1929 -24.1±1.0 -19.9±0.5 -19.9±0.5 -20±8 0.002 Dichlobenil SAMPL1 
1928 -39.5±2.3 -41.2±0.6 -43.8±0.6 -41±8 0.008 Dicamba SAMPL1 
1927 -27±3 -27.2±0.8 -37.9±0.7 -27.1±0.5 0.011 Diazinon SAMPL1 
1926 -22.8±2.7 -23.1±0.6 -28.3±1 -21.1±0.9 0.010 Chlorpyrifos SAMPL1 
1925 7.0±0.9 5.3±0.4 5.3±0.4 -6.1±0.4 0.004 Chloropicrin SAMPL1 
1923 -27±4 -26.2±0.7 -31.9±0.7 -30±6 0.014 Chlorfenvinphos SAMPL1 
1922 1.2±1.5 -3.2±0.6 -12.9±0.6 -14.4±0.4 0.020 Chlordane SAMPL1 
1921 -36.6±1.9 -34.6±0.7 -40.4±0.6 -40.2±1.3 0.010 Carbofuran SAMPL1 
1920 -40.9±1.9 -40.4±0.7 -39.6±0.7 -39.5±0.4 0.009 Carbaryl SAMPL1 
1919 -23.9±2.2 -27.5±0.7 -36.4±0.7 -38±8 0.007 Captan SAMPL1 
1918 -68.0±2.3 -72.1±0.6 -74.9±0.6 -41±8 0.005 Bromacil SAMPL1 
X 
 
1917 -12±5 -5.4±0.7 -5.4±0.9 -15±8 0.019 Benefin SAMPL1 
1915 -21.5±2.2 -22.6±0.7 -30.5±0.6 -32.0±1.4 0.012 Ametryn SAMPL1 
1914 -23.3±2.9 -26.1±0.6 -38.1±0.9 -34.4±1.2 0.017 Alachlor SAMPL1 
1913 -25.5±1.3 -26.8±0.4 -31.5±0.5 -34.2±0.4 0.012 Ethyleneglycol mononitrate SAMPL1 
1912 -4.7±1.4 -4.2±0.5 -6.3±0.5 -7.9±0.4 0.007 Isobutyl nitrate SAMPL1 
1911 -0.3±1.7 -2.5±0.5 -5.2±0.5 -7.6±0.4 0.027 2-butyl nitrate SAMPL1 
1910 -6.3±1.4 -4.6±0.5 -6.2±0.6 -8.7±0.4 0.035 Butyl nitrate SAMPL1 
1909 -11.5±2.2 -8.1±0.6 -13.6±0.7 -20.7±0.4 0.019 1,2-dinitroxypropane SAMPL1 
1742 -11.4±2.2 -10.5±0.6 -14.7±0.6 -24.0±0.4 0.049 Nitroglycol SAMPL1 
2242 -54.6±1.8 -52.9±0.6 -55.1±0.6 -38.5±1.3 0.006 Ethyl paraben SAMPL2 
2027 -55.7±1.2 -40.3±0.5 -40.3±0.5 -41.9±0.5 0.009 4-nitroaniline SAMPL2 
1976 12.1±1.7 13.0±0.6 2.8±0.6 -3.3±0.8 0.007 Trimethyl orthotrifluoroacetate SAMPL2 
1877 -2.6±1.5 -2.0±0.4 -2.0±0.4 -21.8±1.0 0.003 Pentachloronitrobenzene SAMPL2 
1876 -26.3±1.7 -28.2±0.4 -39.3±0.4 -36.4±0.4 0.018 Trimethyl phosphate SAMPL2 
1875 -53.1±2.8 -59.4±0.6 -61.6±0.6 -45.1±0.8 0.008 Ketoprofen SAMPL2 
1874 -31.9±2.6 -33.0±0.6 -37.8±0.7 -29.3±2.7 0.007 Ibuprofen SAMPL2 
1873 -34.5±2.7 -37.1±0.5 -40.3±0.6 -35.2±0.7 0.009 Flurbiprofen SAMPL2 
1868 4.7±1.2 4.6±0.3 4.6±0.3 -5.9±0.4 0.008 Hexachloroethane SAMPL2 
1867 4.3±1.1 2.2±0.4 2.2±0.4 -10±5 0.005 Hexachlorobenzene SAMPL2 
1866 -32.9±1.1 -34.4±0.3 -42.3±0.4 -36.0±1.3 0.003 Sulfolane SAMPL2 
1864 -47.1±1.1 -46.9±0.4 -46.9±0.4 -40.2±2.1 0.003 Phthalimide SAMPL2 
1862 -45±4 -42.4±0.6 -42.4±0.6 -39.3±0.8 0.012 Diflunisal SAMPL2 
1861 -46.5±2.5 -54.6±0.6 -57.7±0.8 -41.6±0.8 0.007 Acetylsalicylic acid SAMPL2 
XI 
 
1860 -52.0±2.6 -60.3±0.6 -59.1±0.6 -36.5±1.1 0.007 Butyl paraben SAMPL2 
1859 -54.6±2.4 -55.6±0.5 -57.1±0.7 -39.2±0.9 0.007 Propyl paraben SAMPL2 
1856 -65.0±1.3 -58.0±0.4 -59.3±0.5 -53±3 0.002 Caffeine SAMPL2 
1855 -82.4±1.1 -84.1±0.4 -84.1±0.4 -76.4±1.1 0.002 Cyanuric acid SAMPL2 
1854 -61.6±1.1 -64.3±0.4 -64.3±0.4 -66±5 0.002 6-chlorouracil SAMPL2 
1853 -62.1±1.2 -64.4±0.4 -64.4±0.4 -64.7±0.7 0.003 5-trilfuoromethyluracil SAMPL2 
1851 -74.7±1.0 -75.4±0.4 -75.4±0.4 -71±4 0.002 5-fluorouracil SAMPL2 
1850 -76.4±1.1 -79.2±0.3 -79.2±0.3 -74±3 0.002 5-chlorouracil SAMPL2 
1848 -72.1±1.1 -76.9±0.4 -76.9±0.4 -69.4±1.2 0.002 Uracil SAMPL2 
1019 -58.3±1.6 -62.1±0.4 -76.0±0.5 -56.1±4.2 0.073 Glycerol SAMPL2 
125 -64.5±2.2 -84.1±0.4 -84.1±0.4 -76.0±2.3 0.002 5-bromouracil SAMPL2 
 
a Automated Topology Builder (ATB) molecule identification; b Hydration free energy calculated using united atom parameters for the ATB 1.0; c Hydration free energy calculated 
using united atom parameters for ATB 2.0;  d Hydration free energy calculated using all atom parameters for the ATB 2.0; e Experimental hydration free energy [1-5]; f Root mean 
square deviation between the quantum mechanics optimised structure and the structure after energy minimisation in vacuum. 
 
 
 
 
 
 
 
XII 
 
Table 2A- 2. A comparison between experimental and calculated free energies of hydration for drug and drug-like molecules from SAMPL4 challenge using parameters 
assigned by the Automated Topology Builder (ATB) 2.0. Hydration free energy and error values in kJ/mol calculated as per section 2.4. 
ATB molida SAMPL IDb FE UAc FE AAd Exp. FEe RMSDf Name 
8017 001 -86.0 ± 1.4 -110.8 ± 1.5 -98.9 ± 1.3 0.027 mannitol 
8018 002 -9.5 ± 0.6 -12.8 ± 0.6 -10 ± 4 0.013 linalyl acetate 
8019 003 -20.8 ± 0.6 -21.7 ± 0.5 -20.0 ± 1.0 0.009 nerol 
8020 004 -16.6 ± 0.5 -22.0 ± 0.4 -18.6 ± 1.0 0.012 geraniol 
8021 005 -12.0 ± 0.6 -18.9 ± 0.7 -22.3 ± 0.4 0.009 1,2-dimethoxybenzene 
8022 006 -43.4 ± 0.7 -48.8 ± 0.6 -22.0 ± 0.8 0.006 4-propylguaiacol 
8025 009 -43.9 ± 0.5 -50.7 ± 0.7 -34 ± 3 0.008 2,6-dichlorosyringaldehyde 
8026 010 -30.8 ± 0.5 -28.8 ± 0.6 -26.1 ± 1.6 0.010 3,5-dichlorosyringol 
8027 011 -40.3 ± 0.6 -44.7 ± 0.7 -33 ± 3 0.007 2-chlorosyringaldehyde 
8028 012 -17.0 ± 0.6 -23.4 ± 0.6 -15.7 ± 0.9 0.005 dihydrocarvone 
8029 013 -13.5 ± 0.5 -24.4 ± 0.8 -18.6 ± 1.8 0.011 carveol 
8030 014 -19.6 ± 0.6 -22.5 ± 0.5 -17.1 ± 0.7 0.009 l-perillaldehyde 
8031 015 -18.8 ± 0.5 -26.2 ± 0.5 -18.9 ± 0.4 0.011 piperitone 
8032 016 -16.7 ± 0.7 -27.1 ± 0.6 -13.4 ± 1.1 0.030 menthol 
8033 017 -12.1 ± 0.6 -20.5 ± 0.6 -10.6 ± 1.0 0.008 menthone 
8035 019 -3.8 ± 0.5 -9.2 ± 0.4 -15.8 ± 0.4 0.003 9,10-dihydroanthracene 
8036 020 -3.8 ± 0.4 -3.8 ± 0.4 -11.6 ± 0.4 0.008 1,1-diphenylethene 
8037 021 -27.6 ± 0.5 -35.8 ± 0.6 -31.9 ± 0.5 0.002 1-benzylimidazole 
8038 022 -36.9 ± 0.7 -39.8 ± 0.6 -28.4 ± 0.4 0.026 mefenamic acid 
XIII 
 
8039 023 -12.0 ± 0.8 -24.4 ± 0.7 -39.1 ± 2.6 0.007 diphenhydramine 
8040 024 -2.9 ± 0.6 -13.6 ± 0.6 -31.1 ± 2.5 0.008 amitriptyline 
8082 025 -18.3 ± 0.5 -26.7 ± 0.6 -24.0 ± 0.6 0.023 1-butoxy-2-propanol 
7956 026 -23.1 ± 0.6 -31.0 ± 0.7 -22.2 ± 0.4 0.010 2-ethoxyethyl acetate 
7957 027 -15.9 ± 0.5 -19.6 ± 0.6 -20.1 ± 1.6 0.058 1,3-bis-(nitrooxy)propane 
7958 028 -13.7 ± 0.5 -17.7 ± 0.5 -18.0 ± 1.6 0.059 1,3-bis-(nitrooxy)butane 
7959 029 -5.0 ± 0.6 -6.1 ± 0.5 -7.0 ± 0.4 0.028 hexyl nitrate 
7960 030 -19.5 ± 0.5 -25.5 ± 0.7 -9.6 ± 0.5 0.005 hexyl acetate 
7962 032 -32.6 ± 0.4 -32.6 ± 0.4 -30.5 ± 0.4 0.003 3,4-dichlorophenol 
7963 033 -30.3 ± 0.6 -35.8 ± 0.6 -29.1 ± 0.4 0.010 2,6-dimethoxyphenol 
7964 034 -36.6 ± 0.6 -39.7 ± 0.8 -24.3 ± 0.4 0.007 4-methyl-2-methoxyphenol 
7965 035 -23.9 ± 0.7 -23.9 ± 0.7 -19.6 ± 0.4 0.004 2-hydroxybenzaldehyde 
7966 036 -24.1 ± 0.5 -23.3 ± 0.5 -23.7 ± 0.4 0.010 2-ethylphenol 
7967 037 -41.6 ± 0.7 -48.0 ± 0.6 -24.9 ± 0.4 0.006 2-methoxyphenol 
7968 038 -19.4 ± 0.5 -19.7 ± 0.5 -16.5 ± 0.4 0.002 2-methylbenzaldehyde 
7969 039 1.4 ± 0.5 -0.8 ± 0.4 -3.6 ± 0.4 0.004 1-ethyl-2-methylbenzene 
7971 041 -5.4 ± 0.5 -10.3 ± 0.5 -21.1 ± 0.4 0.004 piperidine 
7972 042 -4.1 ± 0.5 -10.3 ± 0.6 -13.1 ± 0.4 0.001 tetrahydropyran 
7973 043 7.6 ± 0.4 5.8 ± 0.4 0.6 ± 0.4 0.002 cyclohexene 
7974 044 -7.6 ± 0.5 -17.7 ± 0.5 -21.3 ± 0.4 0.003 1,4-dioxane 
8083 045 -62.0 ± 0.6 -62.0 ± 0.6 -48.3 ± 1.2 0.012 2-amino-9,10-anthraquinone 
7976 046 -43.7 ± 0.6 -43.7 ± 0.6 -40 ± 3 0.009 1-amino-9,10-anthraquinone 
8750 047 -51.6 ± 1 -53.6 ± 0.5 -59 ± 5 0.015 1-(2-hydroxyethylamino)-9,10-anthraquinone 
XIV 
 
8553 048 -61.0 ± 0.6 -61.0 ± 0.6 -49.6 ± 1.5 0.012 1,4-diamino-9,10-anthraquinone 
7979 049 -11.4 ± 0.5 -11.4 ± 0.5 -13.2 ± 0.4 0.002 dibenzo-p-dioxin 
7980 050 -9.1 ± 0.4 -9.1 ± 0.4 -17.3 ± 0.4 0.002 anthracene 
8551 051 -52.9 ± 0.7 -52.9 ± 0.7 -39.9 ± 1.2 0.015 1-amino-4-hydroxy-9,10-anthraquinone 
7982 052 -8.0 ± 0.5 -8.0 ± 0.5 -12.0 ± 2.9 0.006 diphenyl ether 
 
a Automated Topology Builder (ATB) molecule identification ; b SAMPL challenge molecule identification ; c Hydration free energy calculated using united atom parameters; d 
Hydration free energy calculated using all atom parameters; e Experimental hydration free energy [5]; f Root mean square deviation between the quantum mechanics optimised 
structure and the structure after energy minimisation in vacuum. 
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Figure 3A- 1. A plot of the calculated versus experimental hydration free energies for 19 organobromides.  
Values were calculated using united atom Automated Topology Builder (ATB) 2.0 topologies and correct 
thermalisation and are indicated by blue circles (Table 3A-1). The solid line has a slope of one and represents a 
one-to-one agreement between the calculated and experimental numbers. The two dotted lines represent a 5 
kJ/mol deviation from the ideal line. 
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Table 3A- 1.  A comparison between the experimental and calculated hydration free energies for 19 
organobromides from the test set. Calculated values include correct thermalisation. All values are in kJ/mol. 
ATB MolIDa FE Exp.b FE Calc.c 
1180 -1.7 -4.6 
1208 -9.6 -10.9 
24214 -9.9 -7.2 
2905 -10 -7.6 
3177 -3.4 -2.4 
3178 -8.8 -3.9 
3179 -8.3 -9.4 
3180 -2.9 -4.7 
3181 -2.3 -4.8 
3182 -2 -2.8 
3186 -0.3 -3.7 
3187 -3.6 -3.3 
3188 -6.1 -6.7 
3189 -5.8 -6.0 
4054 0.8 -2.7 
4055 1.4 -4.2 
4056 2.2 -2.8 
4057 3.5 -1.0 
4059 -0.1 -2.7 
 
a Molecule identification number as assigned by the Automated Topology Builder (ATB) 2.0; b Experimental hydration 
free energy [1]; c Hydration free energy calculated using united atom parameters from the ATB 2.0 with correct 
thermalisation. The error in the calculated values is ± 1.0 kJ/mol, calculated as per section 3.4. 
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Figure 4A- 1. Individual grid maps showing the average unsigned error between the predicted and experimental 
hydration free energies calculated using single step perturbation protocol for each grid point for each 
organochloride from the data set (34). Black crosses represent current parameter combinations. 
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Figure 4A- 2. Individual grid maps showing the average unsigned error between the predicted and experimental 
hydration free energies calculated using single step perturbation protocol for each grid point for each 
organobromide from the data set (19). Black crosses represent current parameter combinations. 
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Figure 4A- 3. Individual grid maps showing the average unsigned error between the predicted and experimental 
liquid densities calculated for aliphatic organochlorides from the data set for the conditions listed in section 
4.4.3. 
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Figure 4A- 4. Individual grid maps showing the average unsigned error between the predicted and experimental 
heats of vaporisation calculated for aliphatic organochlorides from the data set for the conditions listed in section 
4.4.3 
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Figure 4A- 5. Individual grid maps showing the average unsigned error between the predicted and experimental 
liquid densities calculated for aromatic organochlorides from the data set for the conditions listed in section 
4.4.3. 
 
 
 
 
 
 
 
 
 
 
 
 
                1177                                                                    3176 
                   3798                                                                     3802 
Li
qu
id
 d
en
si
ty
 e
rr
or
 (k
g/
m
3 )
 
Li
qu
id
 d
en
si
ty
 e
rr
or
 (k
g/
m
3 )
 
Li
qu
id
 d
en
si
ty
 e
rr
or
 (k
g/
m
3 )
 
Li
qu
id
 d
en
si
ty
 e
rr
or
 (k
g/
m
3 )
 
XXXIX 
 
Figure 4A- 6, Individual grid maps showing the average unsigned error between the predicted and experimental 
heats of vaporisation calculated for aromatic organochlorides from the data set for the conditions listed in 
section 4.4.3. 
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Figure 4A- 7. Individual grid maps showing the average unsigned error between the predicted and experimental 
liquid densities calculated for aliphatic organobromides from the data set for the conditions listed in section 4.4.3 
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Figure 4A- 8. Individual grid maps showing the average unsigned error between the predicted and experimental 
heats of vaporisation calculated for aliphatic organobromides from the data set for the conditions listed in 
section 4.4.3. 
 
 
                1180                                                                     2905 
                  3178                                                                      3180 
                3181                                                                    3182 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
XLIII 
 
 
 
 
                 3186                                                                     3187 
                   4054                                                                     4055 
                 4056                                                                      4057 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
H
ea
t o
f v
ap
or
is
at
io
n 
er
ro
r (
kJ
/m
ol
) 
XLIV 
 
Table 4A- 1. A comparison between the experimental and calculated free energies of hydration before and after 
parameterisation for 24 aliphatic organochlorides from the test set. All values are in kJ/mol.  
ATB MolIDa FE Exp.b FE Ref.c FE Org.d 
1173 -3.5 0.9 5.3 
1196 -2.6 -1.8 0.7 
1307 -4.5 1.1 8.0 
2801 -7.5 -2.8 1.7 
2802 -0.8 -3.0 3.6 
2803 -8.3 -0.5 6.8 
2804 -5.4 -5.6 3.0 
2805 -10.3 -0.1 8.1 
2806 -5.8 -6.9 3.0 
3169 -5.5 0.2 5.2 
3170 -1.4 -1.4 0.2 
3171 -1.1 -0.2 2.4 
3791 -2.3 -0.2 2.2 
3793 0.3 1.1 2.5 
3800 0.3 -5.1 3.3 
3801 -5.3 -1.6 1.7 
3803 -7.9 -7.2 -2.7 
3804 -9.7 -8.6 -4.1 
3805 4.6 2.6 4.4 
3806 0.0 -1.5 1.3 
3808 -0.7 -0.8 1.4 
3809 -0.3 -0.7 1.7 
3810 0.0 -1.1 0.8 
3811 1.2 0.1 2.1 
 
a Molecule identification number as assigned by the Automated Topology Builder (ATB) 2.0; b Experimental hydration 
free energy [1]; c Hydration free energy calculated using united atom parameters from the ATB 2.0 with refined chorine 
force field parameters, σ = 0.34 nm and ε = 1.83 kJ/mol. The error in the calculated values is ± 1.0 kJ/mol, calculated as 
per the protocol in section 3.4; d Hydration free energy calculated using united atom parameters from the ATB 2.0 with 
original chorine force field parameters, σ = 0.35 nm and ε = 1.26 kJ/mol. The error in the calculated values is ± 1.0 
kJ/mol, calculated as per the protocol in section 3.4. 
 
. 
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Table 4A- 2. A comparison between the experimental and calculated free energies of hydration before and after 
parameterisation for 10 aromatic organochlorides from the test set. All values are in kJ/mol. 
ATB MolIDa FE Exp.b FE Ref.Ali.c FE Ref. Arom.d FE Org.e 
1177 -5.7 -8.1 -6.5 -4.2 
1178 -4.2 -5.7 -4.3 -2.0 
3176 -4.7 -4.6 -3.2 -2.0 
3794 -5.6 -11.7 -7.1 -3.1 
3795 -6.8 -8.1 -4.2 -0.1 
3797 -5.6 -9.7 -4.7 -0.1 
3798 -4.7 -9.2 -5.4 -2.1 
3799 -3.3 -6.0 -2.3 1.5 
3802 -4.1 -5.9 -3.7 -1.4 
3813 -5.2 -10.8 -8.1 -4.7 
 
a Molecule identification number as assigned by the Automated Topology Builder (ATB) 2.0; b Experimental hydration 
free energy [1]; c Hydration free energy calculated using united atom parameters from the ATB 2.0 with refined 
aliphatic chorine force field parameters, σ = 0.34 nm and ε = 1.83 kJ/mol. The error in the calculated values is ± 1.0 
kJ/mol, calculated as per the protocol in section 3.4; d Hydration free energy calculated using united atom parameters 
from the ATB 2.0 with refined aromatic chorine force field parameters, σ = 0.32 nm and ε = 1.49 kJ/mol. The error in 
the calculated values is ± 1.0 kJ/mol, calculated as per the protocol in section 3.4; e Hydration free energy calculated 
using united atom parameters from the ATB 2.0 with original chorine force field parameters, σ = 0.35 nm and ε = 1.26 
kJ/mol. The error in the calculated values is ± 1.0 kJ/mol, calculated as per the protocol in section 3.4. 
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Table 4A- 3. A comparison between the experimental and calculated free energies of hydration before and after 
parameterisation for 15 aliphatic organobromides from the test set. All values are in kJ/mol. 
ATB MolIDa FE Exp.b FE Ref.c FE Org.d 
1180 -1.7 -2.5 -4.6 
2905 -10.0 -5.8 -7.6 
3177 -3.4 -1.0 -2.4 
3178 -8.8 -1.3 -3.9 
3179 -8.3 -6.3 -9.4 
3180 -2.9 -2.7 -4.7 
3181 -2.3 -3.4 -4.8 
3182 -2.0 -1.1 -2.8 
3186 -0.3 -2.1 -3.7 
3187 -3.6 -2.1 -3.3 
4054 0.8 -1.7 -2.7 
4055 1.4 -2.4 -4.2 
4056 2.2 -1.5 -2.8 
4057 3.5 0.7 -1.0 
4059 -0.1 -1.5 -2.7 
 
a Molecule identification number as assigned by the Automated Topology Builder (ATB) 2.0; b Experimental hydration 
free energy [1]; c Hydration free energy calculated using united atom parameters from the ATB 2.0 with refined 
bromine force field parameters, σ = 0.39 nm and ε = 2.43 kJ/mol. The error in the calculated values is ± 1.0 kJ/mol, 
calculated as per the protocol in section 3.4; d Hydration free energy calculated using united atom parameters from the 
ATB 2.0 with original bromine force field parameters, σ = 0.37 nm and ε = 2.92 kJ/mol. The error in the calculated 
values is ± 1.0 kJ/mol, calculated as per the protocol in section 3.4. 
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Table 4A- 4. A comparison between the experimental and calculated free energies of hydration before and after 
parameterisation for biologically relevant small molecules,  drug and drug-like molecules from SAMPL0, 1, 2 
and 4 challenges. All values are in kJ/mol.  
ATB 
MolIDa FE Org.
b FE Ref.c FE Exp.d Namee SAMPLf 
1020 -7.6±0.5 x -12.2±0.8 Dimethoxymethane SAMPL0 
1022 -10.0±0.6 x -13.7±0.8 1,1-diethoxyethane SAMPL0 
1023 -6.1±0.6 x -14.8±0.8 1,2-diethoxyethane SAMPL0 
1199 -31.8±0.7 x -25.1±0.8 Diethyl propanedioate SAMPL0 
1629 23.9±0.5 x 4.5±0.8 m-bis-trifluoromethylbenzene SAMPL0 
1630 -40.9±0.6 x -46.0±0.8 N,N-dimethyl-p-methoxy benzamide SAMPL0 
1631 -34.2±0.6 x -40.8±0.8 N,N,4-trimethylbenzamide SAMPL0 
1633 -23.2±0.7 x -20.8±0.8 1,1-diacetoxyethane SAMPL0 
1634 -4.3±0.6 -10.0±1.0 -17.7±0.8 Bis-2-chloroethyl ether SAMPL0 
1637 -22.1±0.6 x -16.0±0.8 Phenyl formate SAMPL0 
1638 -31.2±0.6 x -26.5±0.8 Ethylene glycol diacetate SAMPL0 
2905 -5.4±0.5 x -9.9±0.8 Benzyl bromide SAMPL0 
1742 -10.5±0.6 x -24.0±0.4 Nitroglycol SAMPL1 
1909 -8.1±0.6 x -20.7±0.4 1,2-dinitroxypropane SAMPL1 
1910 -4.6±0.5 x -8.7±0.4 Butyl nitrate SAMPL1 
1911 -2.5±0.5 x -7.6±0.4 2-butyl nitrate SAMPL1 
1912 -4.2±0.5 x -7.9±0.4 Isobutyl nitrate SAMPL1 
1913 -26.8±0.4 x -34.2±0.4 Ethyleneglycol mononitrate SAMPL1 
1914 -26.1±0.6 -27.6±1.0 -34.4±1.2 Alachlor SAMPL1 
1915 -22.6±0.7 x -32.0±1.4 Ametryn SAMPL1 
1917 -5.4±0.7 x -15±8 Benefin SAMPL1 
1918 -72.1±0.6 -73.0±1.0 -41±8 Bromacil SAMPL1 
1919 -27.5±0.7 -34.8±1.0 -38±8 Captan SAMPL1 
1920 -40.4±0.7 x -39.5±0.4 Carbaryl SAMPL1 
1921 -34.6±0.7 x -40.2±1.3 Carbofuran SAMPL1 
1922 -3.2±0.6 -19.9±1.0 -14.4±0.4 Chlordane SAMPL1 
1923 -26.2±0.7 -32.0±1.0 -30±6 Chlorfenvinphos SAMPL1 
1925 5.3±0.4 -1.7±1.0 -6.1±0.4 Chloropicrin SAMPL1 
1926 -23.1±0.6 -31.9±1.0 -21.1±0.9 Chlorpyrifos SAMPL1 
1927 -27.2±0.8 x -27.1±0.5 Diazinon SAMPL1 
1928 -41.2±0.6 -44.3±1.0 -41±8 Dicamba SAMPL1 
1929 -19.9±0.5 -24.9±1.0 -20±8 Dichlobenil SAMPL1 
1930 -27.6±0.8 x -24±8 Dinitramine SAMPL1 
1931 -17.6±0.6 -30.7±1.0 -17.7±1.1 Endosulfan alpha SAMPL1 
1932 5.9±0.5 -5.5±1.0 -20.2±0.4 Endrin SAMPL1 
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1933 -0.2±0.5 -14.0±1.0 -10.7±0.4 Heptachlor SAMPL1 
1934 -22.3±0.5 x -22±6 Isophorone SAMPL1 
1936 -41.8±0.6 x -45±8 Methomyl SAMPL1 
1939 -16.3±0.4 x -25.1±0.4 Nitroxyacetone SAMPL1 
1940 -65.8±0.8 x -43±8 Oxamyl SAMPL1 
1941 -31.7±0.7 x -28.2±0.4 Parathion SAMPL1 
1942 -15.1±0.7 x -15±8 Pebulate SAMPL1 
1943 -22.9±0.6 x -18.3±0.4 Phorate SAMPL1 
1944 6.9±0.7 x -10±6 Profluralin SAMPL1 
1945 -21.3±0.6 x -35.3±0.4 Prometryn SAMPL1 
1947 -67.5±0.5 -71.7±1.0 -69±8 Pyrazon SAMPL1 
1948 -41.9±0.4 -44.8±1.0 -42.8±0.4 Simazine SAMPL1 
1950 -55.3±0.5 -60.8±1.0 -47±8 Terbacil SAMPL1 
1951 -17.7±0.5 x -27.9±1.8 Terbutryn SAMPL1 
1952 -109.5±0.9 x -68±8 Thifensulfurone SAMPL1 
1953 -0.9±0.7 x -13.6±0.4 Trifluralin SAMPL1 
1954 -19.2±0.7 x -17±9 Vernolate SAMPL1 
1956 -65.0±0.5 x -37±6 1,4,5,8-tetramino-anthraquinone SAMPL1 
1959 -30.2±0.6 x -39±8 Pirimor (pirimacarb) SAMPL1 
1962 -34.6±0.7 x -26±8 Dinoseb SAMPL1 
1964 -42.4±0.7 x -38±8 Fenuron SAMPL1 
1967 -44.7±0.6 x -41.2±0.4 Aldicarb SAMPL1 
1980 -33.5±0.7 -34.9±1.0 -27±4 Carbophenothion SAMPL1 
1981 -51.6±0.9 -52.0±1.0 -24±8 Dialifor SAMPL1 
1983 -58.8±0.8 x -34.1±0.9 Malathion SAMPL1 
1984 -47.7±0.5 x -31±8 1-amino-4-anilino-anthraquinone SAMPL1 
1994 -24.8±0.6 -31.6±1.0 -53±8 Trichlorofon SAMPL1 
2029 -33.1±0.5 x -30.1±0.4 Methyparathion SAMPL1 
2925 -36.8±0.6 -42.6±1.0 -33±8 Propanil SAMPL1 
2928 -44.8±0.5 x -33.3±5.7 1-amino-anthraquinone SAMPL1 
2966 -40.8±0.6 x -47.0±1.8 4-amino-4’-nitroazobenzene SAMPL1 
2968 -47.6±0.7 x -42±6 Azinphosmethyl SAMPL1 
125 -84.1±0.4 -84.8±1.0 -76.0±2.3 5-bromouracil SAMPL2 
1019 -62.1±0.4 x -56.1±4.2 Glycerol SAMPL2 
1848 -76.9±0.4 x -69.4±1.2 Uracil SAMPL2 
1850 -79.2±0.3 -83.6±1.0 -74±3 5-chlorouracil SAMPL2 
1851 -75.4±0.4 x -71±4 5-fluorouracil SAMPL2 
1853 -64.4±0.4 x -64.7±0.7 5-trilfuoromethyluracil SAMPL2 
1854 -64.3±0.4 -68.8±1.0 -66±5 6-chlorouracil SAMPL2 
1855 -84.1±0.4 x -76.4±1.1 Cyanuric acid SAMPL2 
1856 -58.0±0.4 x -53±3 Caffeine SAMPL2 
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1859 -55.6±0.5 x -39.2±0.9 Propyl paraben SAMPL2 
1860 -60.3±0.6 x -36.5±1.1 Butyl paraben SAMPL2 
1861 -54.6±0.6 x -41.6±0.8 Acetylsalicylic acid SAMPL2 
1862 -42.4±0.6 x -39.3±0.8 Diflunisal SAMPL2 
1864 -46.9±0.4 x -40.2±2.1 Phthalimide SAMPL2 
1866 -34.4±0.3 x -36.0±1.3 Sulfolane SAMPL2 
1867 2.2±0.4 -5.7±1.0 -10±5 Hexachlorobenzene SAMPL2 
1868 4.6±0.3 -6.3±1.0 -5.9±0.4 Hexachloroethane SAMPL2 
1873 -37.1±0.5 x -35.2±0.7 Flurbiprofen SAMPL2 
1874 -33.0±0.6 x -29.3±2.7 Ibuprofen SAMPL2 
1875 -59.4±0.6 x -45.1±0.8 Ketoprofen SAMPL2 
1876 -28.2±0.4 x -36.4±0.4 Trimethyl phosphate SAMPL2 
1877 -2.0±0.4 -8.9±1.0 -21.8±1.0 Pentachloronitrobenzene SAMPL2 
1976 13.0±0.6 x -3.3±0.8 Trimethyl orthotrifluoroacetate SAMPL2 
2027 -40.3±0.5 x -41.9±0.5 4-nitroaniline SAMPL2 
2242 -52.9±0.6 x -38.5±1.3 Ethyl paraben SAMPL2 
7956 -23.1±0.6 x -22.2±0.4 2-ethoxyethyl acetate SAMPL4 
7957 -15.9±0.5 x -20.1±1.6 1,3-bis-(nitrooxy)propane SAMPL4 
7958 -13.7±0.5 x -18.0±1.6 1,3-bis-(nitrooxy)butane SAMPL4 
7959 -5.0±0.6 x -7.0±0.4 hexyl nitrate SAMPL4 
7960 -19.5±0.5 x -9.6±0.5 hexyl acetate SAMPL4 
7962 -32.6±0.4 -36.5±1.0 -30.5±0.4 3,4-dichlorophenol SAMPL4 
7963 -30.3±0.6 x -29.1±0.4 2,6-dimethoxyphenol SAMPL4 
7964 -36.6±0.6 x -24.3±0.4 4-methyl-2-methoxyphenol SAMPL4 
7965 -23.9±0.7 x -19.6±0.4 2-hydroxybenzaldehyde SAMPL4 
7966 -24.1±0.5 x -23.7±0.4 2-ethylphenol SAMPL4 
7967 -41.6±0.7 x -24.9±0.4 2-methoxyphenol SAMPL4 
7968 -19.4±0.5 x -16.5±0.4 2-methylbenzaldehyde SAMPL4 
7969 1.4±0.5 x -3.6±0.4 1-ethyl-2-methylbenzene SAMPL4 
7971 -5.4±0.5 x -21.1±0.4 piperidine SAMPL4 
7972 -4.1±0.5 x -13.1±0.4 tetrahydropyran SAMPL4 
7973 7.6±0.4 x 0.6±0.4 cyclohexene SAMPL4 
7974 -7.6±0.5 x -21.3±0.4 1,4-dioxane SAMPL4 
7976 -43.7±0.6 x -40±3 1-amino-9,10-anthraquinone SAMPL4 
7979 -11.4±0.5 x -13.2±0.4 dibenzo-p-dioxin SAMPL4 
7980 -9.1±0.4 x -17.3±0.4 anthracene SAMPL4 
7982 -8.0±0.5 x -12.0±2.9 diphenyl ether SAMPL4 
8017 -86.0±1.4 x -98.9±1.3 mannitol SAMPL4 
8018 -9.5±0.6 x -10±4 linalyl acetate SAMPL4 
8019 -20.8±0.6 x -20.0±1.0 nerol SAMPL4 
8020 -16.6±0.5 x -18.6±1.0 geraniol SAMPL4 
L 
 
8021 -12.0±0.6 x -22.3±0.4 1,2-dimethoxybenzene SAMPL4 
8022 -43.4±0.7 x -22.0±0.8 4-propylguaiacol SAMPL4 
8025 -43.9±0.5 -47.4±1.0 -34±3 2,6-dichlorosyringaldehyde SAMPL4 
8026 -30.8±0.5 -26.0±1.0 -26.1±1.6 3,5-dichlorosyringol SAMPL4 
8027 -40.3±0.6 -42.8±1.0 -33±3 2-chlorosyringaldehyde SAMPL4 
8028 -17.0±0.6 x -15.7±0.9 dihydrocarvone SAMPL4 
8029 -13.5±0.5 x -18.6±1.8 carveol SAMPL4 
8030 -19.6±0.6 x -17.1±0.7 l-perillaldehyde SAMPL4 
8031 -18.8±0.5 x -18.9±0.4 piperitone SAMPL4 
8032 -16.7±0.7 x -13.4±1.1 menthol SAMPL4 
8033 -12.1±0.6 x -10.6±1.0 menthone SAMPL4 
8035 -3.8±0.5 x -15.8±0.4 9,10-dihydroanthracene SAMPL4 
8036 -3.8±0.4 x -11.6±0.4 1,1-diphenylethene SAMPL4 
8037 -27.6±0.5 x -31.9±0.5 1-benzylimidazole SAMPL4 
8038 -36.9±0.7 x -28.4±0.4 mefenamic acid SAMPL4 
8039 -12.0±0.8 x -39.1±2.6 diphenhydramine SAMPL4 
8040 -2.9±0.6 x -31.1±2.5 amitriptyline SAMPL4 
8082 -18.3±0.5 x -24.0±0.6 1-butoxy-2-propanol SAMPL4 
8083 -62.0±0.6 x -48.3±1.2 2-amino-9,10-anthraquinone SAMPL4 
8551 -52.9±0.7 x -39.9±1.2 1-amino-4-hydroxy-9,10-anthraquinone SAMPL4 
8553 -61.0±0.6 x -49.6±1.5 1,4-diamino-9,10-anthraquinone SAMPL4 
8750 -51.6±1 x -59±5 1-(2-hydroxyethylamino)-9,10-anthraquinone SAMPL4 
 
a Molecule identification number as assigned by the Automated Topology Builder (ATB) 2.0; b Hydration free energy 
calculated using united atom parameters from the ATB 2.0 with original halogen force field parameters, for chlorine σ = 
0.35 nm and ε = 1.26 kJ/mol and for bromine σ = 0.37 nm and ε = 2.92 kJ/mol. The error in the calculated values is 
calculated as per the protocol in section 2.4; c Hydration free energy calculated using united atom parameters from the 
ATB 2.0 with refined halogen force field parameters, for aliphatic chlorine = σ = 0.34 nm and ε = 1.83 kJ/mol, for 
aromatic chlorine σ = 0.32 nm and ε = 1.49 kJ/mol and for bromine σ = 0.39 nm and ε = 2.43 kJ/mol. The error in the 
calculated values is ± 1.0 kJ/mol, calculated as per the protocol in section 3.4;  d Experimental hydration free energy [1-
5]; e Name of the molecule; f SAMPL challenge number. 
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